CDC-Data-2025/Vaccination_Coverage_among_Adolescents_13-17_Years.csv

1	Vaccine/Sample	Dose	Geography Type	Geography	Survey Year	Dimension Type	Dimension	Estimate (%)	95% CI (%)	Sample Size
2	HPV	≥1 Dose, Males	States/Local Areas	New York	2023	Age	13-17 Years	81.5	75.2 to 86.5	289
3	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2023	Age	13-17 Years	90.2	86.8 to 92.8	559
4	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New York	2023	Age	13-17 Years	93.6	90.9 to 95.5	559
5	≥1 Dose MenACWY		States/Local Areas	New York	2023	Age	13-17 Years	95.3	92.7 to 97.0	559
6	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2023	Age	13-17 Years	79.4	74.8 to 83.3	559
7	HPV	Up-to-Date, Males	States/Local Areas	New York	2023	Age	13-17 Years	67.8	60.8 to 74.2	289
8	HPV	≥1 Dose, Females	States/Local Areas	New York	2023	Age	13-17 Years	77.2	70.1 to 83.0	270
9	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2023	Age	13-17 Years	68.6	63.5 to 73.2	559
10	≥3 Doses HepB		States/Local Areas	New York	2023	Age	13-17 Years	94.2	91.1 to 96.3	559
11	≥2 Doses MMR		States/Local Areas	New York	2023	Age	13-17 Years	94.6	91.8 to 96.5	559
12	Varicella	≥2 Doses or history of disease	States/Local Areas	New York	2023	Age	13-17 Years	95.5	92.9 to 97.2	559
13	Varicella	≥2 Doses with no disease history	States/Local Areas	New York	2023	Age	13-17 Years	95.0	92.1 to 96.8	512
14	Varicella	≥1 Dose with no disease history	States/Local Areas	New York	2023	Age	13-17 Years	97.7	95.4 to 98.9	512
15	Varicella	History of disease	States/Local Areas	New York	2023	Age	13-17 Years	9.8	7.0 to 13.6	559
16	≥2 Doses Hep A		States/Local Areas	New York	2023	Age	13-17 Years	89.0	85.5 to 91.8	559
17	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2023	Age	13-15 Years	90.2	85.9 to 93.3	350
18	≥1 Dose MenACWY		States/Local Areas	New York	2023	Age	13-15 Years	96.6	94.1 to 98.1	350
19	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2023	Age	13-15 Years	61.7	55.2 to 67.8	350
20	HPV	Up-to-Date, Females	States/Local Areas	New York	2023	Age	13-15 Years	63.0	53.5 to 71.6	168
21	Varicella	≥2 Doses with no disease history	States/Local Areas	New York	2023	Age	13-15 Years	93.9	89.7 to 96.4	320
22	HPV	Up-to-Date, Females	States/Local Areas	New York	2023	Age	13-17 Years	69.3	62.0 to 75.8	270
23	HPV	Up-to-Date, Males	States/Local Areas	New York	2023	Age	13-15 Years	60.5	51.4 to 68.9	182
24	HPV	≥2 Doses, Females	States/Local Areas	New York	2022	Age	13-17 Years	69.0	62.0 to 75.3	263
25	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Insurance Coverage	Uninsured	88.3	68.1 to 96.4	36
26	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Insurance Coverage	Other	91.0	87.0 to 93.8	365
27	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Insurance Coverage	Any Medicaid	89.2	86.4 to 91.4	897
28	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Insurance Coverage	Private Insurance Only	92.6	90.8 to 94.0	1581
29	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Uninsured	40.1	23.3 to 59.6	36
30	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Other	58.8	52.1 to 65.2	365
31	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Any Medicaid	69.9	65.9 to 73.7	897
32	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Uninsured	47.9	28.7 to 67.8	36
33	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Insurance Coverage	Uninsured	82.9	53.5 to 95.4	36
34	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Private Insurance Only	61.1	57.9 to 64.2	1581
35	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Other	72.1	65.5 to 77.8	365
36	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Insurance Coverage	Other	95.7	93.0 to 97.4	365
37	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Any Medicaid	79.7	76.0 to 82.9	897
38	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Insurance Coverage	Private Insurance Only	73.3	70.3 to 76.2	1581
39	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Insurance Coverage	Any Medicaid	93.9	91.7 to 95.6	897
40	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Insurance Coverage	Private Insurance Only	95.4	94.0 to 96.5	1581
41	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Poverty	Below Poverty Level	88.8	85.3 to 91.6	533
42	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Poverty	Living At or Above Poverty Level	91.9	90.4 to 93.2	2180
43	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Poverty	Living At or Above Poverty Level	63.0	60.3 to 65.6	2180
44	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Poverty	Below Poverty Level	67.8	62.4 to 72.7	533
45	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Poverty	Living At or Above Poverty Level	95.4	94.1 to 96.3	2180
46	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Poverty	Below Poverty Level	94.3	92.0 to 96.0	533
47	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Poverty	Living At or Above Poverty Level	73.7	71.1 to 76.1	2180
48	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Poverty	Below Poverty Level	81.3	76.5 to 85.2	533
49	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	White, Non-Hispanic	70.7	67.4 to 73.8	1333
50	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Black, Non-Hispanic	70.4	63.7 to 76.4	322
51	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	89.6	85.0 to 92.9	435
52	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Race and Ethnicity	Hispanic	89.7	86.8 to 92.0	789
53	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Race and Ethnicity	Black, Non-Hispanic	89.7	85.4 to 92.8	322
54	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Race and Ethnicity	Hispanic	95.2	93.5 to 96.5	789
55	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Race and Ethnicity	White, Non-Hispanic	92.8	91.0 to 94.3	1333
56	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Race and Ethnicity	White, Non-Hispanic	94.8	93.1 to 96.2	1333
57	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Race and Ethnicity	Black, Non-Hispanic	94.3	90.9 to 96.5	322
58	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	68.8	62.6 to 74.3	435
59	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Hispanic	70.1	65.7 to 74.2	789
60	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Black, Non-Hispanic	61.8	55.0 to 68.2	322
61	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	82.7	77.2 to 87.0	435
62	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	94.4	90.3 to 96.8	435
63	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Principal City	89.9	88.0 to 91.5	1728
64	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Non-Principal City	92.7	90.4 to 94.4	1005
65	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	Hispanic	82.3	78.5 to 85.5	789
66	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Race and Ethnicity	White, Non-Hispanic	59.3	55.9 to 62.7	1333
67	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Principal City	94.7	93.2 to 95.8	1728
68	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Urbanicity	Living In a Non-MSA	87.1	77.7 to 92.9	146
69	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Non-Principal City	96.0	94.2 to 97.2	1005
70	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Principal City	68.8	65.8 to 71.5	1728
71	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a Non-MSA	51.8	41.2 to 62.3	146
72	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Non-Principal City	58.3	54.4 to 62.1	1005
73	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Principal City	78.7	76.0 to 81.2	1728
74	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a Non-MSA	63.0	51.5 to 73.2	146
75	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Urbanicity	Living In a MSA Non-Principal City	71.7	68.0 to 75.2	1005
76	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Urbanicity	Living In a Non-MSA	92.4	85.9 to 96.1	146
77	HPV	Up-to-Date, Males and Females	States/Local Areas	New York	2018-2022	Overall	Overall	63.5	61.2 to 65.8	2879
78	HPV	≥1 Dose, Males and Females	States/Local Areas	New York	2018-2022	Overall	Overall	75.0	72.8 to 77.1	2879
79	≥1 Dose MenACWY		States/Local Areas	New York	2022	Age	13-17 Years	96.5	94.2 to 97.9	536
80	≥1 Dose MenACWY		States/Local Areas	New York	2020	Age	13-17 Years	93.7	90.8 to 95.7	729
81	≥1 Dose MenACWY		States/Local Areas	New York	2018	Age	13-17 Years	94.9	92.0 to 96.8	535
82	≥1 Dose MenACWY		States/Local Areas	New York	2019	Age	13-17 Years	95.0	92.3 to 96.8	498
83	HPV	≥3 Doses, Females	States/Local Areas	New York	2011	Age	13-15 Years	28.8	22.7 to 35.7	248
84	≥1 Dose MenACWY		States/Local Areas	New York	2021	Age	13-17 Years	93.8	90.8 to 95.9	581
85	≥2 Doses MMR		States/Local Areas	New York	2022	Age	13-17 Years	95.3	92.5 to 97.1	536
86	≥2 Doses MMR		States/Local Areas	New York	2021	Age	13-17 Years	94.2	90.9 to 96.3	581
87	HPV	≥3 Doses, Females	States/Local Areas	New York	2009	Age	13-15 Years	28.2	20.5 to 37.5	167
88	HPV	≥3 Doses, Females	States/Local Areas	New York	2010	Age	13-15 Years	30.0	22.9 to 38.1	200
89	HPV	≥3 Doses, Females	States/Local Areas	New York	2008	Age	13-15 Years	28.7	20.9 to 38.0	174
90	HPV	≥3 Doses, Females	States/Local Areas	New York	2013	Age	13-15 Years	38.0	29.9 to 46.8	205
91	HPV	≥3 Doses, Females	States/Local Areas	New York	2012	Age	13-15 Years	35.3	26.8 to 44.9	191
92	HPV	≥3 Doses, Females	States/Local Areas	New York	2014	Age	13-15 Years	29.7	21.8 to 39.1	171
93	HPV	≥3 Doses, Females	States/Local Areas	New York	2015	Age	13-15 Years	41.5	33.1 to 50.5	169
94	≥2 Doses MMR		States/Local Areas	New York	2017	Age	13-17 Years	94.1	91.7 to 95.9	651
95	≥2 Doses MMR		States/Local Areas	New York	2018	Age	13-17 Years	95.2	92.4 to 97.0	535
96	≥2 Doses MMR		States/Local Areas	New York	2019	Age	13-17 Years	92.4	88.6 to 95.1	498
97	HPV	≥3 Doses, Males and Females	States/Local Areas	New York	2014	Age	13-17 Years	34.2	29.5 to 39.1	594
98	HPV	≥3 Doses, Males and Females	States/Local Areas	New York	2015	Age	13-17 Years	42.6	38.2 to 47.0	665
99	≥2 Doses MMR		States/Local Areas	New York	2020	Age	13-17 Years	94.4	91.8 to 96.2	729
100	HPV	≥3 Doses, Males and Females	States/Local Areas	New York	2013	Age	13-17 Years	32.0	27.8 to 36.4	710
101	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2022	Age	13-17 Years	90.4	86.9 to 93.0	536
102	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2021	Age	13-17 Years	87.3	83.4 to 90.4	581
103	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2020	Age	13-17 Years	93.0	90.2 to 95.1	729
104	≥1 Dose MenACWY		States/Local Areas	New York	2017	Age	13-17 Years	89.3	85.9 to 91.9	651
105	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2019	Age	13-17 Years	93.4	90.5 to 95.4	498
106	≥2 Doses MMR		States/Local Areas	New York	2016	Age	13-17 Years	92.9	90.2 to 94.9	655
107	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2016	Age	13-17 Years	91.1	88.2 to 93.4	655
108	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018	Age	13-17 Years	91.7	88.7 to 94.0	535
109	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2017	Age	13-17 Years	92.9	90.3 to 94.8	651
110	≥2 Doses MMR		States/Local Areas	New York	2013	Age	13-17 Years	93.3	90.3 to 95.4	710
111	≥2 Doses MMR		States/Local Areas	New York	2012	Age	13-17 Years	93.8	90.6 to 96.0	627
112	≥2 Doses MMR		States/Local Areas	New York	2015	Age	13-17 Years	94.6	92.6 to 96.1	665
113	≥2 Doses MMR		States/Local Areas	New York	2014	Age	13-17 Years	91.6	88.2 to 94.1	594
114	≥1 Dose MenACWY		States/Local Areas	New York	2013	Age	13-17 Years	83.3	79.7 to 86.4	710
115	≥1 Dose MenACWY		States/Local Areas	New York	2014	Age	13-17 Years	79.6	75.1 to 83.5	594
116	≥1 Dose MenACWY		States/Local Areas	New York	2015	Age	13-17 Years	86.2	82.9 to 89.0	665
117	≥1 Dose MenACWY		States/Local Areas	New York	2016	Age	13-17 Years	89.2	86.0 to 91.8	655
118	HPV	≥3 Doses, Males and Females	States/Local Areas	New York	2011	Age	13-17 Years	17.4	14.6 to 20.5	840
119	HPV	≥3 Doses, Males and Females	States/Local Areas	New York	2012	Age	13-17 Years	22.2	18.1 to 26.9	627
120	≥1 Dose MenACWY		States/Local Areas	New York	2022	Age	13-15 Years	96.0	93.3 to 97.7	320
121	≥1 Dose MenACWY		States/Local Areas	New York	2012	Age	13-17 Years	78.5	74.1 to 82.3	627
122	≥1 Dose MenACWY		States/Local Areas	New York	2010	Age	13-17 Years	71.2	66.5 to 75.4	701
123	≥1 Dose MenACWY		States/Local Areas	New York	2011	Age	13-17 Years	74.9	70.9 to 78.5	840
124	≥1 Dose MenACWY		States/Local Areas	New York	2008	Age	13-17 Years	56.0	51.1 to 60.8	600
125	≥1 Dose MenACWY		States/Local Areas	New York	2009	Age	13-17 Years	62.9	57.7 to 67.8	539
126	≥1 Dose MenACWY		States/Local Areas	New York	2018-2022	Overall	Overall	94.8	93.7 to 95.7	2879
127	Tetanus	≥1 Dose Tdap	States/Local Areas	New York	2018-2022	Overall	Overall	91.2	89.8 to 92.4	2879
128	Varicella	History of disease	States/Local Areas	NY-City of New York	2018	Age	13-17 Years	12.5	8.3 to 18.4	261
129	Varicella	History of disease	States/Local Areas	NY-City of New York	2016	Age	13-17 Years	13.4	9.6 to 18.4	291
130	Varicella	History of disease	States/Local Areas	NY-City of New York	2015	Age	13-17 Years	13.7	10.0 to 18.6	313
131	Varicella	History of disease	States/Local Areas	NY-City of New York	2009	Age	13-17 Years	51.1	43.5 to 58.7	269
132	Varicella	History of disease	States/Local Areas	NY-City of New York	2017	Age	13-17 Years	10.0	6.8 to 14.4	281
133	Varicella	History of disease	States/Local Areas	NY-City of New York	2008	Age	13-17 Years	50.1	42.9 to 57.2	293
134	Varicella	History of disease	States/Local Areas	NY-City of New York	2019	Age	13-17 Years	10.3	6.8 to 15.2	257
135	Varicella	History of disease	States/Local Areas	NY-City of New York	2020	Age	13-17 Years	6.7	4.2 to 10.5	381
136	Varicella	History of disease	States/Local Areas	NY-City of New York	2021	Age	13-17 Years	7.8	4.6 to 13.0	297
137	Varicella	History of disease	States/Local Areas	NY-City of New York	2012	Age	13-17 Years	23.5	18.6 to 29.2	312
138	Varicella	History of disease	States/Local Areas	NY-City of New York	2013	Age	13-17 Years	20.5	15.6 to 26.4	300
139	Varicella	History of disease	States/Local Areas	NY-City of New York	2011	Age	13-17 Years	27.2	22.7 to 32.1	435
140	Varicella	History of disease	States/Local Areas	NY-City of New York	2010	Age	13-17 Years	31.8	26.6 to 37.6	388
141	HPV	Up-to-Date, Females	States/Local Areas	NY-City of New York	2019	Age	13-15 Years	60.9	47.6 to 72.7	84
142	HPV	Up-to-Date, Females	States/Local Areas	NY-City of New York	2020	Age	13-15 Years	72.1	60.0 to 81.6	108
143	Varicella	History of disease	States/Local Areas	NY-City of New York	2014	Age	13-17 Years	22.5	16.9 to 29.3	288
144	HPV	Up-to-Date, Females	States/Local Areas	NY-City of New York	2018	Age	13-15 Years	48.7	34.7 to 62.8	71
145	Varicella	History of disease	States/Local Areas	New Jersey	2009	Age	13-17 Years	46.3	40.6 to 52.0	427
146	Varicella	History of disease	States/Local Areas	New Jersey	2008	Age	13-17 Years	53.1	46.9 to 59.3	390
147	Varicella	History of disease	States/Local Areas	New Jersey	2010	Age	13-17 Years	44.7	38.2 to 51.4	399
148	Varicella	History of disease	States/Local Areas	New Jersey	2011	Age	13-17 Years	32.8	27.6 to 38.4	432
149	Varicella	History of disease	States/Local Areas	New Jersey	2013	Age	13-17 Years	20.5	15.4 to 26.7	322
150	Varicella	History of disease	States/Local Areas	New Jersey	2012	Age	13-17 Years	25.1	19.6 to 31.4	330
151	Varicella	History of disease	States/Local Areas	New Jersey	2014	Age	13-17 Years	16.8	12.2 to 22.8	328
152	Varicella	History of disease	States/Local Areas	New Jersey	2015	Age	13-17 Years	15.7	11.6 to 20.9	364
153	Varicella	History of disease	States/Local Areas	New Jersey	2016	Age	13-17 Years	10.3	7.4 to 14.2	422
154	Varicella	History of disease	States/Local Areas	New Jersey	2018	Age	13-17 Years	13.8	9.7 to 19.3	351
155	HPV	Up-to-Date, Females	States/Local Areas	New Jersey	2020	Age	13-15 Years	47.4	34.9 to 60.3	109
156	HPV	Up-to-Date, Females	States/Local Areas	New Jersey	2019	Age	13-15 Years	42.3	30.2 to 55.5	99
157	HPV	Up-to-Date, Females	States/Local Areas	New Jersey	2018	Age	13-15 Years	43.2	32.0 to 55.2	105
158	Varicella	History of disease	States/Local Areas	New Jersey	2019	Age	13-17 Years	6.9	4.1 to 11.3	331
159	Varicella	History of disease	States/Local Areas	New Jersey	2017	Age	13-17 Years	11.8	8.2 to 16.6	366
160	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Poverty	Living At or Above Poverty Level	32.0	28.5 to 35.7	1025
161	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Poverty	Below Poverty Level	38.0	31.6 to 44.9	297
162	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Poverty	Living At or Above Poverty Level	60.2	56.3 to 63.9	1025
163	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Poverty	Below Poverty Level	64.1	57.4 to 70.4	297
164	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Poverty	Living At or Above Poverty Level	52.5	48.7 to 56.3	1025
165	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Poverty	Below Poverty Level	64.3	57.7 to 70.3	297
166	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	White, Non-Hispanic	44.1	40.0 to 48.4	822
167	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Black, Non-Hispanic	64.1	58.4 to 69.5	376
168	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	91.1	81.8 to 95.9	98
169	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Hispanic	95.9	90.1 to 98.4	76
170	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Black, Non-Hispanic	90.1	85.7 to 93.3	376
171	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Hispanic	73.5	59.1 to 84.1	76
172	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	White, Non-Hispanic	88.9	86.0 to 91.2	822
173	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	White, Non-Hispanic	53.8	49.6 to 58.0	822
174	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Black, Non-Hispanic	65.1	59.3 to 70.5	376
175	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	38.4	27.3 to 50.9	98
176	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Hispanic	47.3	32.4 to 62.7	76
177	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Black, Non-Hispanic	37.3	31.9 to 43.1	376
178	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	61.7	49.4 to 72.7	98
179	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	72.9	61.4 to 82.0	98
180	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Principal City	88.5	81.5 to 93.1	214
181	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	Hispanic	70.5	56.1 to 81.8	76
182	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Race and Ethnicity	White, Non-Hispanic	27.7	24.1 to 31.7	822
183	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Non-Principal City	91.5	87.8 to 94.2	496
184	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Non-Principal City	59.9	54.4 to 65.2	496
185	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Principal City	69.5	61.6 to 76.4	214
186	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a Non-MSA	57.8	53.0 to 62.4	662
187	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Principal City	42.5	34.6 to 50.8	214
188	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Non-Principal City	34.7	29.7 to 40.1	496
189	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a Non-MSA	28.5	24.3 to 33.2	662
190	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Principal City	62.9	54.7 to 70.4	214
191	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a MSA Non-Principal City	54.7	49.2 to 60.1	496
192	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a Non-MSA	51.7	46.9 to 56.4	662
193	HPV	Up-to-Date, Males and Females	States/Local Areas	Mississippi	2018-2022	Overall	Overall	33.3	30.2 to 36.5	1372
194	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Urbanicity	Living In a Non-MSA	89.1	85.7 to 91.8	662
195	HPV	≥1 Dose, Males and Females	States/Local Areas	Mississippi	2018-2022	Overall	Overall	54.8	51.5 to 58.0	1372
196	Tetanus	≥1 Dose Tdap	States/Local Areas	Mississippi	2018-2022	Overall	Overall	89.9	87.6 to 91.7	1372
197	≥1 Dose MenACWY		States/Local Areas	Mississippi	2018-2022	Overall	Overall	60.6	57.4 to 63.8	1372
198	Varicella	History of disease	States/Local Areas	Kentucky	2012	Age	13-17 Years	33.9	27.4 to 41.0	333
199	Varicella	History of disease	States/Local Areas	Kentucky	2013	Age	13-17 Years	28.2	22.4 to 34.9	291
200	Varicella	History of disease	States/Local Areas	Kentucky	2010	Age	13-17 Years	48.0	41.8 to 54.3	309
201	Varicella	History of disease	States/Local Areas	Kentucky	2011	Age	13-17 Years	45.9	39.3 to 52.6	382
202	Varicella	History of disease	States/Local Areas	Kentucky	2015	Age	13-17 Years	19.1	14.5 to 24.7	330
203	Varicella	History of disease	States/Local Areas	Kentucky	2014	Age	13-17 Years	20.6	15.6 to 26.7	335
204	Varicella	History of disease	States/Local Areas	Maine	2008	Age	13-17 Years	69.4	63.5 to 74.7	333
205	Varicella	History of disease	States/Local Areas	Maine	2009	Age	13-17 Years	61.8	55.1 to 68.0	299
206	Varicella	History of disease	States/Local Areas	Maine	2014	Age	13-17 Years	20.1	15.6 to 25.5	341
207	Varicella	History of disease	States/Local Areas	Maine	2018	Age	13-17 Years	6.6	4.3 to 10.0	317
208	Varicella	History of disease	States/Local Areas	Maine	2015	Age	13-17 Years	18.8	14.6 to 24.0	374
209	Varicella	History of disease	States/Local Areas	Maine	2010	Age	13-17 Years	50.4	44.1 to 56.8	312
210	Varicella	History of disease	States/Local Areas	Maine	2011	Age	13-17 Years	38.0	32.4 to 43.9	411
211	Varicella	History of disease	States/Local Areas	Maine	2013	Age	13-17 Years	30.8	25.4 to 36.8	343
212	Varicella	History of disease	States/Local Areas	Maine	2012	Age	13-17 Years	34.8	28.6 to 41.5	319
213	Varicella	History of disease	States/Local Areas	Maine	2016	Age	13-17 Years	15.4	11.4 to 20.6	347
214	Varicella	History of disease	States/Local Areas	Maine	2019	Age	13-17 Years	10.1	6.5 to 15.3	316
215	Varicella	History of disease	States/Local Areas	Maine	2020	Age	13-17 Years	9.8	6.8 to 14.1	372
216	Varicella	History of disease	States/Local Areas	Maine	2021	Age	13-17 Years	7.4	4.5 to 11.9	293
217	Varicella	History of disease	States/Local Areas	Maine	2022	Age	13-17 Years	6.8	3.9 to 11.6	268
218	Varicella	History of disease	States/Local Areas	Maine	2017	Age	13-17 Years	13.5	10.1 to 17.9	347
219	HPV	Up-to-Date, Females	States/Local Areas	Maine	2019	Age	13-15 Years	42.1	30.3 to 55.0	95
220	HPV	Up-to-Date, Females	States/Local Areas	Maine	2020	Age	13-15 Years	60.0	48.9 to 70.2	108
221	HPV	Up-to-Date, Females	States/Local Areas	Maine	2018	Age	13-15 Years	44.8	33.2 to 57.0	100
222	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2023	Age	13-17 Years	92.3	87.4 to 95.3	273
223	HPV	Up-to-Date, Males	States/Local Areas	New Hampshire	2023	Age	13-15 Years	54.5	42.6 to 65.9	92
224	HPV	Up-to-Date, Females	States/Local Areas	New Hampshire	2023	Age	13-17 Years	75.1	64.4 to 83.5	118
225	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2023	Age	13-15 Years	96.8	93.0 to 98.6	149
226	HPV	Up-to-Date, Females	States/Local Areas	New Hampshire	2023	Age	13-15 Years	68.9	53.7 to 80.9	66
227	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2023	Age	13-15 Years	61.3	51.9 to 70.0	158
228	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2023	Age	13-15 Years	90.2	83.0 to 94.6	158
229	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2023	Age	13-15 Years	90.3	83.3 to 94.5	158
230	≥2 Doses Hep A		States/Local Areas	New Hampshire	2023	Age	13-17 Years	89.3	83.7 to 93.1	273
231	Varicella	History of disease	States/Local Areas	New Hampshire	2023	Age	13-17 Years	4.9	2.8 to 8.5	273
232	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2023	Age	13-17 Years	97.1	94.2 to 98.5	259
233	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2023	Age	13-17 Years	96.1	93.2 to 97.8	259
234	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2023	Age	13-17 Years	96.3	93.5 to 98.0	273
235	≥2 Doses MMR		States/Local Areas	New Hampshire	2023	Age	13-17 Years	96.2	92.7 to 98.0	273
236	≥3 Doses HepB		States/Local Areas	New Hampshire	2023	Age	13-17 Years	94.8	90.7 to 97.1	273
237	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2023	Age	13-17 Years	70.6	63.8 to 76.5	273
238	HPV	Up-to-Date, Males	States/Local Areas	New Hampshire	2023	Age	13-17 Years	66.2	57.3 to 74.2	155
239	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2023	Age	13-17 Years	87.6	78.5 to 93.2	118
240	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2023	Age	13-17 Years	85.6	80.2 to 89.7	273
241	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2023	Age	13-17 Years	93.4	89.1 to 96.1	273
242	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2023	Age	13-17 Years	91.8	87.0 to 95.0	273
243	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2023	Age	13-17 Years	83.7	76.4 to 89.1	155
244	HPV	≥2 Doses, Males and Females	States/Local Areas	New Hampshire	2022	Age	13-17 Years	76.7	69.9 to 82.4	225
245	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2022	Age	13-17 Years	75.9	66.1 to 83.6	116
246	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2022	Age	13-17 Years	77.7	67.5 to 85.4	109
247	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Overall	Overall	81.1	78.5 to 83.4	1524
248	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a Non-MSA	94.5	91.7 to 96.3	608
249	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Overall	Overall	69.6	66.7 to 72.3	1524
250	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a Non-MSA	77.5	72.9 to 81.6	608
251	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Non-Principal City	83.3	79.7 to 86.3	716
252	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Principal City	81.7	74.4 to 87.2	200
253	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a Non-MSA	65.6	60.5 to 70.3	608
254	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Non-Principal City	72.6	68.6 to 76.2	716
255	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Principal City	68.6	60.5 to 75.8	200
256	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a Non-MSA	81.5	77.3 to 85.2	608
257	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Non-Principal City	92.8	90.2 to 94.7	716
258	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Principal City	89.1	82.5 to 93.5	200
259	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Hispanic	84.6	73.6 to 91.6	87
260	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Non-Principal City	94.4	92.0 to 96.2	716
261	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Urbanicity	Living In a MSA Principal City	96.6	92.9 to 98.4	200
262	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	91.4	84.6 to 95.4	133
263	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	White, Non-Hispanic	68.4	65.2 to 71.5	1287
264	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	85.5	76.5 to 91.4	133
265	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	77.9	68.3 to 85.2	133
266	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Hispanic	69.9	57.0 to 80.3	87
267	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	White, Non-Hispanic	88.3	86.0 to 90.3	1287
268	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	White, Non-Hispanic	95.0	93.3 to 96.2	1287
269	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Hispanic	84.9	73.6 to 91.9	87
270	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Hispanic	93.9	87.6 to 97.2	87
271	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	95.1	88.2 to 98.0	133
272	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Race and Ethnicity	White, Non-Hispanic	80.3	77.5 to 82.9	1287
273	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Poverty	Below Poverty Level	78.2	67.4 to 86.1	105
274	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Poverty	Living At or Above Poverty Level	81.3	78.6 to 83.7	1375
275	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Poverty	Below Poverty Level	82.5	72.5 to 89.5	105
276	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Poverty	Living At or Above Poverty Level	89.0	86.9 to 90.9	1375
277	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Poverty	Below Poverty Level	66.5	55.1 to 76.2	105
278	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Poverty	Living At or Above Poverty Level	69.9	66.9 to 72.8	1375
279	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Poverty	Living At or Above Poverty Level	94.5	92.8 to 95.8	1375
280	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Poverty	Below Poverty Level	95.1	86.4 to 98.3	105
281	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Private Insurance Only	90.7	88.6 to 92.5	1058
282	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Any Medicaid	83.9	78.6 to 88.0	361
283	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Private Insurance Only	83.9	81.1 to 86.4	1058
284	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Any Medicaid	76.7	70.9 to 81.6	361
285	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Other	88.3	75.3 to 94.9	72
286	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Other	73.6	59.2 to 84.3	72
287	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Private Insurance Only	72.5	69.2 to 75.6	1058
288	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Uninsured	74.5	49.0 to 89.9	33
289	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Uninsured	68.9	45.1 to 85.6	33
290	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Any Medicaid	66.0	59.8 to 71.7	361
291	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Other	56.1	41.8 to 69.4	72
292	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Uninsured	61.0	38.7 to 79.4	33
293	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Private Insurance Only	95.9	94.2 to 97.0	1058
294	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Any Medicaid	92.9	89.1 to 95.4	361
295	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Other	93.1	79.3 to 98.0	72
296	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Insurance Coverage	Uninsured	89.4	64.3 to 97.5	33
297	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2009	Age	13-17 Years	67.8	61.6 to 73.5	307
298	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2008	Age	13-17 Years	54.6	47.3 to 61.7	300
299	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2011	Age	13-17 Years	80.6	74.9 to 85.3	385
300	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2010	Age	13-17 Years	73.8	68.1 to 78.8	350
301	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2012	Age	13-17 Years	83.1	76.7 to 88.0	278
302	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2022	Age	13-15 Years	87.2	78.5 to 92.7	134
303	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2017	Age	13-17 Years	95.1	91.6 to 97.2	333
304	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018	Age	13-17 Years	97.5	94.9 to 98.8	303
305	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2016	Age	13-17 Years	95.3	91.5 to 97.5	313
306	HPV	≥3 Doses, Males and Females	States/Local Areas	New Hampshire	2012	Age	13-17 Years	18.7	14.0 to 24.6	278
307	HPV	≥3 Doses, Males and Females	States/Local Areas	New Hampshire	2011	Age	13-17 Years	23.2	18.7 to 28.3	385
308	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2016	Age	13-17 Years	88.0	83.1 to 91.6	313
309	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2015	Age	13-17 Years	87.7	82.5 to 91.5	295
310	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2014	Age	13-17 Years	90.6	86.9 to 93.4	402
311	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2013	Age	13-17 Years	85.6	80.6 to 89.4	345
312	≥2 Doses MMR		States/Local Areas	New Hampshire	2016	Age	13-17 Years	98.5	95.9 to 99.5	313
313	≥2 Doses MMR		States/Local Areas	New Hampshire	2014	Age	13-17 Years	97.2	94.8 to 98.5	402
314	≥2 Doses MMR		States/Local Areas	New Hampshire	2015	Age	13-17 Years	97.1	93.6 to 98.7	295
315	≥2 Doses MMR		States/Local Areas	New Hampshire	2012	Age	13-17 Years	97.5	94.7 to 98.8	278
316	≥2 Doses MMR		States/Local Areas	New Hampshire	2013	Age	13-17 Years	97.4	94.0 to 98.9	345
317	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2019	Age	13-17 Years	94.2	89.9 to 96.8	333
318	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2017	Age	13-17 Years	87.9	82.9 to 91.6	333
319	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2020	Age	13-17 Years	94.5	91.4 to 96.5	381
320	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2021	Age	13-17 Years	94.9	90.5 to 97.3	282
321	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2022	Age	13-17 Years	92.8	87.9 to 95.8	225
322	≥2 Doses MMR		States/Local Areas	New Hampshire	2019	Age	13-17 Years	95.6	91.7 to 97.7	333
323	≥2 Doses MMR		States/Local Areas	New Hampshire	2018	Age	13-17 Years	98.8	96.9 to 99.5	303
324	≥2 Doses MMR		States/Local Areas	New Hampshire	2017	Age	13-17 Years	97.0	93.2 to 98.7	333
325	HPV	≥3 Doses, Males and Females	States/Local Areas	New Hampshire	2013	Age	13-17 Years	30.1	24.8 to 35.9	345
326	≥2 Doses MMR		States/Local Areas	New Hampshire	2020	Age	13-17 Years	98.8	97.3 to 99.5	381
327	HPV	≥3 Doses, Males and Females	States/Local Areas	New Hampshire	2015	Age	13-17 Years	49.2	42.5 to 55.9	295
328	HPV	≥3 Doses, Males and Females	States/Local Areas	New Hampshire	2014	Age	13-17 Years	41.3	35.7 to 47.1	402
329	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2015	Age	13-15 Years	37.8	26.0 to 51.3	75
330	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2014	Age	13-15 Years	41.0	30.9 to 51.9	115
331	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2013	Age	13-15 Years	31.7	22.1 to 43.2	98
332	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018-2022	Overall	Overall	88.4	86.3 to 90.2	1524
333	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018-2022	Overall	Overall	94.8	93.2 to 96.0	1524
334	HPV	≥2 Doses, Males and Females	States/Local Areas	New Hampshire	2018	Age	13-17 Years	69.2	62.1 to 75.4	303
335	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2022	Age	13-17 Years	97.3	94.1 to 98.8	208
336	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2019	Age	13-17 Years	80.0	71.6 to 86.3	154
337	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2020	Age	13-17 Years	83.2	76.1 to 88.5	183
338	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2021	Age	13-17 Years	86.9	79.0 to 92.1	133
339	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2022	Age	13-17 Years	85.8	76.1 to 92.0	109
340	HPV	≥2 Doses, Males and Females	States/Local Areas	New Hampshire	2017	Age	13-17 Years	63.4	57.2 to 69.2	333
341	HPV	≥2 Doses, Males and Females	States/Local Areas	New Hampshire	2016	Age	13-17 Years	58.3	51.6 to 64.6	313
342	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2016	Age	13-17 Years	69.3	60.1 to 77.1	152
343	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2015	Age	13-17 Years	69.8	61.4 to 77.1	158
344	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2014	Age	13-17 Years	56.1	48.2 to 63.7	221
345	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2013	Age	13-17 Years	41.4	33.4 to 50.0	177
346	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2017	Age	13-17 Years	73.3	64.7 to 80.4	160
347	HPV	≥2 Doses, Males and Females	States/Local Areas	New Hampshire	2019	Age	13-17 Years	64.4	57.5 to 70.8	333
348	≥3 Doses HepB		States/Local Areas	New Hampshire	2008	Age	13-17 Years	92.7	88.2 to 95.5	300
349	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2022	Age	13-15 Years	98.5	95.3 to 99.5	125
350	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2008	Age	13-17 Years	54.4	44.3 to 64.1	151
351	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2009	Age	13-17 Years	60.0	51.3 to 68.2	150
352	≥3 Doses HepB		States/Local Areas	New Hampshire	2009	Age	13-17 Years	94.7	91.6 to 96.7	307
353	≥3 Doses HepB		States/Local Areas	New Hampshire	2010	Age	13-17 Years	96.9	94.1 to 98.4	350
354	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2011	Age	13-17 Years	88.2	83.0 to 92.0	260
355	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2010	Age	13-17 Years	76.8	69.1 to 83.1	193
356	≥3 Doses HepB		States/Local Areas	New Hampshire	2012	Age	13-17 Years	97.3	94.6 to 98.7	278
357	≥3 Doses HepB		States/Local Areas	New Hampshire	2011	Age	13-17 Years	95.7	92.8 to 97.5	385
358	≥3 Doses HepB		States/Local Areas	New Hampshire	2014	Age	13-17 Years	96.5	93.6 to 98.1	402
359	≥3 Doses HepB		States/Local Areas	New Hampshire	2013	Age	13-17 Years	95.7	92.1 to 97.7	345
360	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2008	Age	13-17 Years	93.2	85.7 to 96.9	130
361	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2012	Age	13-17 Years	92.9	87.9 to 96.0	190
362	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2013	Age	13-17 Years	91.6	86.5 to 94.9	247
363	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2009	Age	13-15 Years	65.8	54.6 to 75.5	103
364	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2008	Age	13-15 Years	40.9	28.7 to 54.4	87
365	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2012	Age	13-17 Years	97.9	94.8 to 99.1	190
366	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2011	Age	13-17 Years	98.6	96.6 to 99.5	260
367	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2009	Age	13-17 Years	67.7	58.0 to 76.0	138
368	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2008	Age	13-17 Years	44.6	34.2 to 55.5	130
369	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2009	Age	13-17 Years	97.1	92.9 to 98.8	138
370	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2010	Age	13-17 Years	97.5	93.1 to 99.1	193
371	≥3 Doses HepB		States/Local Areas	New Hampshire	2017	Age	13-17 Years	95.4	91.7 to 97.5	333
372	≥3 Doses HepB		States/Local Areas	New Hampshire	2019	Age	13-17 Years	94.2	89.4 to 96.8	333
373	≥3 Doses HepB		States/Local Areas	New Hampshire	2018	Age	13-17 Years	97.3	94.7 to 98.6	303
374	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2019	Age	13-17 Years	93.5	88.6 to 96.4	318
375	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2020	Age	13-17 Years	98.9	97.1 to 99.6	349
376	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2021	Age	13-17 Years	98.0	94.7 to 99.2	263
377	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2018	Age	13-17 Years	96.6	92.2 to 98.5	276
378	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2020	Age	13-17 Years	99.8	98.7 to 100.0	349
379	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2019	Age	13-17 Years	96.5	92.2 to 98.4	318
380	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2018	Age	13-17 Years	98.3	94.5 to 99.5	276
381	≥3 Doses HepB		States/Local Areas	New Hampshire	2016	Age	13-17 Years	97.7	95.4 to 98.9	313
382	≥3 Doses HepB		States/Local Areas	New Hampshire	2015	Age	13-17 Years	97.8	94.3 to 99.2	295
383	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2016	Age	13-17 Years	98.8	96.2 to 99.6	269
384	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2015	Age	13-17 Years	99.1	96.4 to 99.8	246
385	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2014	Age	13-17 Years	97.8	95.4 to 98.9	332
386	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2013	Age	13-17 Years	97.3	92.9 to 99.0	247
387	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2017	Age	13-17 Years	94.8	90.4 to 97.2	277
388	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2010	Age	13-17 Years	49.6	41.4 to 57.7	173
389	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2011	Age	13-17 Years	65.8	57.7 to 73.0	191
390	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2017	Age	13-17 Years	97.7	94.6 to 99.0	277
391	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2014	Age	13-17 Years	94.7	90.9 to 97.0	332
392	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2016	Age	13-17 Years	94.4	89.6 to 97.0	269
393	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2015	Age	13-17 Years	95.8	91.5 to 98.0	246
394	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2012	Age	13-17 Years	52.2	41.7 to 62.5	121
395	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2013	Age	13-17 Years	68.0	59.2 to 75.6	168
396	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2014	Age	13-17 Years	71.0	63.4 to 77.7	181
397	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2015	Age	13-17 Years	74.2	64.4 to 82.0	137
398	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2012	Age	13-15 Years	95.6	90.8 to 97.9	116
399	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2013	Age	13-15 Years	93.6	86.4 to 97.1	158
400	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2010	Age	13-15 Years	80.9	71.8 to 87.5	129
401	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2011	Age	13-15 Years	92.3	86.5 to 95.8	169
402	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2020	Age	13-15 Years	99.9	99.1 to 100.0	204
403	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2021	Age	13-15 Years	98.5	95.5 to 99.5	166
404	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2015	Age	13-17 Years	96.5	92.8 to 98.3	295
405	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2012	Age	13-17 Years	95.2	91.6 to 97.3	278
406	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2011	Age	13-17 Years	91.9	88.2 to 94.5	385
407	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2014	Age	13-17 Years	95.6	92.4 to 97.5	402
408	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2013	Age	13-17 Years	93.9	90.0 to 96.3	345
409	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2015	Age	13-15 Years	94.8	88.5 to 97.7	150
410	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2014	Age	13-15 Years	97.3	94.1 to 98.8	216
411	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2018	Age	13-15 Years	95.2	88.0 to 98.2	164
412	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2019	Age	13-15 Years	94.5	86.3 to 97.9	186
413	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2009	Age	13-17 Years	85.1	79.8 to 89.2	307
414	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2010	Age	13-17 Years	87.5	82.8 to 91.0	350
415	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2017	Age	13-15 Years	94.7	88.1 to 97.7	177
416	Varicella	≥2 Doses with no disease history	States/Local Areas	New Hampshire	2016	Age	13-15 Years	94.3	86.8 to 97.7	160
417	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2020	Age	13-17 Years	99.0	97.4 to 99.6	381
418	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2021	Age	13-17 Years	98.2	95.2 to 99.3	282
419	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2022	Age	13-17 Years	97.5	94.5 to 98.9	225
420	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2015	Age	13-15 Years	42.4	31.4 to 54.2	96
421	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2014	Age	13-15 Years	23.2	15.9 to 32.5	130
422	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2019	Age	13-17 Years	93.8	89.2 to 96.6	333
423	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2017	Age	13-17 Years	95.6	92.1 to 97.6	333
424	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2016	Age	13-17 Years	96.4	92.5 to 98.3	313
425	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2014	Age	13-17 Years	95.5	92.4 to 97.3	402
426	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2015	Age	13-17 Years	94.3	89.8 to 96.9	295
427	≥3 Doses HepB		States/Local Areas	New Hampshire	2020	Age	13-17 Years	96.2	93.4 to 97.8	381
428	≥3 Doses HepB		States/Local Areas	New Hampshire	2021	Age	13-17 Years	96.9	93.9 to 98.4	282
429	≥3 Doses HepB		States/Local Areas	New Hampshire	2022	Age	13-17 Years	93.7	89.2 to 96.4	225
430	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2022	Age	13-17 Years	98.4	95.9 to 99.4	208
431	Varicella	≥1 Dose with no disease history	States/Local Areas	New Hampshire	2021	Age	13-17 Years	99.2	97.3 to 99.8	263
432	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2018	Age	13-17 Years	75.1	65.2 to 82.9	152
433	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2012	Age	13-17 Years	20.5	14.2 to 28.7	157
434	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2020	Age	13-17 Years	81.8	74.3 to 87.5	198
435	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2021	Age	13-17 Years	82.4	73.5 to 88.7	149
436	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2019	Age	13-17 Years	70.4	60.2 to 79.0	179
437	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2015	Age	13-15 Years	85.8	78.6 to 90.8	171
438	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2014	Age	13-15 Years	89.1	83.9 to 92.8	245
439	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2012	Age	13-15 Years	81.6	72.2 to 88.4	145
440	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2013	Age	13-15 Years	84.0	76.6 to 89.3	194
441	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2017	Age	13-17 Years	75.2	67.3 to 81.6	173
442	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2016	Age	13-17 Years	70.6	61.9 to 78.1	161
443	HPV	≥1 Dose, Females	States/Local Areas	New Hampshire	2018	Age	13-17 Years	79.7	70.5 to 86.7	151
444	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2008	Age	13-17 Years	45.5	35.4 to 56.0	151
445	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2016	Age	13-15 Years	85.0	78.2 to 90.0	186
446	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2011	Age	13-17 Years	52.8	44.2 to 61.3	191
447	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2010	Age	13-17 Years	46.9	38.8 to 55.1	173
448	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2020	Age	13-15 Years	90.3	85.0 to 93.9	219
449	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2009	Age	13-17 Years	53.0	44.1 to 61.7	150
450	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2012	Age	13-17 Years	43.6	33.6 to 54.1	121
451	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2013	Age	13-17 Years	57.2	48.4 to 65.6	168
452	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2019	Age	13-15 Years	85.7	77.9 to 91.1	196
453	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018	Age	13-15 Years	83.7	76.3 to 89.1	182
454	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2017	Age	13-15 Years	84.5	77.4 to 89.7	211
455	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2017	Age	13-17 Years	74.2	68.5 to 79.2	333
456	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2016	Age	13-17 Years	69.9	63.7 to 75.5	313
457	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2019	Age	13-17 Years	75.1	68.5 to 80.7	333
458	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2021	Age	13-17 Years	97.0	92.8 to 98.8	282
459	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2022	Age	13-17 Years	93.4	88.8 to 96.2	225
460	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2018	Age	13-17 Years	77.4	70.8 to 82.8	303
461	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2018	Age	13-17 Years	98.5	97.0 to 99.2	303
462	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2009	Age	13-17 Years	88.0	82.7 to 91.8	307
463	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2008	Age	13-17 Years	84.2	77.1 to 89.4	300
464	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2012	Age	13-17 Years	97.0	94.2 to 98.5	278
465	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2013	Age	13-17 Years	97.6	95.1 to 98.8	345
466	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2008	Age	13-15 Years	49.7	40.0 to 59.4	172
467	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2009	Age	13-15 Years	66.3	58.1 to 73.7	182
468	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2011	Age	13-17 Years	97.2	94.8 to 98.5	385
469	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2010	Age	13-17 Years	95.9	93.0 to 97.6	350
470	HPV	≥1 Dose, Males	States/Local Areas	New Hampshire	2022	Age	13-17 Years	85.7	76.8 to 91.5	116
471	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2020	Age	13-17 Years	82.5	77.5 to 86.6	381
472	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2021	Age	13-17 Years	84.6	78.9 to 89.0	282
473	HPV	≥1 Dose, Males and Females	States/Local Areas	New Hampshire	2022	Age	13-17 Years	85.7	79.6 to 90.3	225
474	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2019	Age	13-17 Years	95.1	90.8 to 97.4	333
475	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	New Hampshire	2020	Age	13-17 Years	95.5	92.5 to 97.4	381
476	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2010	Age	13-15 Years	69.8	61.9 to 76.8	187
477	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2011	Age	13-15 Years	79.1	70.5 to 85.7	215
478	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2021	Age	13-15 Years	86.4	79.2 to 91.4	178
479	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2017	Age	13-17 Years	66.5	58.0 to 74.0	173
480	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2016	Age	13-17 Years	62.7	53.5 to 71.0	161
481	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2015	Age	13-17 Years	59.7	49.4 to 69.2	137
482	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2014	Age	13-17 Years	61.2	53.1 to 68.7	181
483	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2008	Age	13-15 Years	23.8	12.9 to 39.7	85
484	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2010	Age	13-15 Years	28.1	18.9 to 39.6	86
485	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2009	Age	13-15 Years	30.4	20.6 to 42.4	86
486	≥2 Doses MMR		States/Local Areas	New Hampshire	2021	Age	13-17 Years	97.2	93.8 to 98.7	282
487	≥2 Doses MMR		States/Local Areas	New Hampshire	2022	Age	13-17 Years	97.8	95.4 to 99.0	225
488	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2011	Age	13-15 Years	40.1	29.7 to 51.5	108
489	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2022	Age	13-17 Years	90.5	84.7 to 94.2	225
490	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2019	Age	13-17 Years	86.0	80.4 to 90.2	333
491	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2018	Age	13-17 Years	86.2	81.0 to 90.2	303
492	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2020	Age	13-17 Years	91.1	87.5 to 93.7	381
493	≥1 Dose MenACWY		States/Local Areas	New Hampshire	2021	Age	13-17 Years	88.1	82.8 to 91.9	282
494	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2012	Age	13-15 Years	94.7	89.7 to 97.4	145
495	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2011	Age	13-15 Years	95.9	91.9 to 98.0	215
496	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2008	Age	13-15 Years	62.1	51.9 to 71.4	172
497	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2010	Age	13-15 Years	90.8	85.2 to 94.4	187
498	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2009	Age	13-15 Years	77.7	70.4 to 83.6	182
499	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2019	Age	13-17 Years	67.7	58.1 to 76.0	154
500	HPV	≥2 Doses, Females	States/Local Areas	New Hampshire	2018	Age	13-17 Years	68.3	58.2 to 76.9	151
501	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2017	Age	13-15 Years	92.5	87.3 to 95.7	211
502	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2016	Age	13-15 Years	93.4	87.1 to 96.8	186
503	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2015	Age	13-15 Years	92.3	85.2 to 96.2	171
504	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2014	Age	13-15 Years	94.9	90.7 to 97.2	245
505	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2013	Age	13-15 Years	95.1	88.9 to 97.9	194
506	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2018	Age	13-17 Years	70.0	59.9 to 78.4	152
507	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2017	Age	13-17 Years	60.4	51.3 to 68.9	160
508	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2016	Age	13-17 Years	54.1	44.5 to 63.4	152
509	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2012	Age	13-17 Years	12.2	7.6 to 18.9	157
510	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2013	Age	13-17 Years	28.5	21.4 to 37.0	177
511	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2014	Age	13-17 Years	46.9	39.1 to 54.8	221
512	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2015	Age	13-17 Years	55.1	46.0 to 63.9	158
513	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2019	Age	13-15 Years	92.3	85.1 to 96.2	196
514	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2020	Age	13-15 Years	94.1	89.2 to 96.8	219
515	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2021	Age	13-15 Years	95.6	89.4 to 98.2	178
516	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2018	Age	13-15 Years	97.4	92.9 to 99.1	182
517	≥2 Doses MMR		States/Local Areas	New Hampshire	2011	Age	13-17 Years	97.0	94.4 to 98.4	385
518	≥2 Doses MMR		States/Local Areas	New Hampshire	2010	Age	13-17 Years	97.2	94.6 to 98.6	350
519	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2015	Age	13-17 Years	92.4	87.5 to 95.5	295
520	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2018	Age	13-17 Years	96.9	92.9 to 98.7	303
521	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2016	Age	13-17 Years	95.2	91.1 to 97.5	313
522	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2017	Age	13-17 Years	95.7	92.0 to 97.7	333
523	Varicella	≥2 Doses or history of disease	States/Local Areas	New Hampshire	2008	Age	13-17 Years	76.1	69.2 to 81.8	300
524	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2013	Age	13-15 Years	17.3	10.0 to 28.3	96
525	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2013	Age	13-17 Years	17.8	12.0 to 25.4	177
526	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2015	Age	13-17 Years	47.1	38.2 to 56.2	158
527	HPV	≥3 Doses, Males	States/Local Areas	New Hampshire	2014	Age	13-17 Years	33.0	25.9 to 41.0	221
528	≥2 Doses Hep A		States/Local Areas	New Hampshire	2022	Age	13-17 Years	86.7	80.9 to 90.9	225
529	≥2 Doses Hep A		States/Local Areas	New Hampshire	2021	Age	13-17 Years	84.1	78.5 to 88.5	282
530	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2010	Age	13-17 Years	42.2	34.4 to 50.4	173
531	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2015	Age	13-17 Years	51.4	41.5 to 61.3	137
532	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2009	Age	13-17 Years	39.8	31.3 to 48.8	150
533	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2008	Age	13-17 Years	23.2	15.3 to 33.5	151
534	≥2 Doses Hep A		States/Local Areas	New Hampshire	2020	Age	13-17 Years	77.8	72.6 to 82.2	381
535	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2012	Age	13-17 Years	34.5	25.5 to 44.7	121
536	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2011	Age	13-17 Years	46.0	37.8 to 54.4	191
537	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2014	Age	13-17 Years	50.1	41.8 to 58.4	181
538	HPV	≥3 Doses, Females	States/Local Areas	New Hampshire	2013	Age	13-17 Years	43.2	34.9 to 51.9	168
539	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2012	Age	13-17 Years	96.3	93.3 to 98.0	278
540	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2016	Age	13-17 Years	51.2	44.6 to 57.8	313
541	HPV	≥2 Doses, Males	States/Local Areas	New Hampshire	2019	Age	13-17 Years	61.2	51.2 to 70.4	179
542	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2009	Age	13-17 Years	72.2	66.2 to 77.5	307
543	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2010	Age	13-17 Years	87.9	83.5 to 91.3	350
544	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2011	Age	13-17 Years	95.0	91.9 to 96.9	385
545	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2022	Age	13-15 Years	90.6	83.6 to 94.8	134
546	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2008	Age	13-17 Years	53.1	45.8 to 60.2	300
547	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2019	Age	13-17 Years	63.2	56.2 to 69.6	333
548	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2020	Age	13-17 Years	68.8	63.1 to 73.9	381
549	≥2 Doses MMR		States/Local Areas	New Hampshire	2009	Age	13-17 Years	95.2	92.1 to 97.1	307
550	≥2 Doses MMR		States/Local Areas	New Hampshire	2008	Age	13-17 Years	94.9	90.0 to 97.5	300
551	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2014	Age	13-17 Years	94.4	91.1 to 96.6	402
552	Tetanus	≥1 Dose Tdap	States/Local Areas	New Hampshire	2013	Age	13-17 Years	94.7	91.0 to 97.0	345
553	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2021	Age	13-17 Years	72.3	65.7 to 78.1	282
554	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2022	Age	13-17 Years	76.2	69.4 to 82.0	225
555	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2018	Age	13-17 Years	67.4	60.4 to 73.8	303
556	HPV	Up-to-Date, Males and Females	States/Local Areas	New Hampshire	2017	Age	13-17 Years	59.9	53.7 to 65.8	333
557	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2022	Age	13-17 Years	65.1	56.9 to 72.5	182
558	HPV	≥2 Doses, Males and Females	States/Local Areas	Colorado	2022	Age	13-17 Years	67.2	61.2 to 72.7	342
559	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2012	Age	13-17 Years	81.6	74.0 to 87.3	236
560	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2013	Age	13-17 Years	78.5	72.2 to 83.6	265
561	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2008	Age	13-17 Years	33.5	25.6 to 42.6	181
562	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2022	Age	13-15 Years	95.6	91.8 to 97.6	191
563	≥3 Doses HepB		States/Local Areas	Colorado	2010	Age	13-17 Years	93.1	89.6 to 95.5	317
564	≥3 Doses HepB		States/Local Areas	Colorado	2009	Age	13-17 Years	91.2	87.5 to 93.9	411
565	≥3 Doses HepB		States/Local Areas	Colorado	2019	Age	13-17 Years	92.6	86.5 to 96.1	262
566	≥3 Doses HepB		States/Local Areas	Colorado	2008	Age	13-17 Years	94.6	91.0 to 96.8	347
567	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2020	Age	13-17 Years	95.4	91.7 to 97.5	327
568	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2019	Age	13-17 Years	93.4	87.7 to 96.6	238
569	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2021	Age	13-17 Years	94.5	90.8 to 96.8	277
570	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2020	Age	13-17 Years	93.2	89.1 to 95.9	327
571	≥3 Doses HepB		States/Local Areas	Colorado	2011	Age	13-17 Years	88.5	82.2 to 92.8	431
572	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2019	Age	13-17 Years	95.4	89.5 to 98.0	238
573	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2018	Age	13-17 Years	97.0	94.3 to 98.5	256
574	≥3 Doses HepB		States/Local Areas	Colorado	2018	Age	13-17 Years	93.5	88.4 to 96.4	278
575	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2018	Age	13-17 Years	90.7	84.6 to 94.6	256
576	≥3 Doses HepB		States/Local Areas	Colorado	2017	Age	13-17 Years	89.2	84.3 to 92.6	354
577	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2016	Age	13-17 Years	97.1	94.3 to 98.6	283
578	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2015	Age	13-17 Years	96.9	94.2 to 98.3	293
579	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2013	Age	13-17 Years	95.1	90.9 to 97.4	265
580	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2014	Age	13-17 Years	94.8	90.6 to 97.2	322
581	≥3 Doses HepB		States/Local Areas	Colorado	2016	Age	13-17 Years	91.6	86.4 to 94.9	322
582	≥3 Doses HepB		States/Local Areas	Colorado	2015	Age	13-17 Years	93.2	89.6 to 95.6	354
583	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2021	Age	13-15 Years	94.6	90.3 to 97.0	184
584	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2020	Age	13-15 Years	92.6	86.0 to 96.3	192
585	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2012	Age	13-15 Years	81.3	71.0 to 88.6	148
586	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2013	Age	13-15 Years	81.4	73.8 to 87.2	179
587	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2010	Age	13-15 Years	68.5	58.9 to 76.7	134
588	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2011	Age	13-15 Years	81.8	71.1 to 89.2	187
589	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2009	Age	13-15 Years	54.6	44.7 to 64.2	147
590	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2017	Age	13-17 Years	95.6	92.3 to 97.5	309
591	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2014	Age	13-17 Years	83.7	78.0 to 88.1	322
592	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2016	Age	13-17 Years	90.3	85.0 to 93.9	283
593	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2015	Age	13-17 Years	91.6	87.5 to 94.4	293
594	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2017	Age	13-17 Years	89.7	85.2 to 92.9	309
595	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2011	Age	13-17 Years	45.9	35.8 to 56.3	220
596	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2010	Age	13-17 Years	52.5	43.5 to 61.4	166
597	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2012	Age	13-17 Years	61.4	50.2 to 71.5	156
598	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2013	Age	13-17 Years	58.2	49.4 to 66.4	163
599	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2014	Age	13-17 Years	62.5	53.9 to 70.3	189
600	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2015	Age	13-17 Years	65.3	56.7 to 73.0	180
601	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2014	Age	13-15 Years	86.2	79.1 to 91.1	193
602	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2019	Age	13-15 Years	93.8	85.9 to 97.4	156
603	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2015	Age	13-15 Years	91.7	86.5 to 95.0	178
604	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2017	Age	13-15 Years	88.7	82.8 to 92.7	215
605	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2018	Age	13-15 Years	89.5	80.0 to 94.8	155
606	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2016	Age	13-15 Years	88.9	80.9 to 93.8	172
607	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2010	Age	13-17 Years	78.7	73.2 to 83.4	317
608	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2009	Age	13-17 Years	79.8	74.4 to 84.2	411
609	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2012	Age	13-17 Years	86.5	80.6 to 90.8	311
610	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2011	Age	13-17 Years	84.1	78.0 to 88.8	431
611	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2013	Age	13-17 Years	82.5	77.3 to 86.8	331
612	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2014	Age	13-17 Years	87.2	82.5 to 90.8	394
613	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2008	Age	13-15 Years	54.2	41.7 to 66.2	101
614	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2022	Age	13-17 Years	93.1	89.4 to 95.5	342
615	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2021	Age	13-17 Years	95.0	91.5 to 97.0	298
616	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2020	Age	13-17 Years	93.8	90.0 to 96.2	354
617	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2017	Age	13-17 Years	91.1	87.1 to 93.9	354
618	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2018	Age	13-17 Years	91.7	86.1 to 95.1	278
619	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2016	Age	13-17 Years	91.4	86.7 to 94.6	322
620	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2015	Age	13-17 Years	93.1	89.7 to 95.4	354
621	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2019	Age	13-17 Years	94.2	89.2 to 97.0	262
622	HPV	≥3 Doses, Males	States/Local Areas	Colorado	2014	Age	13-15 Years	23.7	15.4 to 34.6	119
623	HPV	≥3 Doses, Males	States/Local Areas	Colorado	2015	Age	13-15 Years	30.6	21.1 to 42.1	108
624	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2015	Age	13-17 Years	46.0	37.5 to 54.7	180
625	Varicella	≥2 Doses or history of disease	States/Local Areas	Colorado	2008	Age	13-17 Years	77.4	70.8 to 82.8	347
626	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2017	Age	13-17 Years	53.8	47.4 to 60.0	354
627	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2018	Age	13-17 Years	62.5	55.0 to 69.4	278
628	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2019	Age	13-17 Years	63.5	55.3 to 71.0	262
629	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2013	Age	13-17 Years	87.1	82.0 to 90.9	331
630	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2014	Age	13-17 Years	90.2	86.0 to 93.3	394
631	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2012	Age	13-17 Years	93.2	88.7 to 96.0	311
632	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2016	Age	13-17 Years	48.0	41.0 to 55.0	322
633	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2008	Age	13-17 Years	63.0	56.0 to 69.5	347
634	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2022	Age	13-15 Years	91.9	86.3 to 95.3	205
635	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2011	Age	13-17 Years	84.7	78.0 to 89.6	431
636	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2010	Age	13-17 Years	85.7	80.9 to 89.5	317
637	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2009	Age	13-17 Years	76.6	70.9 to 81.5	411
638	≥2 Doses MMR		States/Local Areas	Colorado	2008	Age	13-17 Years	91.0	86.8 to 94.0	347
639	≥2 Doses MMR		States/Local Areas	Colorado	2009	Age	13-17 Years	88.6	84.5 to 91.7	411
640	≥2 Doses MMR		States/Local Areas	Colorado	2010	Age	13-17 Years	92.6	88.6 to 95.2	317
641	≥2 Doses MMR		States/Local Areas	Colorado	2011	Age	13-17 Years	88.1	81.9 to 92.4	431
642	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2015	Age	13-17 Years	93.3	89.7 to 95.7	354
643	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2019	Age	13-17 Years	62.2	51.2 to 72.2	153
644	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2022	Age	13-17 Years	65.7	59.7 to 71.3	342
645	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2021	Age	13-17 Years	69.2	62.1 to 75.5	298
646	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2020	Age	13-17 Years	66.4	59.9 to 72.4	354
647	HPV	≥3 Doses, Males	States/Local Areas	Colorado	2013	Age	13-17 Years	9.9	6.0 to 15.7	168
648	HPV	≥3 Doses, Males	States/Local Areas	Colorado	2014	Age	13-17 Years	21.9	15.7 to 29.7	205
649	HPV	≥3 Doses, Males	States/Local Areas	Colorado	2015	Age	13-17 Years	37.1	28.8 to 46.2	174
650	≥2 Doses Hep A		States/Local Areas	Colorado	2022	Age	13-17 Years	85.5	81.1 to 89.1	342
651	≥2 Doses Hep A		States/Local Areas	Colorado	2021	Age	13-17 Years	88.4	83.4 to 92.0	298
652	≥2 Doses Hep A		States/Local Areas	Colorado	2020	Age	13-17 Years	84.6	79.4 to 88.8	354
653	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2012	Age	13-17 Years	38.0	27.6 to 49.6	156
654	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2013	Age	13-17 Years	39.1	30.9 to 48.1	163
655	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2014	Age	13-17 Years	42.1	33.7 to 50.9	189
656	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2010	Age	13-17 Years	40.9	32.5 to 49.9	166
657	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2011	Age	13-17 Years	25.3	18.4 to 33.8	220
658	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2008	Age	13-17 Years	19.0	12.7 to 27.4	181
659	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2009	Age	13-17 Years	32.5	24.3 to 41.8	198
660	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2014	Age	13-15 Years	41.1	30.7 to 52.4	114
661	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2015	Age	13-15 Years	34.7	24.9 to 45.9	108
662	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2013	Age	13-15 Years	30.0	21.0 to 40.7	109
663	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2010	Age	13-15 Years	39.7	29.3 to 51.0	101
664	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2009	Age	13-15 Years	30.4	20.9 to 42.0	123
665	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2012	Age	13-15 Years	26.2	15.8 to 40.1	92
666	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2011	Age	13-15 Years	17.2	10.4 to 27.2	129
667	HPV	≥3 Doses, Females	States/Local Areas	Colorado	2008	Age	13-15 Years	19.5	11.8 to 30.4	112
668	≥1 Dose MenACWY		States/Local Areas	Colorado	2022	Age	13-17 Years	83.6	78.7 to 87.6	342
669	≥2 Doses MMR		States/Local Areas	Colorado	2022	Age	13-17 Years	91.6	87.8 to 94.3	342
670	≥2 Doses MMR		States/Local Areas	Colorado	2021	Age	13-17 Years	95.6	92.5 to 97.5	298
671	≥1 Dose MenACWY		States/Local Areas	Colorado	2018	Age	13-17 Years	84.9	78.7 to 89.6	278
672	≥1 Dose MenACWY		States/Local Areas	Colorado	2019	Age	13-17 Years	89.4	84.0 to 93.1	262
673	≥1 Dose MenACWY		States/Local Areas	Colorado	2021	Age	13-17 Years	84.8	78.5 to 89.5	298
674	≥1 Dose MenACWY		States/Local Areas	Colorado	2020	Age	13-17 Years	87.3	82.1 to 91.2	354
675	HPV	≥3 Doses, Males and Females	States/Local Areas	Colorado	2015	Age	13-17 Years	41.4	35.4 to 47.8	354
676	HPV	≥3 Doses, Males and Females	States/Local Areas	Colorado	2014	Age	13-17 Years	31.8	26.4 to 37.7	394
677	HPV	≥3 Doses, Males and Females	States/Local Areas	Colorado	2013	Age	13-17 Years	24.2	19.3 to 29.8	331
678	≥2 Doses MMR		States/Local Areas	Colorado	2020	Age	13-17 Years	94.0	90.5 to 96.3	354
679	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2022	Age	13-17 Years	92.4	88.6 to 95.0	342
680	≥2 Doses MMR		States/Local Areas	Colorado	2018	Age	13-17 Years	92.7	87.2 to 96.0	278
681	≥2 Doses MMR		States/Local Areas	Colorado	2019	Age	13-17 Years	91.0	84.3 to 95.1	262
682	HPV	≥3 Doses, Males and Females	States/Local Areas	Colorado	2012	Age	13-17 Years	25.7	18.6 to 34.4	311
683	HPV	≥3 Doses, Males and Females	States/Local Areas	Colorado	2011	Age	13-17 Years	13.9	10.1 to 18.8	431
684	≥1 Dose MenACWY		States/Local Areas	Colorado	2017	Age	13-17 Years	82.4	77.2 to 86.6	354
685	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2021	Age	13-17 Years	90.2	84.7 to 93.8	298
686	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2020	Age	13-17 Years	90.0	85.1 to 93.4	354
687	≥1 Dose MenACWY		States/Local Areas	Colorado	2016	Age	13-17 Years	77.5	71.3 to 82.7	322
688	≥1 Dose MenACWY		States/Local Areas	Colorado	2015	Age	13-17 Years	85.6	80.7 to 89.3	354
689	≥1 Dose MenACWY		States/Local Areas	Colorado	2013	Age	13-17 Years	73.6	67.6 to 78.8	331
690	≥1 Dose MenACWY		States/Local Areas	Colorado	2014	Age	13-17 Years	76.8	71.6 to 81.4	394
691	≥2 Doses MMR		States/Local Areas	Colorado	2017	Age	13-17 Years	90.2	85.4 to 93.6	354
692	≥2 Doses MMR		States/Local Areas	Colorado	2016	Age	13-17 Years	91.5	86.8 to 94.6	322
693	≥2 Doses MMR		States/Local Areas	Colorado	2014	Age	13-17 Years	92.1	88.1 to 94.8	394
694	≥2 Doses MMR		States/Local Areas	Colorado	2015	Age	13-17 Years	92.3	88.6 to 94.9	354
695	≥2 Doses MMR		States/Local Areas	Colorado	2012	Age	13-17 Years	94.6	90.4 to 97.0	311
696	≥2 Doses MMR		States/Local Areas	Colorado	2013	Age	13-17 Years	92.4	88.3 to 95.2	331
697	≥1 Dose MenACWY		States/Local Areas	Colorado	2010	Age	13-17 Years	59.6	53.0 to 65.8	317
698	≥1 Dose MenACWY		States/Local Areas	Colorado	2011	Age	13-17 Years	64.4	57.1 to 71.0	431
699	≥1 Dose MenACWY		States/Local Areas	Colorado	2008	Age	13-17 Years	32.4	26.3 to 39.1	347
700	≥1 Dose MenACWY		States/Local Areas	Colorado	2009	Age	13-17 Years	53.7	47.5 to 59.9	411
701	≥1 Dose MenACWY		States/Local Areas	Colorado	2012	Age	13-17 Years	73.2	66.1 to 79.2	311
702	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2013	Age	13-15 Years	87.7	81.1 to 92.3	211
703	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2019	Age	13-15 Years	92.0	84.7 to 96.0	170
704	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2020	Age	13-15 Years	88.6	80.7 to 93.6	206
705	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2021	Age	13-15 Years	87.4	79.5 to 92.5	196
706	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2016	Age	13-17 Years	58.8	49.2 to 67.8	168
707	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2015	Age	13-17 Years	63.2	54.5 to 71.1	174
708	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2013	Age	13-17 Years	33.5	25.5 to 42.5	168
709	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2014	Age	13-17 Years	40.7	32.8 to 49.1	205
710	HPV	≥2 Doses, Males and Females	States/Local Areas	Colorado	2017	Age	13-17 Years	57.3	50.9 to 63.4	354
711	HPV	≥2 Doses, Males and Females	States/Local Areas	Colorado	2016	Age	13-17 Years	52.1	45.1 to 59.1	322
712	HPV	≥2 Doses, Males and Females	States/Local Areas	Colorado	2018	Age	13-17 Years	66.0	58.6 to 72.7	278
713	HPV	≥2 Doses, Males and Females	States/Local Areas	Colorado	2019	Age	13-17 Years	68.8	61.0 to 75.7	262
714	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2011	Age	13-17 Years	13.6	7.8 to 22.7	211
715	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2022	Age	13-17 Years	81.1	72.9 to 87.3	160
716	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2021	Age	13-17 Years	82.1	72.2 to 89.0	135
717	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2020	Age	13-17 Years	81.2	73.1 to 87.4	167
718	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2012	Age	13-17 Years	31.3	20.2 to 45.0	155
719	≥3 Doses HepB		States/Local Areas	Colorado	2022	Age	13-17 Years	91.9	88.3 to 94.4	342
720	≥3 Doses HepB		States/Local Areas	Colorado	2021	Age	13-17 Years	93.8	89.4 to 96.5	298
721	≥3 Doses HepB		States/Local Areas	Colorado	2020	Age	13-17 Years	91.9	87.5 to 94.9	354
722	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2022	Age	13-17 Years	94.4	91.0 to 96.6	321
723	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2019	Age	13-17 Years	85.1	75.2 to 91.5	109
724	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2008	Age	13-17 Years	85.3	77.2 to 90.9	140
725	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2010	Age	13-17 Years	94.8	90.4 to 97.2	190
726	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2009	Age	13-17 Years	86.6	79.2 to 91.6	202
727	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2012	Age	13-17 Years	95.0	87.8 to 98.1	236
728	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2011	Age	13-17 Years	94.5	89.2 to 97.3	274
729	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2008	Age	13-17 Years	42.2	31.7 to 53.4	140
730	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2009	Age	13-17 Years	54.4	45.4 to 63.2	202
731	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2017	Age	13-17 Years	74.4	65.9 to 81.4	169
732	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2016	Age	13-17 Years	68.3	57.9 to 77.1	154
733	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2022	Age	13-17 Years	92.6	88.8 to 95.2	321
734	Varicella	≥1 Dose with no disease history	States/Local Areas	Colorado	2021	Age	13-17 Years	96.8	94.0 to 98.3	277
735	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2018	Age	13-17 Years	72.3	61.6 to 81.0	131
736	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2010	Age	13-17 Years	65.3	57.1 to 72.6	190
737	Varicella	≥2 Doses with no disease history	States/Local Areas	Colorado	2011	Age	13-17 Years	74.0	65.1 to 81.3	274
738	HPV	≥1 Dose, Females	States/Local Areas	Colorado	2009	Age	13-17 Years	52.7	43.7 to 61.4	198
739	≥3 Doses HepB		States/Local Areas	Colorado	2013	Age	13-17 Years	92.3	88.2 to 95.0	331
740	≥3 Doses HepB		States/Local Areas	Colorado	2014	Age	13-17 Years	95.1	91.8 to 97.1	394
741	≥3 Doses HepB		States/Local Areas	Colorado	2012	Age	13-17 Years	96.4	93.7 to 98.0	311
742	≥1 Dose MenACWY		States/Local Areas	Colorado	2016	Age	13-15 Years	72.8	64.2 to 80.0	199
743	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2021	Age	13-17 Years	78.0	69.1 to 85.0	163
744	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2020	Age	13-17 Years	81.9	74.0 to 87.7	187
745	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2019	Age	13-17 Years	75.6	64.9 to 83.8	153
746	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2017	Age	13-17 Years	69.8	61.4 to 77.1	185
747	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2018	Age	13-17 Years	81.9	73.0 to 88.3	147
748	≥1 Dose MenACWY		States/Local Areas	Colorado	2017	Age	13-15 Years	81.4	74.7 to 86.6	235
749	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2018	Age	13-17 Years	93.2	88.1 to 96.1	278
750	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2017	Age	13-17 Years	90.2	85.5 to 93.4	354
751	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2016	Age	13-17 Years	88.9	83.6 to 92.6	322
752	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2014	Age	13-17 Years	92.4	88.5 to 95.1	394
753	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2015	Age	13-17 Years	95.3	92.6 to 97.1	354
754	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2017	Age	13-17 Years	72.1	66.2 to 77.3	354
755	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2016	Age	13-17 Years	63.5	56.5 to 69.9	322
756	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2018	Age	13-17 Years	77.2	70.4 to 82.8	278
757	≥1 Dose MenACWY		States/Local Areas	Colorado	2014	Age	13-15 Years	76.7	69.7 to 82.4	233
758	≥1 Dose MenACWY		States/Local Areas	Colorado	2015	Age	13-15 Years	81.2	74.3 to 86.6	216
759	≥1 Dose MenACWY		States/Local Areas	Colorado	2013	Age	13-15 Years	73.4	65.8 to 79.9	211
760	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2008	Age	13-17 Years	24.5	17.5 to 33.2	181
761	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2012	Age	13-17 Years	44.9	34.1 to 56.3	156
762	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2013	Age	13-17 Years	50.0	41.2 to 58.7	163
763	≥1 Dose MenACWY		States/Local Areas	Colorado	2018	Age	13-15 Years	85.1	76.5 to 91.0	167
764	≥1 Dose MenACWY		States/Local Areas	Colorado	2019	Age	13-15 Years	87.2	79.8 to 92.2	170
765	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2019	Age	13-17 Years	92.1	86.5 to 95.5	262
766	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2020	Age	13-17 Years	92.2	87.9 to 95.0	354
767	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2019	Age	13-17 Years	80.2	73.1 to 85.8	262
768	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2022	Age	13-17 Years	92.8	89.0 to 95.3	342
769	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2021	Age	13-17 Years	91.9	86.6 to 95.2	298
770	≥1 Dose MenACWY		States/Local Areas	Colorado	2012	Age	13-15 Years	74.9	66.0 to 82.1	186
771	≥1 Dose MenACWY		States/Local Areas	Colorado	2010	Age	13-15 Years	58.5	50.3 to 66.3	204
772	≥1 Dose MenACWY		States/Local Areas	Colorado	2011	Age	13-15 Years	64.1	54.2 to 72.9	254
773	≥1 Dose MenACWY		States/Local Areas	Colorado	2008	Age	13-15 Years	37.1	28.9 to 46.2	209
774	≥1 Dose MenACWY		States/Local Areas	Colorado	2009	Age	13-15 Years	50.8	42.8 to 58.7	250
775	HPV	≥1 Dose, Males	States/Local Areas	Colorado	2022	Age	13-17 Years	78.3	70.8 to 84.3	182
776	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2008	Age	13-17 Years	77.4	70.9 to 82.9	347
777	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2009	Age	13-17 Years	83.6	78.8 to 87.5	411
778	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2010	Age	13-17 Years	46.2	37.5 to 55.2	166
779	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2011	Age	13-17 Years	32.9	24.8 to 42.3	220
780	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2009	Age	13-17 Years	42.7	34.0 to 51.9	198
781	≥1 Dose MenACWY		States/Local Areas	Colorado	2020	Age	13-15 Years	86.1	78.4 to 91.3	206
782	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2012	Age	13-17 Years	93.3	88.8 to 96.1	311
783	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2013	Age	13-17 Years	90.5	85.9 to 93.8	331
784	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2010	Age	13-17 Years	89.6	85.3 to 92.8	317
785	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Colorado	2011	Age	13-17 Years	87.4	80.7 to 92.0	431
786	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2014	Age	13-17 Years	55.1	46.4 to 63.6	189
787	≥1 Dose MenACWY		States/Local Areas	Colorado	2021	Age	13-15 Years	82.0	73.4 to 88.3	196
788	≥1 Dose MenACWY		States/Local Areas	Colorado	2022	Age	13-15 Years	82.9	76.0 to 88.0	205
789	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2022	Age	13-17 Years	79.7	74.3 to 84.2	342
790	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2021	Age	13-17 Years	80.0	73.6 to 85.2	298
791	HPV	≥1 Dose, Males and Females	States/Local Areas	Colorado	2020	Age	13-17 Years	81.6	76.1 to 86.0	354
792	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2017	Age	13-17 Years	54.1	45.0 to 63.0	169
793	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2016	Age	13-17 Years	54.1	43.8 to 64.1	154
794	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2015	Age	13-17 Years	57.7	48.9 to 66.0	180
795	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2018	Age	13-17 Years	62.4	51.3 to 72.2	131
796	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2010	Age	13-15 Years	84.1	77.7 to 89.0	204
797	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2009	Age	13-15 Years	72.8	65.2 to 79.3	250
798	HPV	≥2 Doses, Females	States/Local Areas	Colorado	2019	Age	13-17 Years	75.6	64.5 to 84.1	109
799	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2012	Age	13-15 Years	91.7	84.6 to 95.6	186
800	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2011	Age	13-15 Years	87.8	77.8 to 93.7	254
801	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2008	Age	13-15 Years	69.0	60.4 to 76.3	209
802	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2017	Age	13-15 Years	86.3	79.1 to 91.2	235
803	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2016	Age	13-15 Years	86.8	78.9 to 92.0	199
804	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2014	Age	13-15 Years	89.3	83.8 to 93.1	233
805	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2015	Age	13-15 Years	93.0	88.6 to 95.8	216
806	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2017	Age	13-17 Years	60.3	51.6 to 68.5	185
807	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2016	Age	13-17 Years	50.2	40.7 to 59.7	168
808	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2018	Age	13-17 Years	69.5	59.4 to 78.0	147
809	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2014	Age	13-17 Years	30.8	23.5 to 39.1	205
810	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2013	Age	13-17 Years	21.7	15.1 to 30.2	168
811	HPV	≥2 Doses, Males	States/Local Areas	Colorado	2015	Age	13-17 Years	52.7	43.7 to 61.4	174
812	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2018	Age	13-15 Years	91.1	83.5 to 95.4	167
813	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2018	Age	13-17 Years	90.3	85.2 to 93.8	278
814	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2017	Age	13-17 Years	88.6	83.6 to 92.2	354
815	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2019	Age	13-17 Years	91.3	85.8 to 94.8	262
816	Tetanus	≥1 Dose Tdap	States/Local Areas	Colorado	2016	Age	13-17 Years	87.5	82.1 to 91.4	322
817	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2022	Age	13-15 Years	69.0	56.9 to 78.9	91
818	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2021	Age	13-15 Years	65.6	52.2 to 76.9	95
819	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2017	Age	13-17 Years	53.1	44.1 to 62.0	169
820	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2018	Age	13-17 Years	59.0	48.0 to 69.2	131
821	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2019	Age	13-17 Years	70.4	58.3 to 80.2	109
822	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2020	Age	13-17 Years	69.4	60.0 to 77.4	167
823	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2019	Age	13-15 Years	55.3	41.5 to 68.3	100
824	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2016	Age	13-17 Years	44.0	34.7 to 53.7	168
825	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2022	Age	13-15 Years	58.6	48.0 to 68.5	114
826	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2021	Age	13-15 Years	61.3	48.2 to 73.0	101
827	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2017	Age	13-17 Years	54.4	45.6 to 62.9	185
828	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2020	Age	13-15 Years	64.0	51.7 to 74.7	111
829	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2018	Age	13-15 Years	66.8	52.5 to 78.6	80
830	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2022	Age	13-17 Years	69.4	60.4 to 77.1	160
831	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2021	Age	13-17 Years	68.6	57.5 to 77.9	135
832	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2022	Age	13-15 Years	63.4	55.5 to 70.6	205
833	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2021	Age	13-17 Years	69.8	60.3 to 77.8	163
834	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2018	Age	13-17 Years	65.8	55.6 to 74.8	147
835	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2019	Age	13-17 Years	56.9	45.8 to 67.4	153
836	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2020	Age	13-17 Years	63.6	54.3 to 72.0	187
837	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2019	Age	13-15 Years	62.4	52.3 to 71.5	170
838	HPV	Up-to-Date, Males	States/Local Areas	Colorado	2022	Age	13-17 Years	62.3	54.0 to 69.9	182
839	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2021	Age	13-15 Years	63.6	54.3 to 72.0	196
840	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2016	Age	13-17 Years	52.1	41.9 to 62.2	154
841	HPV	Up-to-Date, Males and Females	States/Local Areas	Colorado	2020	Age	13-15 Years	64.8	56.0 to 72.7	206
842	Varicella	History of disease	States/Local Areas	Colorado	2017	Age	13-17 Years	13.6	9.6 to 19.0	354
843	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2019	Age	13-15 Years	70.2	55.3 to 81.7	70
844	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2020	Age	13-15 Years	65.6	52.7 to 76.6	95
845	HPV	Up-to-Date, Females	States/Local Areas	Colorado	2018	Age	13-15 Years	54.9	41.3 to 67.8	87
846	Varicella	History of disease	States/Local Areas	Colorado	2022	Age	13-17 Years	5.9	3.7 to 9.4	342
847	Varicella	History of disease	States/Local Areas	Colorado	2021	Age	13-17 Years	8.1	4.7 to 13.9	298
848	Varicella	History of disease	States/Local Areas	Colorado	2020	Age	13-17 Years	8.9	5.7 to 13.6	354
849	Varicella	History of disease	States/Local Areas	Colorado	2009	Age	13-17 Years	55.6	49.4 to 61.7	411
850	Varicella	History of disease	States/Local Areas	Colorado	2008	Age	13-17 Years	60.9	53.8 to 67.5	347
851	Varicella	History of disease	States/Local Areas	Colorado	2018	Age	13-17 Years	10.4	6.4 to 16.6	278
852	Varicella	History of disease	States/Local Areas	Colorado	2019	Age	13-17 Years	12.3	7.6 to 19.3	262
853	Varicella	History of disease	States/Local Areas	Colorado	2016	Age	13-17 Years	11.8	8.0 to 17.1	322
854	Varicella	History of disease	States/Local Areas	Colorado	2012	Age	13-17 Years	26.6	19.5 to 35.1	311
855	Varicella	History of disease	States/Local Areas	Colorado	2013	Age	13-17 Years	18.7	14.5 to 23.9	331
856	Varicella	History of disease	States/Local Areas	Colorado	2010	Age	13-17 Years	38.8	32.7 to 45.3	317
857	Varicella	History of disease	States/Local Areas	Colorado	2011	Age	13-17 Years	39.0	32.2 to 46.2	431
858	Varicella	History of disease	States/Local Areas	Colorado	2015	Age	13-17 Years	18.0	13.7 to 23.3	354
859	Varicella	History of disease	States/Local Areas	Colorado	2014	Age	13-17 Years	21.5	16.6 to 27.3	394
860	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2011	Age	13-17 Years	49.0	43.7 to 54.3	732
861	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2010	Age	13-17 Years	44.1	39.4 to 48.8	616
862	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2017	Age	13-17 Years	83.9	80.9 to 86.6	1140
863	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2013	Age	13-17 Years	67.4	62.8 to 71.7	858
864	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2014	Age	13-17 Years	70.7	66.5 to 74.5	1015
865	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2015	Age	13-17 Years	76.8	73.1 to 80.1	1170
866	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2016	Age	13-17 Years	79.7	76.1 to 82.8	1137
867	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2015	Age	13-15 Years	76.3	71.5 to 80.4	784
868	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2014	Age	13-15 Years	76.1	71.2 to 80.4	634
869	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2018	Age	13-15 Years	90.8	87.3 to 93.3	656
870	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2019	Age	13-15 Years	91.7	88.2 to 94.2	731
871	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2017	Age	13-15 Years	87.2	83.4 to 90.2	726
872	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2016	Age	13-15 Years	83.1	78.7 to 86.7	743
873	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2010	Age	13-17 Years	74.9	71.8 to 77.8	1291
874	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2009	Age	13-17 Years	78.6	75.8 to 81.2	1250
875	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2012	Age	13-15 Years	67.3	61.2 to 72.9	539
876	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2013	Age	13-15 Years	67.5	61.6 to 72.9	590
877	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2011	Age	13-15 Years	56.9	50.8 to 62.8	599
878	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2010	Age	13-15 Years	54.7	49.0 to 60.3	438
879	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2008	Age	13-15 Years	32.4	25.4 to 40.2	311
880	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2009	Age	13-15 Years	44.0	37.7 to 50.4	341
881	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2012	Age	13-17 Years	78.2	74.3 to 81.6	1285
882	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2011	Age	13-17 Years	75.6	72.2 to 78.8	1528
883	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2013	Age	13-17 Years	77.6	74.0 to 80.7	1251
884	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2007	Age	13-17 Years	78.1	68.9 to 85.2	165
885	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2020	Age	13-17 Years	92.6	90.6 to 94.2	1446
886	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2021	Age	13-17 Years	92.8	90.3 to 94.7	1154
887	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2022	Age	13-17 Years	92.1	89.6 to 94.0	1048
888	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2015	Age	13-17 Years	81.4	78.3 to 84.2	1451
889	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2014	Age	13-17 Years	78.6	75.3 to 81.6	1362
890	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2012	Age	13-15 Years	5.2	2.9 to 9.2	394
891	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2014	Age	13-15 Years	16.0	12.1 to 20.9	436
892	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2019	Age	13-17 Years	91.2	88.5 to 93.4	1256
893	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2017	Age	13-17 Years	86.2	83.5 to 88.5	1340
894	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2018	Age	13-17 Years	89.2	86.6 to 91.3	1191
895	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2016	Age	13-17 Years	83.4	80.4 to 86.0	1394
896	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2008	Age	13-17 Years	77.0	74.0 to 79.8	1295
897	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2006	Age	13-17 Years	77.9	69.8 to 84.3	165
898	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2013	Age	13-17 Years	9.4	7.1 to 12.4	659
899	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2012	Age	13-17 Years	5.3	3.4 to 8.1	681
900	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2015	Age	13-17 Years	24.4	20.1 to 29.2	760
901	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2014	Age	13-17 Years	16.3	13.0 to 20.1	717
902	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2015	Age	13-15 Years	20.3	15.9 to 25.6	502
903	HPV	≥3 Doses, Males	HHS Regions/National	Region 7	2013	Age	13-15 Years	8.5	5.9 to 12.2	416
904	≥2 Doses Hep A		HHS Regions/National	Region 7	2020	Age	13-17 Years	76.6	73.5 to 79.5	1446
905	≥2 Doses Hep A		HHS Regions/National	Region 7	2022	Age	13-17 Years	83.9	80.7 to 86.7	1048
906	≥2 Doses Hep A		HHS Regions/National	Region 7	2021	Age	13-17 Years	82.6	79.4 to 85.5	1154
907	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2010	Age	13-17 Years	30.1	26.1 to 34.4	616
908	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2012	Age	13-17 Years	33.1	28.0 to 38.5	604
909	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2011	Age	13-17 Years	31.3	26.6 to 36.4	732
910	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2013	Age	13-17 Years	31.7	27.0 to 36.8	592
911	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2014	Age	13-17 Years	31.6	27.2 to 36.4	645
912	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2015	Age	13-17 Years	37.9	33.0 to 43.1	691
913	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2008	Age	13-17 Years	18.1	14.5 to 22.3	608
914	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2009	Age	13-17 Years	26.2	22.2 to 30.6	607
915	≥1 Dose MenACWY		HHS Regions/National	Region 7	2016	Age	13-15 Years	70.1	65.7 to 74.2	876
916	≥1 Dose MenACWY		HHS Regions/National	Region 7	2012	Age	13-15 Years	58.6	53.4 to 63.7	755
917	≥1 Dose MenACWY		HHS Regions/National	Region 7	2013	Age	13-15 Years	61.2	56.3 to 65.9	790
918	≥1 Dose MenACWY		HHS Regions/National	Region 7	2015	Age	13-15 Years	70.4	66.0 to 74.4	925
919	≥1 Dose MenACWY		HHS Regions/National	Region 7	2014	Age	13-15 Years	66.4	61.7 to 70.8	815
920	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2016	Age	13-17 Years	88.2	85.7 to 90.3	1394
921	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2014	Age	13-17 Years	85.1	82.2 to 87.5	1362
922	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2015	Age	13-17 Years	88.4	85.8 to 90.6	1451
923	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	66.2	61.3 to 70.7	624
924	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	60.7	55.7 to 65.5	664
925	≥3 Doses HepB		HHS Regions/National	Region 7	2022	Age	13-17 Years	90.8	88.2 to 93.0	1048
926	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	70.1	65.1 to 74.7	548
927	≥3 Doses HepB		HHS Regions/National	Region 7	2020	Age	13-17 Years	92.2	90.0 to 94.0	1446
928	≥3 Doses HepB		HHS Regions/National	Region 7	2021	Age	13-17 Years	93.1	90.8 to 94.9	1154
929	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2022	Age	13-17 Years	94.5	92.4 to 96.1	979
930	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2021	Age	13-17 Years	95.4	93.2 to 96.9	1073
931	HPV	≥2 Doses, Males and Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	57.6	53.7 to 61.4	1256
932	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2013	Age	13-17 Years	26.0	21.8 to 30.6	659
933	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2014	Age	13-17 Years	31.0	26.6 to 35.9	717
934	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2015	Age	13-17 Years	44.8	39.9 to 49.9	760
935	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2016	Age	13-17 Years	50.2	45.3 to 55.1	730
936	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2012	Age	13-17 Years	19.1	14.7 to 24.6	681
937	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2017	Age	13-17 Years	57.0	52.1 to 61.7	716
938	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2018	Age	13-17 Years	62.7	57.7 to 67.5	643
939	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2019	Age	13-17 Years	69.4	64.2 to 74.1	648
940	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2020	Age	13-17 Years	69.0	64.4 to 73.2	795
941	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2021	Age	13-17 Years	74.6	69.4 to 79.2	619
942	HPV	≥2 Doses, Males and Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	51.3	47.6 to 54.9	1191
943	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	71.5	66.3 to 76.2	608
944	HPV	≥2 Doses, Males and Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	49.1	45.7 to 52.5	1340
945	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2022	Age	13-17 Years	91.5	88.9 to 93.5	979
946	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2020	Age	13-17 Years	73.7	68.7 to 78.1	651
947	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2021	Age	13-17 Years	81.3	76.5 to 85.3	535
948	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2011	Age	13-17 Years	6.2	4.3 to 8.9	796
949	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	80.1	75.5 to 84.0	503
950	HPV	≥2 Doses, Males and Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	43.6	40.2 to 47.1	1394
951	≥3 Doses HepB		HHS Regions/National	Region 7	2012	Age	13-17 Years	90.2	87.4 to 92.4	1285
952	≥3 Doses HepB		HHS Regions/National	Region 7	2011	Age	13-17 Years	89.7	86.8 to 92.0	1528
953	≥3 Doses HepB		HHS Regions/National	Region 7	2013	Age	13-17 Years	90.4	87.5 to 92.7	1251
954	≥3 Doses HepB		HHS Regions/National	Region 7	2014	Age	13-17 Years	89.0	86.2 to 91.3	1362
955	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2009	Age	13-17 Years	39.4	34.8 to 44.2	607
956	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2007	Age	13-17 Years	52.0	32.1 to 71.3	36
957	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2012	Age	13-17 Years	64.6	59.3 to 69.6	810
958	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2008	Age	13-17 Years	33.3	28.6 to 38.3	608
959	≥3 Doses HepB		HHS Regions/National	Region 7	2008	Age	13-17 Years	82.5	79.8 to 84.9	1295
960	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2007	Age	13-17 Years	22.9	14.6 to 34.0	81
961	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2008	Age	13-17 Years	67.1	60.9 to 72.8	414
962	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2010	Age	13-17 Years	82.5	78.3 to 86.1	617
963	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2009	Age	13-17 Years	81.1	76.7 to 84.9	477
964	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2008	Age	13-17 Years	29.4	23.5 to 36.0	414
965	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2009	Age	13-17 Years	42.4	37.2 to 47.8	477
966	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2006	Age	13-17 Years	50.3	32.3 to 68.2	40
967	≥3 Doses HepB		HHS Regions/National	Region 7	2007	Age	13-17 Years	84.2	76.2 to 89.8	165
968	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2011	Age	13-17 Years	86.1	81.5 to 89.7	831
969	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2010	Age	13-17 Years	49.8	45.0 to 54.5	617
970	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2011	Age	13-17 Years	54.6	49.4 to 59.6	831
971	≥3 Doses HepB		HHS Regions/National	Region 7	2006	Age	13-17 Years	70.2	61.2 to 77.9	165
972	≥3 Doses HepB		HHS Regions/National	Region 7	2010	Age	13-17 Years	89.8	87.7 to 91.6	1291
973	≥3 Doses HepB		HHS Regions/National	Region 7	2009	Age	13-17 Years	84.8	82.1 to 87.2	1250
974	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2022	Age	13-15 Years	92.8	89.4 to 95.2	609
975	≥3 Doses HepB		HHS Regions/National	Region 7	2017	Age	13-17 Years	91.5	89.4 to 93.3	1340
976	≥3 Doses HepB		HHS Regions/National	Region 7	2018	Age	13-17 Years	90.9	88.6 to 92.7	1191
977	≥3 Doses HepB		HHS Regions/National	Region 7	2019	Age	13-17 Years	92.0	89.4 to 94.0	1256
978	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2019	Age	13-17 Years	94.4	91.8 to 96.2	1116
979	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2012	Age	13-17 Years	90.6	85.6 to 94.0	810
980	≥3 Doses HepB		HHS Regions/National	Region 7	2016	Age	13-17 Years	90.8	88.7 to 92.5	1394
981	≥3 Doses HepB		HHS Regions/National	Region 7	2015	Age	13-17 Years	90.2	87.7 to 92.2	1451
982	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2018	Age	13-17 Years	94.3	92.1 to 96.0	1026
983	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2019	Age	13-17 Years	90.3	87.3 to 92.6	1116
984	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2020	Age	13-17 Years	91.7	89.6 to 93.5	1291
985	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2021	Age	13-17 Years	92.3	89.6 to 94.3	1073
986	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2018	Age	13-17 Years	87.5	84.6 to 89.9	1026
987	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2020	Age	13-17 Years	95.4	93.7 to 96.7	1291
988	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2017	Age	13-17 Years	95.3	93.5 to 96.7	1140
989	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2013	Age	13-17 Years	92.9	89.9 to 95.0	858
990	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2014	Age	13-17 Years	89.7	86.4 to 92.2	1015
991	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2015	Age	13-17 Years	94.1	92.0 to 95.7	1170
992	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2016	Age	13-17 Years	94.9	92.8 to 96.3	1137
993	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2020	Age	13-15 Years	92.4	89.6 to 94.5	807
994	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2021	Age	13-15 Years	91.5	87.7 to 94.3	671
995	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2012	Age	13-17 Years	53.1	47.4 to 58.7	604
996	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2013	Age	13-17 Years	49.7	44.2 to 55.3	592
997	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2014	Age	13-17 Years	49.8	44.7 to 54.9	645
998	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2015	Age	13-17 Years	60.2	55.0 to 65.2	691
999	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2007	Age	13-17 Years	70.7	61.7 to 78.3	165
1000	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2006	Age	13-17 Years	64.7	56.4 to 72.2	165
1001	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2010	Age	13-17 Years	38.8	34.3 to 43.5	616
1002	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2011	Age	13-17 Years	39.2	34.1 to 44.4	732
1003	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2009	Age	13-17 Years	32.0	27.7 to 36.5	607
1004	≥1 Dose MenACWY		HHS Regions/National	Region 7	2020	Age	13-15 Years	84.2	80.4 to 87.3	894
1005	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2012	Age	13-17 Years	42.4	37.0 to 48.1	604
1006	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2013	Age	13-17 Years	41.7	36.4 to 47.2	592
1007	≥1 Dose MenACWY		HHS Regions/National	Region 7	2017	Age	13-15 Years	76.8	72.7 to 80.4	833
1008	≥1 Dose MenACWY		HHS Regions/National	Region 7	2018	Age	13-15 Years	81.5	77.2 to 85.1	726
1009	≥1 Dose MenACWY		HHS Regions/National	Region 7	2019	Age	13-15 Years	85.1	81.4 to 88.1	799
1010	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2017	Age	13-17 Years	87.8	85.0 to 90.1	1340
1011	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	61.5	58.0 to 64.8	1340
1012	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	55.3	51.8 to 58.8	1394
1013	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2022	Age	13-17 Years	76.0	70.6 to 80.6	545
1014	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2012	Age	13-17 Years	88.0	85.2 to 90.3	1285
1015	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2013	Age	13-17 Years	83.9	80.9 to 86.5	1251
1016	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2010	Age	13-17 Years	77.1	74.1 to 79.9	1291
1017	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2011	Age	13-17 Years	82.6	79.7 to 85.2	1528
1018	≥1 Dose MenACWY		HHS Regions/National	Region 7	2009	Age	13-15 Years	46.9	42.5 to 51.3	727
1019	≥1 Dose MenACWY		HHS Regions/National	Region 7	2008	Age	13-15 Years	33.2	29.2 to 37.6	783
1020	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2008	Age	13-17 Years	26.0	21.7 to 30.9	608
1021	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2007	Age	13-17 Years	18.4	11.0 to 29.1	81
1022	≥1 Dose MenACWY		HHS Regions/National	Region 7	2011	Age	13-15 Years	60.2	55.6 to 64.7	933
1023	≥1 Dose MenACWY		HHS Regions/National	Region 7	2010	Age	13-15 Years	54.7	50.5 to 58.8	775
1024	≥1 Dose MenACWY		HHS Regions/National	Region 7	2006	Age	13-15 Years	23.2	13.5 to 36.8	91
1025	≥1 Dose MenACWY		HHS Regions/National	Region 7	2007	Age	13-15 Years	30.8	20.9 to 42.9	95
1026	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2018	Age	13-17 Years	88.1	85.2 to 90.5	1191
1027	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2019	Age	13-17 Years	90.1	87.4 to 92.2	1256
1028	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2020	Age	13-17 Years	89.3	86.8 to 91.4	1446
1029	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	70.4	66.8 to 73.8	1256
1030	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	66.4	62.8 to 69.7	1191
1031	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2021	Age	13-17 Years	92.0	89.5 to 94.0	1154
1032	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2008	Age	13-17 Years	68.4	65.0 to 71.5	1295
1033	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2009	Age	13-17 Years	74.3	71.2 to 77.1	1250
1034	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	54.9	50.0 to 59.8	624
1035	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	48.9	43.9 to 53.9	664
1036	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2015	Age	13-17 Years	49.3	44.0 to 54.6	691
1037	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2014	Age	13-17 Years	40.6	35.8 to 45.7	645
1038	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2020	Age	13-17 Years	71.3	67.9 to 74.4	1446
1039	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2021	Age	13-17 Years	77.9	74.4 to 81.0	1154
1040	≥1 Dose MenACWY		HHS Regions/National	Region 7	2021	Age	13-15 Years	90.1	86.8 to 92.7	715
1041	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	57.2	51.9 to 62.2	548
1042	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	57.6	51.9 to 63.0	608
1043	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2006	Age	13-15 Years	22.2	14.0 to 33.5	91
1044	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2007	Age	13-15 Years	46.9	35.2 to 59.1	95
1045	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2012	Age	13-15 Years	85.0	81.0 to 88.2	755
1046	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2011	Age	13-15 Years	80.0	75.9 to 83.5	933
1047	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2009	Age	13-15 Years	61.9	57.5 to 66.1	727
1048	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2010	Age	13-15 Years	67.5	63.3 to 71.5	775
1049	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2008	Age	13-15 Years	47.2	42.8 to 51.7	783
1050	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2022	Age	13-17 Years	92.5	90.2 to 94.3	1048
1051	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2017	Age	13-15 Years	84.8	80.9 to 88.0	833
1052	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2016	Age	13-15 Years	84.9	81.3 to 87.9	876
1053	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2015	Age	13-15 Years	84.1	80.2 to 87.3	925
1054	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2014	Age	13-15 Years	84.0	80.0 to 87.2	815
1055	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2013	Age	13-15 Years	80.1	75.8 to 83.7	790
1056	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2018	Age	13-17 Years	45.6	40.7 to 50.7	643
1057	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2017	Age	13-17 Years	43.6	38.9 to 48.4	716
1058	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2016	Age	13-17 Years	38.6	34.0 to 43.4	730
1059	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2015	Age	13-17 Years	34.6	30.0 to 39.6	760
1060	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2019	Age	13-15 Years	88.0	84.3 to 90.8	799
1061	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2020	Age	13-15 Years	85.9	82.1 to 89.1	894
1062	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2021	Age	13-15 Years	89.5	85.9 to 92.2	715
1063	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2018	Age	13-15 Years	85.9	81.6 to 89.3	726
1064	≥1 Dose MenACWY		HHS Regions/National	Region 7	2017	Age	13-17 Years	77.3	74.2 to 80.2	1340
1065	≥1 Dose MenACWY		HHS Regions/National	Region 7	2018	Age	13-17 Years	80.9	77.7 to 83.7	1191
1066	≥1 Dose MenACWY		HHS Regions/National	Region 7	2019	Age	13-17 Years	86.1	83.2 to 88.5	1256
1067	≥1 Dose MenACWY		HHS Regions/National	Region 7	2020	Age	13-17 Years	86.4	83.7 to 88.7	1446
1068	≥2 Doses MMR		HHS Regions/National	Region 7	2021	Age	13-17 Years	92.5	90.0 to 94.5	1154
1069	≥2 Doses MMR		HHS Regions/National	Region 7	2022	Age	13-17 Years	91.3	88.7 to 93.4	1048
1070	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2011	Age	13-15 Years	25.7	19.9 to 32.4	443
1071	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2010	Age	13-15 Years	28.2	23.3 to 33.7	379
1072	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2009	Age	13-15 Years	22.6	18.0 to 27.9	362
1073	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2008	Age	13-15 Years	15.7	11.4 to 21.2	360
1074	≥1 Dose MenACWY		HHS Regions/National	Region 7	2022	Age	13-17 Years	90.7	88.0 to 92.8	1048
1075	≥1 Dose MenACWY		HHS Regions/National	Region 7	2021	Age	13-17 Years	90.4	87.8 to 92.5	1154
1076	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2011	Age	13-17 Years	2.3	1.3 to 4.0	796
1077	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2012	Age	13-17 Years	11.0	8.0 to 14.8	681
1078	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2013	Age	13-17 Years	16.6	13.5 to 20.4	659
1079	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2014	Age	13-17 Years	23.8	19.7 to 28.3	717
1080	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2012	Age	13-15 Years	26.3	20.6 to 32.9	361
1081	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2013	Age	13-15 Years	22.7	18.0 to 28.3	374
1082	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2015	Age	13-15 Years	30.3	24.7 to 36.6	423
1083	HPV	≥3 Doses, Females	HHS Regions/National	Region 7	2014	Age	13-15 Years	24.3	19.2 to 30.3	379
1084	≥1 Dose MenACWY		HHS Regions/National	Region 7	2012	Age	13-17 Years	61.4	57.3 to 65.4	1285
1085	≥2 Doses MMR		HHS Regions/National	Region 7	2016	Age	13-17 Years	89.6	87.3 to 91.6	1394
1086	HPV	≥3 Doses, Males and Females	HHS Regions/National	Region 7	2011	Age	13-17 Years	15.6	13.1 to 18.4	1528
1087	≥2 Doses MMR		HHS Regions/National	Region 7	2014	Age	13-17 Years	87.7	84.8 to 90.2	1362
1088	≥2 Doses MMR		HHS Regions/National	Region 7	2015	Age	13-17 Years	89.0	86.3 to 91.3	1451
1089	≥2 Doses MMR		HHS Regions/National	Region 7	2012	Age	13-17 Years	88.8	85.7 to 91.3	1285
1090	≥2 Doses MMR		HHS Regions/National	Region 7	2013	Age	13-17 Years	89.0	86.2 to 91.2	1251
1091	≥1 Dose MenACWY		HHS Regions/National	Region 7	2007	Age	13-17 Years	26.9	19.7 to 35.4	165
1092	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2022	Age	13-17 Years	91.4	89.0 to 93.4	1048
1093	≥1 Dose MenACWY		HHS Regions/National	Region 7	2006	Age	13-17 Years	19.3	12.6 to 28.5	165
1094	≥2 Doses MMR		HHS Regions/National	Region 7	2018	Age	13-17 Years	90.8	88.4 to 92.7	1191
1095	≥2 Doses MMR		HHS Regions/National	Region 7	2017	Age	13-17 Years	90.7	88.4 to 92.5	1340
1096	≥2 Doses MMR		HHS Regions/National	Region 7	2019	Age	13-17 Years	91.8	89.2 to 93.8	1256
1097	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2019	Age	13-17 Years	88.3	85.4 to 90.6	1256
1098	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2020	Age	13-17 Years	87.9	85.3 to 90.2	1446
1099	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2021	Age	13-17 Years	90.2	87.6 to 92.4	1154
1100	HPV	≥3 Doses, Males and Females	HHS Regions/National	Region 7	2012	Age	13-17 Years	18.8	16.0 to 22.0	1285
1101	HPV	≥3 Doses, Males and Females	HHS Regions/National	Region 7	2013	Age	13-17 Years	20.2	17.6 to 23.2	1251
1102	≥2 Doses MMR		HHS Regions/National	Region 7	2020	Age	13-17 Years	92.9	90.9 to 94.4	1446
1103	HPV	≥3 Doses, Males and Females	HHS Regions/National	Region 7	2015	Age	13-17 Years	31.0	27.7 to 34.5	1451
1104	HPV	≥3 Doses, Males and Females	HHS Regions/National	Region 7	2014	Age	13-17 Years	23.8	20.9 to 26.8	1362
1105	HPV	≥2 Doses, Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	66.5	61.0 to 71.5	503
1106	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2016	Age	13-17 Years	86.2	83.6 to 88.4	1394
1107	≥1 Dose MenACWY		HHS Regions/National	Region 7	2010	Age	13-17 Years	52.6	49.3 to 55.9	1291
1108	≥1 Dose MenACWY		HHS Regions/National	Region 7	2011	Age	13-17 Years	57.2	53.6 to 60.8	1528
1109	≥1 Dose MenACWY		HHS Regions/National	Region 7	2008	Age	13-17 Years	32.8	29.6 to 36.2	1295
1110	≥1 Dose MenACWY		HHS Regions/National	Region 7	2009	Age	13-17 Years	45.2	41.9 to 48.6	1250
1111	≥1 Dose MenACWY		HHS Regions/National	Region 7	2013	Age	13-17 Years	62.5	58.8 to 66.2	1251
1112	≥1 Dose MenACWY		HHS Regions/National	Region 7	2014	Age	13-17 Years	65.4	61.7 to 68.9	1362
1113	≥1 Dose MenACWY		HHS Regions/National	Region 7	2015	Age	13-17 Years	70.7	67.3 to 74.0	1451
1114	≥1 Dose MenACWY		HHS Regions/National	Region 7	2016	Age	13-17 Years	70.8	67.4 to 74.0	1394
1115	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2018	Age	13-17 Years	86.6	83.7 to 89.2	1191
1116	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2017	Age	13-17 Years	86.8	84.0 to 89.2	1340
1117	≥1 Dose MenACWY		HHS Regions/National	Region 7	2022	Age	13-15 Years	90.9	87.6 to 93.4	654
1118	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	78.0	74.5 to 81.1	1048
1119	HPV	≥1 Dose, Males	HHS Regions/National	Region 7	2023	Age	13-17 Years	77.7	72.2 to 82.4	577
1120	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2023	Age	13-15 Years	57.5	49.7 to 65.0	328
1121	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2023	Age	13-17 Years	63.3	57.3 to 68.9	562
1122	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2023	Age	13-15 Years	89.6	85.2 to 92.8	631
1123	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2023	Age	13-15 Years	56.4	50.9 to 61.8	674
1124	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2023	Age	13-15 Years	55.4	47.7 to 62.9	346
1125	≥1 Dose MenACWY		HHS Regions/National	Region 7	2023	Age	13-15 Years	89.3	85.4 to 92.3	674
1126	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2023	Age	13-15 Years	89.1	85.1 to 92.1	674
1127	Varicella	≥2 Doses or history of disease	HHS Regions/National	Region 7	2023	Age	13-17 Years	91.2	88.5 to 93.4	1139
1128	≥2 Doses Hep A		HHS Regions/National	Region 7	2023	Age	13-17 Years	86.8	83.7 to 89.3	1139
1129	Varicella	≥2 Doses with no disease history	HHS Regions/National	Region 7	2023	Age	13-17 Years	90.7	87.8 to 93.0	1071
1130	Varicella	≥1 Dose with no disease history	HHS Regions/National	Region 7	2023	Age	13-17 Years	93.8	91.4 to 95.5	1071
1131	≥3 Doses HepB		HHS Regions/National	Region 7	2023	Age	13-17 Years	91.1	88.3 to 93.3	1139
1132	Varicella	History of disease	HHS Regions/National	Region 7	2023	Age	13-17 Years	5.4	3.8 to 7.8	1139
1133	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2023	Age	13-17 Years	60.7	54.7 to 66.4	577
1134	≥2 Doses MMR		HHS Regions/National	Region 7	2023	Age	13-17 Years	90.3	87.3 to 92.6	1139
1135	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2023	Age	13-17 Years	62.0	57.8 to 66.0	1139
1136	HPV	≥1 Dose, Females	HHS Regions/National	Region 7	2023	Age	13-17 Years	79.8	74.5 to 84.2	562
1137	HPV	≥1 Dose, Males and Females	HHS Regions/National	Region 7	2023	Age	13-17 Years	78.7	75.0 to 82.0	1139
1138	≥1 Dose MenACWY		HHS Regions/National	Region 7	2023	Age	13-17 Years	90.1	87.2 to 92.4	1139
1139	Tetanus	≥1 Dose Td or Tdap	HHS Regions/National	Region 7	2023	Age	13-17 Years	90.6	87.7 to 92.8	1139
1140	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2023	Age	13-17 Years	89.4	86.4 to 91.8	1139
1141	HPV	≥2 Doses, Males and Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	65.2	61.3 to 68.9	1048
1142	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2022	Age	13-17 Years	64.0	58.4 to 69.3	545
1143	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2018	Age	13-17 Years	62.7	57.1 to 67.9	895
1144	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2019	Age	13-17 Years	67.4	61.7 to 72.6	950
1145	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2021	Age	13-15 Years	69.9	62.4 to 76.6	550
1146	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2022	Age	13-15 Years	69.5	61.9 to 76.2	456
1147	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2017	Age	13-17 Years	66.2	61.4 to 70.6	989
1148	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2018	Age	13-15 Years	63.0	56.3 to 69.2	576
1149	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2021	Age	13-17 Years	73.9	68.2 to 78.8	898
1150	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2022	Age	13-17 Years	75.4	69.9 to 80.2	778
1151	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2019	Age	13-15 Years	58.8	51.3 to 65.9	669
1152	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2020	Age	13-15 Years	64.6	58.2 to 70.4	661
1153	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2021	Age	13-15 Years	66.4	59.4 to 72.8	636
1154	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2022	Age	13-15 Years	69.4	62.6 to 75.5	491
1155	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2021	Age	13-17 Years	69.5	64.0 to 74.5	1025
1156	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 1	2019	Age	13-15 Years	58.5	53.1 to 63.8	1209
1157	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2022	Age	13-17 Years	74.8	69.7 to 79.3	817
1158	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 1	2021	Age	13-15 Years	68.1	63.0 to 72.8	1186
1159	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 1	2020	Age	13-15 Years	64.9	60.6 to 69.0	1297
1160	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 1	2022	Age	13-15 Years	69.5	64.4 to 74.1	947
1161	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2018	Age	13-17 Years	64.1	58.9 to 69.0	1007
1162	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2017	Age	13-17 Years	60.5	56.1 to 64.8	1118
1163	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2019	Age	13-17 Years	64.8	59.3 to 70.0	1084
1164	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2020	Age	13-17 Years	69.5	64.9 to 73.7	1132
1165	HPV	Up-to-Date, Males	HHS Regions/National	Region 1	2016	Age	13-17 Years	49.3	44.7 to 54.0	1080
1166	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2019	Age	13-15 Years	58.2	50.2 to 65.9	540
1167	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2020	Age	13-15 Years	65.3	59.2 to 70.9	636
1168	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2018	Age	13-15 Years	56.9	49.8 to 63.8	564
1169	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2016	Age	13-17 Years	61.0	56.2 to 65.5	1017
1170	HPV	Up-to-Date, Females	HHS Regions/National	Region 1	2020	Age	13-17 Years	72.6	68.1 to 76.7	1015
1171	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2023	Age	13-17 Years	82.3	72.9 to 88.9	128
1172	HPV	Up-to-Date, Females	States/Local Areas	Nebraska	2023	Age	13-17 Years	67.9	57.3 to 76.9	128
1173	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2023	Age	13-15 Years	88.1	79.1 to 93.6	140
1174	HPV	Up-to-Date, Females	States/Local Areas	Nebraska	2023	Age	13-15 Years	58.4	44.0 to 71.5	70
1175	HPV	Up-to-Date, Males	States/Local Areas	Nebraska	2023	Age	13-15 Years	58.4	45.3 to 70.5	83
1176	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2023	Age	13-15 Years	58.4	48.8 to 67.5	153
1177	≥1 Dose MenACWY		States/Local Areas	Nebraska	2023	Age	13-15 Years	90.4	84.4 to 94.3	153
1178	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2023	Age	13-15 Years	88.2	79.9 to 93.3	153
1179	≥2 Doses Hep A		States/Local Areas	Nebraska	2023	Age	13-17 Years	87.4	81.5 to 91.6	272
1180	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2023	Age	13-17 Years	90.9	85.3 to 94.5	272
1181	Varicella	History of disease	States/Local Areas	Nebraska	2023	Age	13-17 Years	8.4	4.9 to 14.0	272
1182	≥3 Doses HepB		States/Local Areas	Nebraska	2023	Age	13-17 Years	89.6	84.2 to 93.3	272
1183	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2023	Age	13-17 Years	94.2	89.9 to 96.8	251
1184	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2023	Age	13-17 Years	90.1	84.0 to 94.0	251
1185	HPV	Up-to-Date, Males	States/Local Areas	Nebraska	2023	Age	13-17 Years	66.9	56.5 to 75.9	144
1186	≥2 Doses MMR		States/Local Areas	Nebraska	2023	Age	13-17 Years	93.7	89.7 to 96.2	272
1187	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2023	Age	13-17 Years	67.4	60.1 to 73.9	272
1188	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2023	Age	13-17 Years	83.9	77.7 to 88.6	272
1189	≥1 Dose MenACWY		States/Local Areas	Nebraska	2023	Age	13-17 Years	92.2	88.1 to 95.0	272
1190	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2023	Age	13-17 Years	89.5	83.5 to 93.5	272
1191	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2023	Age	13-17 Years	93.6	89.1 to 96.3	272
1192	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2023	Age	13-17 Years	85.4	76.3 to 91.5	144
1193	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2022	Age	13-17 Years	73.9	63.9 to 82.0	113
1194	HPV	≥2 Doses, Males and Females	States/Local Areas	Nebraska	2022	Age	13-17 Years	65.8	58.4 to 72.4	247
1195	≥1 Dose MenACWY		States/Local Areas	Nebraska	2009	Age	13-17 Years	53.2	46.8 to 59.6	286
1196	≥1 Dose MenACWY		States/Local Areas	Nebraska	2008	Age	13-17 Years	37.2	31.8 to 42.9	365
1197	≥1 Dose MenACWY		States/Local Areas	Nebraska	2011	Age	13-17 Years	76.0	69.9 to 81.2	368
1198	≥1 Dose MenACWY		States/Local Areas	Nebraska	2010	Age	13-17 Years	65.7	59.3 to 71.6	307
1199	≥1 Dose MenACWY		States/Local Areas	Nebraska	2012	Age	13-17 Years	75.5	68.9 to 81.1	328
1200	≥1 Dose MenACWY		States/Local Areas	Nebraska	2022	Age	13-15 Years	88.8	81.2 to 93.5	156
1201	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2017	Age	13-17 Years	92.3	87.5 to 95.4	324
1202	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018	Age	13-17 Years	89.0	83.3 to 92.9	295
1203	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2016	Age	13-17 Years	86.8	81.5 to 90.8	330
1204	HPV	≥3 Doses, Males and Females	States/Local Areas	Nebraska	2012	Age	13-17 Years	21.7	16.8 to 27.6	328
1205	HPV	≥3 Doses, Males and Females	States/Local Areas	Nebraska	2011	Age	13-17 Years	16.6	12.6 to 21.5	368
1206	≥1 Dose MenACWY		States/Local Areas	Nebraska	2016	Age	13-17 Years	80.2	74.6 to 84.8	330
1207	≥1 Dose MenACWY		States/Local Areas	Nebraska	2015	Age	13-17 Years	78.1	73.0 to 82.5	393
1208	≥1 Dose MenACWY		States/Local Areas	Nebraska	2014	Age	13-17 Years	74.1	67.9 to 79.5	321
1209	≥1 Dose MenACWY		States/Local Areas	Nebraska	2013	Age	13-17 Years	77.5	71.9 to 82.3	301
1210	≥2 Doses MMR		States/Local Areas	Nebraska	2016	Age	13-17 Years	89.7	84.7 to 93.2	330
1211	≥2 Doses MMR		States/Local Areas	Nebraska	2014	Age	13-17 Years	94.5	90.3 to 96.9	321
1212	≥2 Doses MMR		States/Local Areas	Nebraska	2015	Age	13-17 Years	92.2	88.7 to 94.8	393
1213	≥2 Doses MMR		States/Local Areas	Nebraska	2012	Age	13-17 Years	90.6	85.5 to 94.0	328
1214	≥2 Doses MMR		States/Local Areas	Nebraska	2013	Age	13-17 Years	92.3	88.4 to 94.9	301
1215	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2019	Age	13-17 Years	91.2	85.6 to 94.7	285
1216	≥1 Dose MenACWY		States/Local Areas	Nebraska	2017	Age	13-17 Years	84.8	79.4 to 89.0	324
1217	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2020	Age	13-17 Years	91.3	87.3 to 94.1	405
1218	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2021	Age	13-17 Years	92.3	88.0 to 95.1	315
1219	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2022	Age	13-17 Years	90.1	84.9 to 93.6	247
1220	≥2 Doses MMR		States/Local Areas	Nebraska	2019	Age	13-17 Years	91.4	85.9 to 94.9	285
1221	≥2 Doses MMR		States/Local Areas	Nebraska	2018	Age	13-17 Years	93.1	88.8 to 95.8	295
1222	≥2 Doses MMR		States/Local Areas	Nebraska	2017	Age	13-17 Years	93.4	88.8 to 96.2	324
1223	HPV	≥3 Doses, Males and Females	States/Local Areas	Nebraska	2013	Age	13-17 Years	30.3	24.8 to 36.5	301
1224	≥2 Doses MMR		States/Local Areas	Nebraska	2020	Age	13-17 Years	91.1	86.9 to 94.0	405
1225	HPV	≥3 Doses, Males and Females	States/Local Areas	Nebraska	2015	Age	13-17 Years	40.0	34.5 to 45.9	393
1226	HPV	≥3 Doses, Males and Females	States/Local Areas	Nebraska	2014	Age	13-17 Years	32.8	26.8 to 39.4	321
1227	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2015	Age	13-15 Years	41.2	31.0 to 52.3	113
1228	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2014	Age	13-15 Years	41.0	29.1 to 54.2	85
1229	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2013	Age	13-15 Years	28.6	19.4 to 40.0	86
1230	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2008	Age	13-15 Years	19.7	13.2 to 28.3	122
1231	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2010	Age	13-15 Years	42.9	31.7 to 54.9	89
1232	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2009	Age	13-15 Years	33.3	22.2 to 46.6	78
1233	≥1 Dose MenACWY		States/Local Areas	Nebraska	2022	Age	13-17 Years	88.3	82.5 to 92.4	247
1234	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2012	Age	13-15 Years	37.9	26.1 to 51.2	84
1235	HPV	≥3 Doses, Females	States/Local Areas	Nebraska	2011	Age	13-15 Years	28.6	19.4 to 40.0	115
1236	≥2 Doses MMR		States/Local Areas	Nebraska	2021	Age	13-17 Years	94.0	90.1 to 96.5	315
1237	≥2 Doses MMR		States/Local Areas	Nebraska	2022	Age	13-17 Years	90.6	85.4 to 94.0	247
1238	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Overall	Overall	87.1	84.8 to 89.1	1547
1239	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Overall	Overall	90.8	88.8 to 92.4	1547
1240	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2022	Age	13-17 Years	57.1	46.8 to 66.9	134
1241	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Overall	Overall	79.2	76.5 to 81.7	1547
1242	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a Non-MSA	89.0	84.8 to 92.1	478
1243	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Overall	Overall	63.1	60.0 to 66.1	1547
1244	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a Non-MSA	71.3	65.6 to 76.3	478
1245	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Non-Principal City	80.1	73.8 to 85.3	316
1246	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Principal City	83.7	80.1 to 86.7	753
1247	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a Non-MSA	51.9	46.3 to 57.5	478
1248	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Non-Principal City	65.1	58.1 to 71.5	316
1249	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Principal City	69.1	64.8 to 73.0	753
1250	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Non-Principal City	88.5	82.8 to 92.5	316
1251	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a Non-MSA	84.1	79.3 to 87.9	478
1252	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Principal City	88.5	85.3 to 91.1	753
1253	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	White, Non-Hispanic	63.1	59.4 to 66.5	1149
1254	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Hispanic	87.5	81.5 to 91.7	237
1255	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Principal City	91.3	88.5 to 93.4	753
1256	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Urbanicity	Living In a MSA Non-Principal City	92.3	86.9 to 95.5	316
1257	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	89.7	79.9 to 95.0	107
1258	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Black, Non-Hispanic	48.5	33.7 to 63.5	54
1259	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	77.1	65.9 to 85.5	107
1260	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	58.8	47.1 to 69.7	107
1261	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Hispanic	70.1	62.8 to 76.5	237
1262	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	White, Non-Hispanic	87.2	84.5 to 89.5	1149
1263	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Black, Non-Hispanic	73.9	58.3 to 85.2	54
1264	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	White, Non-Hispanic	90.8	88.4 to 92.8	1149
1265	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Hispanic	90.0	84.3 to 93.8	237
1266	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Hispanic	88.5	82.2 to 92.7	237
1267	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Black, Non-Hispanic	91.5	80.7 to 96.5	54
1268	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	94.7	88.7 to 97.6	107
1269	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	White, Non-Hispanic	77.9	74.6 to 80.9	1149
1270	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Race and Ethnicity	Black, Non-Hispanic	73.2	57.7 to 84.6	54
1271	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Poverty	Below Poverty Level	78.1	70.0 to 84.5	202
1272	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Poverty	Below Poverty Level	84.0	76.5 to 89.4	202
1273	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Poverty	Living At or Above Poverty Level	79.4	76.4 to 82.1	1308
1274	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Poverty	Living At or Above Poverty Level	87.7	85.3 to 89.8	1308
1275	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Poverty	Below Poverty Level	61.0	52.5 to 68.9	202
1276	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Poverty	Living At or Above Poverty Level	63.5	60.2 to 66.8	1308
1277	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Poverty	Living At or Above Poverty Level	90.9	88.7 to 92.7	1308
1278	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Poverty	Below Poverty Level	88.9	82.2 to 93.2	202
1279	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Private Insurance Only	86.7	83.7 to 89.2	1027
1280	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Any Medicaid	84.8	79.6 to 88.9	364
1281	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Private Insurance Only	78.3	74.9 to 81.5	1027
1282	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Any Medicaid	80.2	74.6 to 84.9	364
1283	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Other	98.5	95.9 to 99.5	89
1284	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Other	83.4	71.6 to 90.9	89
1285	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Private Insurance Only	63.9	60.1 to 67.6	1027
1286	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Uninsured	93.5	83.4 to 97.6	67
1287	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Uninsured	80.5	66.4 to 89.6	67
1288	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Any Medicaid	62.5	56.2 to 68.3	364
1289	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Other	62.1	48.9 to 73.7	89
1290	HPV	Up-to-Date, Males and Females	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Uninsured	57.7	43.2 to 71.0	67
1291	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Private Insurance Only	90.9	88.5 to 92.9	1027
1292	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Any Medicaid	89.0	84.1 to 92.5	364
1293	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Other	96.3	87.7 to 99.0	89
1294	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018-2022	Insurance Coverage	Uninsured	92.8	80.5 to 97.6	67
1295	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2020	Age	13-17 Years	82.9	76.0 to 88.1	221
1296	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2021	Age	13-17 Years	79.7	70.8 to 86.3	168
1297	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2018	Age	13-17 Years	70.9	61.1 to 79.0	161
1298	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2012	Age	13-17 Years	19.6	13.6 to 27.3	182
1299	HPV	≥2 Doses, Males and Females	States/Local Areas	Nebraska	2018	Age	13-17 Years	64.4	57.3 to 70.9	295
1300	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2019	Age	13-17 Years	74.0	63.2 to 82.5	132
1301	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2020	Age	13-17 Years	82.3	74.1 to 88.3	184
1302	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2021	Age	13-17 Years	85.9	77.6 to 91.4	147
1303	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2022	Age	13-17 Years	76.2	65.9 to 84.1	134
1304	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2011	Age	13-17 Years	14.2	7.8 to 24.3	194
1305	HPV	≥2 Doses, Males and Females	States/Local Areas	Nebraska	2017	Age	13-17 Years	62.8	56.4 to 68.7	324
1306	HPV	≥2 Doses, Males and Females	States/Local Areas	Nebraska	2016	Age	13-17 Years	52.1	45.5 to 58.6	330
1307	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2019	Age	13-17 Years	73.9	63.5 to 82.2	153
1308	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2017	Age	13-17 Years	70.0	61.6 to 77.3	179
1309	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2016	Age	13-17 Years	58.3	49.3 to 66.8	179
1310	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2015	Age	13-17 Years	54.3	46.4 to 62.0	209
1311	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2014	Age	13-17 Years	39.5	30.8 to 48.9	167
1312	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2013	Age	13-17 Years	38.2	29.9 to 47.2	160
1313	HPV	≥2 Doses, Males and Females	States/Local Areas	Nebraska	2019	Age	13-17 Years	62.5	55.1 to 69.3	285
1314	≥3 Doses HepB		States/Local Areas	Nebraska	2008	Age	13-17 Years	90.6	86.1 to 93.8	365
1315	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2022	Age	13-15 Years	91.2	84.6 to 95.1	148
1316	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2008	Age	13-17 Years	29.5	23.0 to 37.0	186
1317	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2011	Age	13-17 Years	76.4	67.8 to 83.3	221
1318	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2010	Age	13-17 Years	59.8	49.9 to 68.9	145
1319	≥3 Doses HepB		States/Local Areas	Nebraska	2012	Age	13-17 Years	90.0	84.5 to 93.7	328
1320	≥3 Doses HepB		States/Local Areas	Nebraska	2011	Age	13-17 Years	94.0	90.0 to 96.4	368
1321	≥3 Doses HepB		States/Local Areas	Nebraska	2014	Age	13-17 Years	93.9	89.6 to 96.5	321
1322	≥3 Doses HepB		States/Local Areas	Nebraska	2013	Age	13-17 Years	93.8	90.1 to 96.2	301
1323	≥1 Dose MenACWY		States/Local Areas	Nebraska	2015	Age	13-15 Years	76.8	70.0 to 82.5	247
1324	≥1 Dose MenACWY		States/Local Areas	Nebraska	2014	Age	13-15 Years	73.5	65.5 to 80.3	186
1325	≥1 Dose MenACWY		States/Local Areas	Nebraska	2012	Age	13-15 Years	74.7	66.2 to 81.6	188
1326	≥1 Dose MenACWY		States/Local Areas	Nebraska	2013	Age	13-15 Years	79.0	71.8 to 84.8	179
1327	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2017	Age	13-17 Years	72.0	62.5 to 79.8	145
1328	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2016	Age	13-17 Years	69.4	59.8 to 77.6	151
1329	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2021	Age	13-17 Years	94.4	90.6 to 96.7	292
1330	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2022	Age	13-17 Years	89.1	83.3 to 93.0	232
1331	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2008	Age	13-17 Years	24.4	18.4 to 31.5	186
1332	≥1 Dose MenACWY		States/Local Areas	Nebraska	2016	Age	13-15 Years	81.1	73.5 to 86.8	199
1333	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2017	Age	13-17 Years	95.3	91.2 to 97.6	324
1334	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2016	Age	13-17 Years	90.8	86.1 to 94.0	330
1335	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2014	Age	13-17 Years	85.6	79.8 to 89.9	321
1336	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2015	Age	13-17 Years	90.5	86.1 to 93.6	393
1337	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2018	Age	13-17 Years	80.6	70.8 to 87.7	134
1338	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2022	Age	13-17 Years	93.2	88.0 to 96.2	232
1339	≥3 Doses HepB		States/Local Areas	Nebraska	2020	Age	13-17 Years	90.6	86.1 to 93.7	405
1340	≥3 Doses HepB		States/Local Areas	Nebraska	2021	Age	13-17 Years	92.9	89.0 to 95.5	315
1341	≥3 Doses HepB		States/Local Areas	Nebraska	2022	Age	13-17 Years	90.2	84.9 to 93.8	247
1342	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2009	Age	13-17 Years	78.8	73.1 to 83.5	286
1343	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2008	Age	13-17 Years	71.5	65.6 to 76.7	365
1344	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2012	Age	13-17 Years	85.2	79.1 to 89.8	328
1345	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2013	Age	13-17 Years	88.7	83.6 to 92.4	301
1346	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2011	Age	13-17 Years	87.3	82.1 to 91.1	368
1347	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2010	Age	13-17 Years	82.7	77.1 to 87.1	307
1348	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2011	Age	13-17 Years	40.6	31.7 to 50.2	174
1349	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2010	Age	13-17 Years	48.5	39.1 to 57.9	148
1350	≥1 Dose MenACWY		States/Local Areas	Nebraska	2020	Age	13-15 Years	88.2	81.8 to 92.6	238
1351	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2009	Age	13-17 Years	40.7	31.9 to 50.1	143
1352	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2012	Age	13-17 Years	58.3	47.4 to 68.5	146
1353	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2013	Age	13-17 Years	55.3	45.9 to 64.3	141
1354	≥1 Dose MenACWY		States/Local Areas	Nebraska	2019	Age	13-15 Years	87.7	78.6 to 93.3	181
1355	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018	Age	13-15 Years	86.2	78.4 to 91.5	181
1356	≥1 Dose MenACWY		States/Local Areas	Nebraska	2017	Age	13-15 Years	82.9	75.0 to 88.7	190
1357	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2017	Age	13-17 Years	71.0	64.8 to 76.5	324
1358	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2016	Age	13-17 Years	63.7	57.2 to 69.8	330
1359	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2019	Age	13-17 Years	73.9	66.7 to 80.1	285
1360	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2021	Age	13-17 Years	94.0	90.1 to 96.4	315
1361	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2022	Age	13-17 Years	91.5	86.4 to 94.8	247
1362	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2018	Age	13-17 Years	75.6	68.9 to 81.3	295
1363	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2018	Age	13-17 Years	91.1	85.7 to 94.6	295
1364	≥1 Dose MenACWY		States/Local Areas	Nebraska	2010	Age	13-15 Years	76.4	68.7 to 82.6	175
1365	≥1 Dose MenACWY		States/Local Areas	Nebraska	2011	Age	13-15 Years	78.5	70.9 to 84.5	243
1366	≥1 Dose MenACWY		States/Local Areas	Nebraska	2008	Age	13-15 Years	44.5	37.5 to 51.8	227
1367	≥1 Dose MenACWY		States/Local Areas	Nebraska	2009	Age	13-15 Years	64.4	55.9 to 72.2	162
1368	HPV	≥1 Dose, Males	States/Local Areas	Nebraska	2022	Age	13-17 Years	85.7	76.2 to 91.8	113
1369	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2020	Age	13-17 Years	82.6	77.5 to 86.8	405
1370	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2021	Age	13-17 Years	82.7	76.8 to 87.3	315
1371	HPV	≥1 Dose, Males and Females	States/Local Areas	Nebraska	2022	Age	13-17 Years	81.1	74.3 to 86.4	247
1372	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2019	Age	13-17 Years	92.7	87.1 to 96.0	285
1373	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	Nebraska	2020	Age	13-17 Years	93.3	89.7 to 95.7	405
1374	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2017	Age	13-17 Years	63.3	53.6 to 72.0	145
1375	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2016	Age	13-17 Years	54.8	45.2 to 64.1	151
1376	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2015	Age	13-17 Years	55.5	46.9 to 63.7	184
1377	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2014	Age	13-17 Years	51.2	41.8 to 60.5	154
1378	≥1 Dose MenACWY		States/Local Areas	Nebraska	2021	Age	13-15 Years	89.4	83.1 to 93.6	196
1379	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2018	Age	13-17 Years	68.0	57.7 to 76.8	134
1380	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2012	Age	13-15 Years	84.4	77.0 to 89.8	188
1381	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2011	Age	13-15 Years	84.3	77.3 to 89.4	243
1382	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2008	Age	13-15 Years	55.2	47.8 to 62.3	227
1383	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2010	Age	13-15 Years	81.9	73.8 to 87.8	175
1384	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2009	Age	13-15 Years	64.2	55.6 to 71.9	162
1385	HPV	≥2 Doses, Females	States/Local Areas	Nebraska	2019	Age	13-17 Years	63.0	52.3 to 72.6	132
1386	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2019	Age	13-15 Years	90.4	81.8 to 95.2	181
1387	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2020	Age	13-15 Years	94.5	89.7 to 97.1	238
1388	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2021	Age	13-15 Years	91.2	85.3 to 94.9	196
1389	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2018	Age	13-15 Years	91.6	85.4 to 95.3	181
1390	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2013	Age	13-15 Years	86.8	79.4 to 91.7	179
1391	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2018	Age	13-17 Years	60.9	51.0 to 70.1	161
1392	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2017	Age	13-17 Years	62.3	53.7 to 70.1	179
1393	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2016	Age	13-17 Years	49.4	40.5 to 58.4	179
1394	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2012	Age	13-17 Years	11.6	7.4 to 17.7	182
1395	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2017	Age	13-15 Years	89.2	81.5 to 94.0	190
1396	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2016	Age	13-15 Years	89.1	82.8 to 93.3	199
1397	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2015	Age	13-15 Years	85.8	79.3 to 90.5	247
1398	Tetanus	≥1 Dose Tdap	States/Local Areas	Nebraska	2014	Age	13-15 Years	84.5	76.9 to 89.9	186
1399	≥1 Dose MenACWY		States/Local Areas	Nebraska	2019	Age	13-17 Years	86.3	79.9 to 90.9	285
1400	≥1 Dose MenACWY		States/Local Areas	Nebraska	2018	Age	13-17 Years	84.0	78.0 to 88.6	295
1401	≥1 Dose MenACWY		States/Local Areas	Nebraska	2020	Age	13-17 Years	87.3	82.5 to 91.0	405
1402	≥1 Dose MenACWY		States/Local Areas	Nebraska	2021	Age	13-17 Years	89.7	84.9 to 93.1	315
1403	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2013	Age	13-17 Years	26.4	19.4 to 34.9	160
1404	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2014	Age	13-17 Years	31.0	23.0 to 40.4	167
1405	HPV	≥2 Doses, Males	States/Local Areas	Nebraska	2015	Age	13-17 Years	46.9	39.2 to 54.7	209
1406	≥3 Doses HepB		States/Local Areas	Nebraska	2009	Age	13-17 Years	90.5	85.9 to 93.7	286
1407	≥3 Doses HepB		States/Local Areas	Nebraska	2010	Age	13-17 Years	92.8	88.7 to 95.5	307
1408	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2009	Age	13-17 Years	49.4	40.2 to 58.6	143
1409	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2008	Age	13-17 Years	86.1	78.3 to 91.4	126
1410	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2012	Age	13-17 Years	82.2	74.9 to 87.7	224
1411	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2013	Age	13-17 Years	84.6	78.3 to 89.3	215
1412	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2009	Age	13-15 Years	47.0	36.0 to 58.4	89
1413	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2008	Age	13-15 Years	39.6	29.7 to 50.3	109
1414	≥3 Doses HepB		States/Local Areas	Nebraska	2017	Age	13-17 Years	96.4	93.4 to 98.1	324
1415	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2012	Age	13-17 Years	94.3	88.2 to 97.3	224
1416	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2011	Age	13-17 Years	94.7	89.1 to 97.5	221
1417	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2009	Age	13-17 Years	47.8	38.4 to 57.3	124
1418	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2008	Age	13-17 Years	36.7	27.7 to 46.8	126
1419	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2009	Age	13-17 Years	91.4	84.8 to 95.3	124
1420	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2010	Age	13-17 Years	92.5	86.1 to 96.1	145
1421	≥3 Doses HepB		States/Local Areas	Nebraska	2019	Age	13-17 Years	93.8	88.9 to 96.7	285
1422	≥3 Doses HepB		States/Local Areas	Nebraska	2018	Age	13-17 Years	91.9	87.1 to 95.0	295
1423	≥3 Doses HepB		States/Local Areas	Nebraska	2016	Age	13-17 Years	91.2	86.7 to 94.3	330
1424	≥3 Doses HepB		States/Local Areas	Nebraska	2015	Age	13-17 Years	92.5	88.9 to 95.0	393
1425	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2019	Age	13-17 Years	89.5	83.6 to 93.5	260
1426	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2020	Age	13-17 Years	87.7	82.6 to 91.4	368
1427	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2021	Age	13-17 Years	94.0	90.2 to 96.4	292
1428	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2018	Age	13-17 Years	91.8	86.5 to 95.2	250
1429	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2020	Age	13-17 Years	93.3	89.5 to 95.8	368
1430	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2019	Age	13-17 Years	95.0	90.1 to 97.5	260
1431	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2018	Age	13-17 Years	95.3	90.8 to 97.7	250
1432	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2016	Age	13-17 Years	96.8	93.1 to 98.6	274
1433	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2015	Age	13-17 Years	97.0	93.7 to 98.6	321
1434	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2014	Age	13-17 Years	96.8	93.2 to 98.5	247
1435	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2013	Age	13-17 Years	96.1	91.9 to 98.2	215
1436	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2020	Age	13-15 Years	86.0	79.1 to 90.9	220
1437	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2021	Age	13-15 Years	93.1	87.7 to 96.2	185
1438	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2017	Age	13-17 Years	93.0	87.7 to 96.1	271
1439	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2010	Age	13-17 Years	52.3	42.8 to 61.6	148
1440	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2011	Age	13-17 Years	59.0	48.8 to 68.4	174
1441	Varicella	≥1 Dose with no disease history	States/Local Areas	Nebraska	2017	Age	13-17 Years	98.2	96.2 to 99.2	271
1442	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2014	Age	13-17 Years	83.5	76.8 to 88.5	247
1443	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2016	Age	13-17 Years	86.7	80.6 to 91.0	274
1444	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2015	Age	13-17 Years	88.7	83.6 to 92.3	321
1445	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2012	Age	13-17 Years	67.5	56.8 to 76.6	146
1446	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2013	Age	13-17 Years	65.1	55.5 to 73.7	141
1447	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2014	Age	13-17 Years	59.6	50.2 to 68.3	154
1448	HPV	≥1 Dose, Females	States/Local Areas	Nebraska	2015	Age	13-17 Years	67.3	58.9 to 74.6	184
1449	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2012	Age	13-15 Years	81.4	71.8 to 88.2	144
1450	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2013	Age	13-15 Years	87.1	79.3 to 92.2	136
1451	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2010	Age	13-15 Years	67.3	56.2 to 76.7	104
1452	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2011	Age	13-15 Years	80.3	70.4 to 87.4	169
1453	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2015	Age	13-15 Years	89.7	83.3 to 93.8	207
1454	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2014	Age	13-15 Years	85.1	76.3 to 91.0	150
1455	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2018	Age	13-15 Years	94.0	86.9 to 97.4	166
1456	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2019	Age	13-15 Years	90.6	83.1 to 95.0	172
1457	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2009	Age	13-17 Years	77.9	72.3 to 82.7	286
1458	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2010	Age	13-17 Years	81.2	75.2 to 86.0	307
1459	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2017	Age	13-15 Years	90.6	82.3 to 95.3	165
1460	Varicella	≥2 Doses with no disease history	States/Local Areas	Nebraska	2016	Age	13-15 Years	90.1	83.5 to 94.2	168
1461	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2012	Age	13-17 Years	88.2	83.0 to 92.0	328
1462	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2011	Age	13-17 Years	85.9	80.3 to 90.1	368
1463	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2014	Age	13-17 Years	87.5	82.2 to 91.4	321
1464	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2013	Age	13-17 Years	88.9	84.2 to 92.4	301
1465	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2020	Age	13-17 Years	88.7	84.1 to 92.2	405
1466	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2021	Age	13-17 Years	94.5	90.9 to 96.7	315
1467	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2022	Age	13-17 Years	89.5	83.9 to 93.3	247
1468	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2019	Age	13-17 Years	90.3	84.8 to 94.0	285
1469	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2018	Age	13-17 Years	92.9	88.3 to 95.8	295
1470	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2016	Age	13-17 Years	89.0	83.9 to 92.6	330
1471	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2017	Age	13-17 Years	94.1	89.6 to 96.7	324
1472	HPV	≥3 Doses, Males	States/Local Areas	Nebraska	2013	Age	13-15 Years	20.6	13.0 to 31.0	93
1473	HPV	≥3 Doses, Males	States/Local Areas	Nebraska	2013	Age	13-17 Years	19.7	13.4 to 27.9	160
1474	HPV	≥3 Doses, Males	States/Local Areas	Nebraska	2012	Age	13-17 Years	7.0	4.0 to 11.8	182
1475	HPV	≥3 Doses, Males	States/Local Areas	Nebraska	2015	Age	13-17 Years	32.2	25.4 to 39.8	209
1476	HPV	≥3 Doses, Males	States/Local Areas	Nebraska	2014	Age	13-17 Years	22.8	15.9 to 31.5	167
1477	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2015	Age	13-17 Years	90.7	86.5 to 93.8	393
1478	Varicella	≥2 Doses or history of disease	States/Local Areas	Nebraska	2008	Age	13-17 Years	78.3	73.0 to 82.8	365
1479	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2018	Age	13-15 Years	90.1	85.6 to 93.3	334
1480	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2020	Age	13-15 Years	92.5	87.5 to 95.6	249
1481	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	32.2	24.7 to 40.7	166
1482	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	29.3	22.6 to 37.1	187
1483	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	44.1	35.1 to 53.6	223
1484	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	73.2	66.7 to 78.8	440
1485	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	72.2	66.4 to 77.4	365
1486	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	55.5	47.5 to 63.3	208
1487	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	90.0	84.8 to 93.6	349
1488	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	79.3	72.1 to 85.0	345
1489	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	78.9	73.5 to 83.4	373
1490	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	80.0	74.6 to 84.5	441
1491	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	41.1	32.6 to 50.1	174
1492	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	24.5	16.5 to 34.7	165
1493	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2019	Age	13-15 Years	92.8	88.4 to 95.6	282
1494	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	70.2	61.8 to 77.5	200
1495	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	62.7	57.4 to 67.7	479
1496	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	61.4	55.8 to 66.6	448
1497	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	93.4	90.5 to 95.4	529
1498	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	66.3	61.4 to 70.9	529
1499	HPV	≥2 Doses, Females	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	19.3	13.1 to 27.5	200
1500	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2012	Age	13-15 Years	64.7	55.0 to 73.3	210
1501	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2013	Age	13-15 Years	80.4	73.3 to 86.0	209
1502	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	94.9	91.7 to 96.8	479
1503	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	94.8	91.7 to 96.7	448
1504	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	91.6	87.8 to 94.3	496
1505	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	95.9	93.2 to 97.6	435
1506	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	86.3	81.0 to 90.3	389
1507	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	89.0	84.1 to 92.5	366
1508	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	90.2	85.5 to 93.5	343
1509	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2016	Age	13-15 Years	89.6	80.5 to 94.8	93
1510	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2018	Age	13-15 Years	94.6	82.0 to 98.5	105
1511	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2017	Age	13-15 Years	87.9	76.2 to 94.3	101
1512	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2013	Age	13-15 Years	82.2	69.7 to 90.2	104
1513	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2012	Age	13-15 Years	73.2	62.0 to 82.0	144
1514	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2010	Age	13-15 Years	64.0	54.1 to 72.8	145
1515	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2011	Age	13-15 Years	72.1	62.9 to 79.8	187
1516	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2008	Age	13-15 Years	23.4	15.6 to 33.6	101
1517	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	90.4	84.9 to 94.1	256
1518	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	93.6	84.0 to 97.6	144
1519	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	90.6	83.5 to 94.9	271
1520	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2013	Age	13-15 Years	21.4	11.9 to 35.4	66
1521	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	88.3	80.4 to 93.2	160
1522	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	90.3	85.8 to 93.5	283
1523	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	92.9	85.6 to 96.6	192
1524	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	91.3	84.3 to 95.3	157
1525	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	88.0	80.8 to 92.8	204
1526	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	68.6	62.5 to 74.1	389
1527	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	79.9	74.6 to 84.3	366
1528	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	69.0	63.0 to 74.4	343
1529	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	26.1	18.0 to 36.4	133
1530	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	41.6	32.3 to 51.5	136
1531	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	19.8	12.7 to 29.6	115
1532	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	17.0	9.6 to 28.3	144
1533	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	79.6	72.6 to 85.2	287
1534	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	78.6	73.1 to 83.1	407
1535	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	87.8	81.8 to 92.0	274
1536	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	83.9	76.1 to 89.6	209
1537	Varicella	History of disease	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	61.4	55.2 to 67.2	343
1538	Varicella	History of disease	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	8.7	4.9 to 15.0	271
1539	HPV	Up-to-Date, Females	States/Local Areas	IL-City of Chicago	2018	Age	13-15 Years	63.0	43.2 to 79.3	55
1540	HPV	Up-to-Date, Females	States/Local Areas	IL-City of Chicago	2019	Age	13-15 Years	68.5	49.5 to 82.8	47
1541	HPV	Up-to-Date, Females	States/Local Areas	IL-City of Chicago	2020	Age	13-15 Years	71.0	56.6 to 82.2	93
1542	Varicella	History of disease	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	47.9	41.8 to 54.0	389
1543	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2014	Age	13-15 Years	23.3	13.8 to 36.5	87
1544	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	47.7	38.4 to 57.3	147
1545	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	24.7	17.4 to 33.9	181
1546	HPV	≥3 Doses, Males	States/Local Areas	IL-City of Chicago	2015	Age	13-15 Years	37.5	27.0 to 49.4	91
1547	≥2 Doses Hep A		States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	91.5	82.2 to 96.1	144
1548	≥2 Doses Hep A		States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	87.1	80.4 to 91.8	256
1549	≥2 Doses Hep A		States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	79.7	71.9 to 85.8	271
1550	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	28.4	20.5 to 38.0	175
1551	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	15.6	11.1 to 21.4	199
1552	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	11.2	6.5 to 18.6	173
1553	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	37.8	27.8 to 49.1	143
1554	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	52.6	41.9 to 63.0	141
1555	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	38.6	27.4 to 51.2	94
1556	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	79.4	74.0 to 83.8	407
1557	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	76.6	70.5 to 81.8	366
1558	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	83.8	77.5 to 88.6	287
1559	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	91.2	84.7 to 95.0	209
1560	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	71.4	65.2 to 76.8	389
1561	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	71.8	65.6 to 77.3	343
1562	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	85.4	72.8 to 92.7	98
1563	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	84.9	74.4 to 91.6	95
1564	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	89.9	84.1 to 93.8	241
1565	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	96.6	88.2 to 99.1	135
1566	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	79.7	66.0 to 88.8	76
1567	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2008	Age	13-15 Years	45.9	37.9 to 54.0	221
1568	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2009	Age	13-15 Years	60.0	51.9 to 67.6	239
1569	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	80.7	65.1 to 90.3	74
1570	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	93.9	88.5 to 96.8	241
1571	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	91.9	85.7 to 95.6	256
1572	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	93.6	83.6 to 97.7	144
1573	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	91.6	85.2 to 95.3	271
1574	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	40.2	30.3 to 50.9	144
1575	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	68.9	60.1 to 76.6	204
1576	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	61.9	51.9 to 71.1	157
1577	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	82.9	68.8 to 91.4	94
1578	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	36.2	28.8 to 44.2	199
1579	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	81.5	68.5 to 89.9	86
1580	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	81.2	69.0 to 89.4	119
1581	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	86.8	70.0 to 94.9	72
1582	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	85.9	76.2 to 92.1	142
1583	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	67.3	57.2 to 76.1	192
1584	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	79.2	62.0 to 89.9	72
1585	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	86.7	76.9 to 92.8	129
1586	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	78.8	66.1 to 87.6	109
1587	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	64.9	54.4 to 74.2	133
1588	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	50.0	38.5 to 61.5	115
1589	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	68.1	58.5 to 76.3	136
1590	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	66.8	52.0 to 79.0	81
1591	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	65.9	55.1 to 75.2	160
1592	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	98.2	94.9 to 99.4	170
1593	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	85.0	77.1 to 90.5	204
1594	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	92.8	86.7 to 96.2	160
1595	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	91.9	84.4 to 96.0	192
1596	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	78.1	69.0 to 85.2	141
1597	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	70.8	62.0 to 78.3	147
1598	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	61.4	50.6 to 71.2	143
1599	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	61.8	48.5 to 73.5	94
1600	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	93.2	83.0 to 97.5	135
1601	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	89.7	82.0 to 94.4	248
1602	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	88.0	80.0 to 93.1	153
1603	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	91.5	83.6 to 95.7	248
1604	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	91.9	83.7 to 96.2	170
1605	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	94.9	89.3 to 97.7	153
1606	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	93.0	86.7 to 96.5	232
1607	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	91.3	83.3 to 95.6	165
1608	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	93.8	89.5 to 96.4	246
1609	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	96.0	90.1 to 98.5	131
1610	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	50.6	41.5 to 59.7	175
1611	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	47.0	37.8 to 56.5	181
1612	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	86.0	77.7 to 91.5	178
1613	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	85.4	78.4 to 90.4	232
1614	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	90.8	82.9 to 95.3	178
1615	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	88.7	83.5 to 92.4	246
1616	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	89.4	81.2 to 94.3	131
1617	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	91.6	87.0 to 94.7	283
1618	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	93.6	87.6 to 96.8	157
1619	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	72.2	63.3 to 79.6	216
1620	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	79.4	70.0 to 86.5	165
1621	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	28.6	20.8 to 37.9	173
1622	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	93.8	89.3 to 96.5	287
1623	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	89.0	82.8 to 93.2	274
1624	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	92.9	86.7 to 96.4	209
1625	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	79.3	70.8 to 85.8	145
1626	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	66.2	58.6 to 73.1	272
1627	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	62.4	54.0 to 70.1	200
1628	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2021	Age	13-15 Years	96.7	82.7 to 99.5	88
1629	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2020	Age	13-15 Years	89.4	78.7 to 95.1	159
1630	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	88.7	81.4 to 93.4	216
1631	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	86.6	80.4 to 91.1	272
1632	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	19.8	13.6 to 27.8	145
1633	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	39.7	32.1 to 47.8	211
1634	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	80.3	71.7 to 86.7	211
1635	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	86.4	79.7 to 91.2	200
1636	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2022	Age	13-15 Years	90.5	83.2 to 94.8	150
1637	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	90.6	86.2 to 93.7	407
1638	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2019	Age	13-15 Years	87.5	76.4 to 93.8	96
1639	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2009	Age	13-15 Years	42.4	32.8 to 52.7	142
1640	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2015	Age	13-15 Years	88.5	82.2 to 92.8	162
1641	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2014	Age	13-15 Years	86.2	77.9 to 91.8	158
1642	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2013	Age	13-15 Years	87.8	78.4 to 93.4	126
1643	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	27.8	18.9 to 38.9	144
1644	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	44.3	34.0 to 55.2	133
1645	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	29.1	19.8 to 40.5	115
1646	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	65.4	50.5 to 77.8	98
1647	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	65.3	49.6 to 78.2	74
1648	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2010	Age	13-15 Years	69.2	61.4 to 76.0	226
1649	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2009	Age	13-15 Years	57.1	48.9 to 64.8	239
1650	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2021	Age	13-15 Years	93.7	83.0 to 97.8	94
1651	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	62.1	52.8 to 70.6	147
1652	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	73.2	61.5 to 82.3	95
1653	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	69.2	55.4 to 80.3	76
1654	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2008	Age	13-15 Years	48.6	40.6 to 56.7	221
1655	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	44.5	33.9 to 55.5	143
1656	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	49.2	36.8 to 61.8	94
1657	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	83.0	75.4 to 88.6	256
1658	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	82.9	71.6 to 90.4	144
1659	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	86.3	79.9 to 91.0	271
1660	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	92.1	86.8 to 95.3	256
1661	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	92.7	83.5 to 96.9	144
1662	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	81.1	71.5 to 88.0	160
1663	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	94.0	89.0 to 96.9	271
1664	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	92.1	83.3 to 96.4	160
1665	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	36.7	28.2 to 46.1	181
1666	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	41.0	32.2 to 50.4	175
1667	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	27.4	21.0 to 34.8	199
1668	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2020	Age	13-15 Years	89.7	81.5 to 94.5	171
1669	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	68.8	58.6 to 77.4	141
1670	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018	Age	13-15 Years	91.4	82.4 to 96.1	118
1671	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	95.8	89.4 to 98.4	192
1672	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2019	Age	13-15 Years	94.0	85.9 to 97.6	100
1673	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	81.9	73.9 to 87.8	204
1674	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	73.1	63.2 to 81.2	157
1675	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2013	Age	13-15 Years	79.6	69.4 to 87.0	126
1676	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2012	Age	13-15 Years	77.4	69.0 to 84.0	183
1677	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	87.9	81.5 to 92.3	274
1678	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	90.4	85.6 to 93.8	283
1679	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	93.7	88.4 to 96.7	204
1680	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	94.6	89.4 to 97.3	157
1681	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	84.1	75.3 to 90.2	192
1682	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	20.5	14.1 to 28.8	173
1683	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2015	Age	13-15 Years	81.0	73.6 to 86.7	185
1684	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2014	Age	13-15 Years	83.9	75.3 to 89.9	175
1685	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	84.7	74.4 to 91.3	137
1686	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2010	Age	13-15 Years	66.9	59.0 to 73.9	226
1687	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2011	Age	13-15 Years	70.5	62.4 to 77.4	250
1688	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2016	Age	13-15 Years	86.7	77.2 to 92.6	104
1689	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2017	Age	13-15 Years	90.3	79.4 to 95.7	120
1690	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	58.7	52.5 to 64.7	389
1691	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	69.5	63.2 to 75.1	366
1692	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	69.8	63.9 to 75.1	407
1693	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	44.2	38.0 to 50.5	343
1694	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2022	Age	13-15 Years	91.0	84.6 to 94.9	161
1695	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	92.0	88.3 to 94.7	407
1696	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	88.8	83.9 to 92.3	366
1697	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	66.4	51.4 to 78.8	86
1698	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	84.6	79.1 to 88.8	389
1699	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	83.4	78.3 to 87.5	343
1700	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	84.6	77.9 to 89.6	274
1701	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	89.7	83.3 to 93.9	209
1702	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018	Age	13-15 Years	93.0	82.6 to 97.4	118
1703	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2011	Age	13-15 Years	68.1	60.3 to 75.0	250
1704	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2012	Age	13-15 Years	77.8	69.2 to 84.5	183
1705	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	78.5	71.8 to 84.0	287
1706	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	64.2	53.6 to 73.6	160
1707	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	65.0	54.8 to 73.9	192
1708	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	66.6	57.7 to 74.4	204
1709	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2019	Age	13-15 Years	94.9	87.6 to 98.0	100
1710	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2020	Age	13-15 Years	87.9	78.9 to 93.5	171
1711	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2021	Age	13-15 Years	88.8	75.6 to 95.3	94
1712	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	69.2	55.0 to 80.6	94
1713	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	64.7	51.5 to 76.0	109
1714	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	54.9	40.6 to 68.4	81
1715	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	53.9	44.1 to 63.4	136
1716	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2016	Age	13-15 Years	85.2	74.2 to 92.1	104
1717	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2017	Age	13-15 Years	93.9	87.4 to 97.1	120
1718	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2015	Age	13-15 Years	85.9	78.6 to 91.0	185
1719	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2014	Age	13-15 Years	84.0	75.4 to 90.0	175
1720	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	55.7	45.6 to 65.3	157
1721	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	69.2	60.9 to 76.4	256
1722	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	70.4	59.0 to 79.7	144
1723	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	72.3	64.2 to 79.1	271
1724	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	87.2	81.7 to 91.1	283
1725	HPV	≥2 Doses, Males	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	68.9	57.3 to 78.4	137
1726	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	69.5	61.1 to 76.7	256
1727	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	77.0	70.3 to 82.6	287
1728	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2022	Age	13-15 Years	91.5	85.2 to 95.3	161
1729	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	84.2	75.2 to 90.3	157
1730	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2009	Age	13-17 Years	58.4	52.2 to 64.3	389
1731	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2008	Age	13-17 Years	41.1	35.1 to 47.5	343
1732	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	72.2	66.1 to 77.5	407
1733	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2010	Age	13-17 Years	63.8	57.4 to 69.8	366
1734	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	90.4	82.0 to 95.2	160
1735	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	90.5	84.9 to 94.2	204
1736	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	93.0	85.5 to 96.8	192
1737	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	83.4	76.6 to 88.5	274
1738	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	83.3	76.1 to 88.7	209
1739	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	82.8	77.1 to 87.3	283
1740	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	91.1	84.6 to 95.0	157
1741	HPV	≥3 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2011	Age	13-17 Years	14.0	9.8 to 19.7	407
1742	HPV	≥3 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	27.4	20.8 to 35.1	287
1743	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2012	Age	13-17 Years	88.4	82.7 to 92.4	287
1744	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2013	Age	13-17 Years	88.8	82.3 to 93.2	209
1745	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	90.1	84.1 to 94.0	274
1746	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	91.6	87.1 to 94.6	283
1747	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	86.2	78.4 to 91.5	204
1748	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2016	Age	13-17 Years	92.6	86.6 to 96.0	157
1749	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	90.0	80.3 to 95.2	144
1750	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	89.7	83.4 to 93.8	271
1751	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	92.9	86.0 to 96.5	160
1752	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	93.7	88.2 to 96.7	192
1753	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	92.1	86.5 to 95.5	256
1754	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	92.2	82.2 to 96.8	144
1755	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	89.1	82.6 to 93.4	256
1756	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2009	Age	13-15 Years	15.4	9.4 to 24.2	114
1757	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2010	Age	13-15 Years	27.6	18.0 to 39.7	113
1758	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2011	Age	13-15 Years	25.1	15.5 to 38.1	111
1759	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2012	Age	13-15 Years	38.7	26.3 to 52.8	97
1760	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	90.5	85.2 to 94.1	256
1761	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2021	Age	13-17 Years	88.9	79.7 to 94.3	144
1762	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	88.2	81.4 to 92.8	271
1763	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2017	Age	13-17 Years	90.9	83.4 to 95.2	204
1764	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2019	Age	13-17 Years	92.0	85.2 to 95.8	160
1765	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2018	Age	13-17 Years	94.9	89.1 to 97.6	192
1766	HPV	≥3 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2014	Age	13-17 Years	39.1	32.0 to 46.7	274
1767	HPV	≥3 Doses, Males and Females	States/Local Areas	IL-City of Chicago	2015	Age	13-17 Years	44.6	37.9 to 51.5	283
1768	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2020	Age	13-17 Years	91.6	85.4 to 95.3	271
1769	HPV	≥2 Doses, Females	States/Local Areas	IL-City of Chicago	2022	Age	13-17 Years	70.1	57.6 to 80.2	119
1770	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2015	Age	13-15 Years	42.6	31.0 to 55.0	94
1771	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2014	Age	13-15 Years	42.8	30.0 to 56.6	88
1772	HPV	≥3 Doses, Females	States/Local Areas	IL-City of Chicago	2013	Age	13-15 Years	35.6	22.5 to 51.2	60
1773	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Any Medicaid	88.4	83.8 to 91.9	496
1774	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Private Insurance Only	93.4	89.6 to 95.9	470
1775	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Any Medicaid	68.8	62.9 to 74.1	496
1776	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Private Insurance Only	69.0	62.3 to 75.0	470
1777	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Any Medicaid	83.9	78.8 to 88.0	496
1778	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Private Insurance Only	82.6	76.5 to 87.4	470
1779	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Any Medicaid	87.7	83.1 to 91.2	496
1780	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Living At or Above Poverty Level	91.5	87.6 to 94.2	667
1781	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Insurance Coverage	Private Insurance Only	95.9	93.2 to 97.6	470
1782	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Living At or Above Poverty Level	70.0	64.6 to 74.9	667
1783	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Below Poverty Level	88.4	82.9 to 92.3	313
1784	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Below Poverty Level	71.2	63.8 to 77.6	313
1785	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Below Poverty Level	84.1	77.4 to 89.0	313
1786	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Living At or Above Poverty Level	94.6	91.6 to 96.5	667
1787	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Living At or Above Poverty Level	84.2	79.5 to 88.0	667
1788	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Poverty	Below Poverty Level	84.0	77.7 to 88.8	313
1789	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Hispanic	87.1	82.1 to 90.9	460
1790	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Black, Non-Hispanic	78.8	71.2 to 84.9	218
1791	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	White, Non-Hispanic	81.2	71.4 to 88.2	261
1792	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	94.7	86.2 to 98.1	84
1793	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Black, Non-Hispanic	85.4	78.3 to 90.5	218
1794	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Hispanic	91.2	87.5 to 93.9	460
1795	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Hispanic	90.1	85.7 to 93.2	460
1796	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Black, Non-Hispanic	88.3	82.2 to 92.5	218
1797	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	White, Non-Hispanic	97.1	93.9 to 98.7	261
1798	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	White, Non-Hispanic	96.2	92.5 to 98.1	261
1799	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	77.5	62.7 to 87.6	84
1800	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Black, Non-Hispanic	61.4	53.0 to 69.2	218
1801	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Hispanic	71.6	65.6 to 76.9	460
1802	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	98.3	93.4 to 99.6	84
1803	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	90.1	77.9 to 95.9	84
1804	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Urbanicity	Living In a MSA Principal City	90.2	87.3 to 92.5	1023
1805	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Race and Ethnicity	White, Non-Hispanic	70.3	60.8 to 78.4	261
1806	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Urbanicity	Living In a MSA Principal City	91.0	88.3 to 93.2	1023
1807	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Urbanicity	Living In a MSA Principal City	68.2	64.0 to 72.2	1023
1808	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Urbanicity	Living In a MSA Principal City	83.5	79.9 to 86.6	1023
1809	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Overall	Overall	83.5	79.9 to 86.6	1023
1810	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2018-2022	Overall	Overall	68.2	64.0 to 72.2	1023
1811	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	88.3	81.2 to 93.0	204
1812	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	87.4	80.3 to 92.2	204
1813	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	90.0	82.8 to 94.4	204
1814	HPV	≥1 Dose, Males and Females	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	88.5	81.4 to 93.1	204
1815	HPV	≥1 Dose, Females	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	91.4	83.6 to 95.7	108
1816	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	74.6	65.8 to 81.8	204
1817	≥2 Doses MMR		States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	86.6	79.6 to 91.5	204
1818	HPV	Up-to-Date, Males	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	70.9	57.2 to 81.6	96
1819	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	82.2	73.5 to 88.4	204
1820	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	91.9	85.4 to 95.7	193
1821	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	81.0	71.9 to 87.6	193
1822	≥3 Doses HepB		States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	86.1	78.5 to 91.3	204
1823	≥2 Doses Hep A		States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	78.9	70.1 to 85.6	204
1824	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	88.1	79.3 to 93.4	134
1825	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	91.3	82.0 to 96.0	134
1826	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	75.6	65.0 to 83.8	134
1827	HPV	Up-to-Date, Males	States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	76.7	60.4 to 87.7	60
1828	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	84.9	73.8 to 91.9	128
1829	HPV	Up-to-Date, Females	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	78.4	66.6 to 86.8	108
1830	HPV	Up-to-Date, Females	States/Local Areas	IL-City of Chicago	2023	Age	13-15 Years	74.7	59.8 to 85.4	74
1831	HPV	≥1 Dose, Males	States/Local Areas	IL-City of Chicago	2023	Age	13-17 Years	85.6	72.9 to 92.9	96
1832	Tetanus	≥1 Dose Tdap	States/Local Areas	IL-City of Chicago	2018-2022	Overall	Overall	90.2	87.3 to 92.5	1023
1833	≥1 Dose MenACWY		States/Local Areas	IL-City of Chicago	2018-2022	Overall	Overall	91.0	88.3 to 93.2	1023
1834	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2014	Age	13-15 Years	75.4	68.5 to 81.1	289
1835	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2015	Age	13-15 Years	76.4	70.2 to 81.7	316
1836	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	97.1	93.5 to 98.7	350
1837	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	57.4	49.4 to 65.0	215
1838	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	66.0	58.2 to 73.0	217
1839	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	97.1	94.9 to 98.4	413
1840	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	94.1	90.3 to 96.5	350
1841	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2017	Age	13-15 Years	88.7	83.3 to 92.5	283
1842	≥1 Dose MenACWY		States/Local Areas	IL-Rest of state	2016	Age	13-15 Years	79.9	73.2 to 85.3	258
1843	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	70.6	63.7 to 76.7	261
1844	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	94.7	91.4 to 96.8	428
1845	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	96.7	94.5 to 98.0	434
1846	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	94.7	90.8 to 97.0	374
1847	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	72.5	64.8 to 79.1	238
1848	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	76.0	68.6 to 82.2	224
1849	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	62.3	55.2 to 68.8	268
1850	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	20.5	12.6 to 31.4	180
1851	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	69.2	61.6 to 75.9	242
1852	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	55.4	50.3 to 60.3	529
1853	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	75.0	66.0 to 82.3	190
1854	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	74.2	66.0 to 81.0	210
1855	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	81.6	73.2 to 87.8	175
1856	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	52.0	46.7 to 57.3	479
1857	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	50.9	45.3 to 56.4	448
1858	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	56.9	49.2 to 64.4	231
1859	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	39.1	32.0 to 46.7	242
1860	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	31.4	23.3 to 40.8	175
1861	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	40.0	32.7 to 47.8	227
1862	HPV	≥1 Dose, Males	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	67.7	60.9 to 73.9	264
1863	HPV	≥2 Doses, Males and Females	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	56.9	51.1 to 62.4	442
1864	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	94.0	89.1 to 96.8	440
1865	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	97.0	94.3 to 98.4	373
1866	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	95.5	92.2 to 97.5	365
1867	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	95.7	92.9 to 97.4	441
1868	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2022	Age	13-15 Years	92.5	86.4 to 96.0	210
1869	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	49.8	41.6 to 58.1	187
1870	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	63.1	55.4 to 70.3	274
1871	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	72.6	61.0 to 81.8	163
1872	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	87.4	80.5 to 92.1	187
1873	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	82.7	74.1 to 88.9	140
1874	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	42.2	33.2 to 51.8	140
1875	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	28.4	20.0 to 38.7	163
1876	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	93.0	88.6 to 95.7	274
1877	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	88.3	80.2 to 93.4	223
1878	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	26.6	19.2 to 35.6	200
1879	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	80.0	73.2 to 85.5	242
1880	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	60.9	51.6 to 69.4	223
1881	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	96.1	93.7 to 97.6	479
1882	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	33.8	26.2 to 42.4	166
1883	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	96.4	93.3 to 98.1	349
1884	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	95.2	92.0 to 97.2	435
1885	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	89.9	83.6 to 93.9	345
1886	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	96.3	93.3 to 98.0	442
1887	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	95.0	92.5 to 96.7	529
1888	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	93.3	89.0 to 96.0	391
1889	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	94.9	91.4 to 97.0	394
1890	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	94.2	90.8 to 96.4	413
1891	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	94.1	91.1 to 96.1	466
1892	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	96.7	93.5 to 98.4	394
1893	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	97.3	93.7 to 98.9	391
1894	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	96.4	93.9 to 97.9	466
1895	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	95.7	93.4 to 97.3	448
1896	≥3 Doses HepB		States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	93.4	90.5 to 95.5	496
1897	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	96.7	93.8 to 98.3	366
1898	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	95.6	92.4 to 97.5	399
1899	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	96.1	92.2 to 98.1	242
1900	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	95.2	91.5 to 97.3	344
1901	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2020	Age	13-15 Years	95.6	91.9 to 97.7	232
1902	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2021	Age	13-15 Years	95.7	91.5 to 97.8	251
1903	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2011	Age	13-15 Years	64.6	55.3 to 73.0	182
1904	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2010	Age	13-15 Years	51.7	42.0 to 61.3	138
1905	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2012	Age	13-15 Years	67.0	55.4 to 76.8	147
1906	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2013	Age	13-15 Years	84.4	76.8 to 89.9	160
1907	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	94.7	92.1 to 96.5	427
1908	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	52.7	43.7 to 61.5	223
1909	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	36.8	29.4 to 44.9	187
1910	Varicella	≥1 Dose with no disease history	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	98.4	96.9 to 99.2	427
1911	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	81.7	76.1 to 86.3	344
1912	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	92.7	89.3 to 95.1	366
1913	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	84.0	79.3 to 87.8	399
1914	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	51.2	42.3 to 60.0	174
1915	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	36.2	26.8 to 46.7	165
1916	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	60.0	52.9 to 66.8	254
1917	HPV	≥1 Dose, Females	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	61.2	53.3 to 68.6	208
1918	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2019	Age	13-15 Years	92.8	87.6 to 95.9	256
1919	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2014	Age	13-15 Years	82.3	75.3 to 87.6	240
1920	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2015	Age	13-15 Years	84.2	78.0 to 88.8	272
1921	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2009	Age	13-15 Years	42.7	32.3 to 53.8	104
1922	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2018	Age	13-15 Years	95.2	91.3 to 97.4	303
1923	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2016	Age	13-15 Years	94.1	89.6 to 96.7	215
1924	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2017	Age	13-15 Years	93.8	89.9 to 96.2	260
1925	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	86.7	81.8 to 90.4	349
1926	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	85.9	81.4 to 89.5	435
1927	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	76.8	71.3 to 81.5	441
1928	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	75.9	69.0 to 81.7	345
1929	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	95.2	91.9 to 97.2	428
1930	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	94.6	91.4 to 96.6	434
1931	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	94.6	91.0 to 96.8	374
1932	Varicella	≥2 Doses with no disease history	States/Local Areas	IL-Rest of state	2008	Age	13-15 Years	35.1	23.8 to 48.3	109
1933	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	74.7	69.2 to 79.6	373
1934	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	78.9	73.8 to 83.3	365
1935	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	94.2	90.4 to 96.5	442
1936	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	75.8	69.6 to 81.0	440
1937	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	94.8	92.2 to 96.6	529
1938	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	94.1	91.2 to 96.0	448
1939	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	95.3	93.0 to 96.9	479
1940	Varicella	≥2 Doses or history of disease	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	86.9	82.9 to 90.1	496
1941	HPV	≥3 Doses, Males	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	15.8	9.6 to 24.9	175
1942	HPV	≥3 Doses, Males	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	23.6	17.7 to 30.6	242
1943	HPV	≥3 Doses, Males	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	21.8	15.9 to 29.2	227
1944	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	52.5	44.7 to 60.2	242
1945	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	60.4	52.0 to 68.1	238
1946	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	47.9	40.8 to 55.0	268
1947	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2018	Age	13-15 Years	50.4	41.4 to 59.4	163
1948	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	62.3	53.7 to 70.1	210
1949	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	66.6	57.5 to 74.6	175
1950	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	62.1	52.9 to 70.5	190
1951	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-Rest of state	2022	Age	13-15 Years	67.0	58.7 to 74.4	222
1952	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-Rest of state	2019	Age	13-15 Years	47.7	40.5 to 54.9	282
1953	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	63.3	54.2 to 71.6	199
1954	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-Rest of state	2021	Age	13-15 Years	57.4	49.8 to 64.6	261
1955	HPV	Up-to-Date, Males and Females	States/Local Areas	IL-Rest of state	2020	Age	13-15 Years	55.6	47.4 to 63.5	249
1956	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2019	Age	13-15 Years	45.9	36.3 to 55.8	156
1957	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	58.6	50.3 to 66.4	224
1958	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	50.1	43.0 to 57.2	264
1959	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2020	Age	13-15 Years	57.9	46.8 to 68.2	142
1960	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	42.6	35.2 to 50.3	231
1961	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2021	Age	13-15 Years	56.5	45.7 to 66.7	132
1962	HPV	Up-to-Date, Males	States/Local Areas	IL-Rest of state	2022	Age	13-15 Years	66.5	54.5 to 76.8	122
1963	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	43.6	36.1 to 51.4	215
1964	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2021	Age	13-15 Years	58.2	47.7 to 68.1	129
1965	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2022	Age	13-15 Years	67.6	55.7 to 77.6	100
1966	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	49.8	41.8 to 57.7	217
1967	Varicella	History of disease	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	33.2	27.3 to 39.7	349
1968	Varicella	History of disease	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	38.5	31.6 to 45.9	345
1969	Varicella	History of disease	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	49.6	43.7 to 55.5	373
1970	Varicella	History of disease	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	37.0	31.1 to 43.4	441
1971	Varicella	History of disease	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	18.0	14.4 to 22.1	496
1972	Varicella	History of disease	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	23.0	18.5 to 28.2	435
1973	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	53.4	45.0 to 61.5	200
1974	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	54.3	47.1 to 61.2	261
1975	Varicella	History of disease	States/Local Areas	IL-Rest of state	2017	Age	13-17 Years	11.1	8.2 to 15.1	479
1976	Varicella	History of disease	States/Local Areas	IL-Rest of state	2018	Age	13-17 Years	12.6	9.6 to 16.4	529
1977	Varicella	History of disease	States/Local Areas	IL-Rest of state	2016	Age	13-17 Years	18.8	14.6 to 23.8	448
1978	Varicella	History of disease	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	66.2	59.6 to 72.1	440
1979	Varicella	History of disease	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	63.5	57.7 to 69.0	365
1980	Varicella	History of disease	States/Local Areas	IL-Rest of state	2019	Age	13-17 Years	12.9	9.4 to 17.4	442
1981	Varicella	History of disease	States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	5.5	3.5 to 8.4	428
1982	Varicella	History of disease	States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	6.0	3.5 to 9.8	434
1983	Varicella	History of disease	States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	7.3	4.4 to 12.0	374
1984	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2019	Age	13-15 Years	49.5	39.1 to 60.0	126
1985	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2020	Age	13-15 Years	53.1	41.1 to 64.7	107
1986	HPV	Up-to-Date, Females	States/Local Areas	IL-Rest of state	2018	Age	13-15 Years	52.7	43.9 to 61.4	171
1987	HPV	≥3 Doses, Males	States/Local Areas	IL-Rest of state	2015	Age	13-15 Years	20.0	13.8 to 28.1	149
1988	HPV	≥3 Doses, Males	States/Local Areas	IL-Rest of state	2014	Age	13-15 Years	21.3	14.1 to 30.7	152
1989	≥2 Doses Hep A		States/Local Areas	IL-Rest of state	2020	Age	13-17 Years	76.6	71.3 to 81.1	428
1990	≥2 Doses Hep A		States/Local Areas	IL-Rest of state	2022	Age	13-17 Years	82.7	77.2 to 87.0	374
1991	≥2 Doses Hep A		States/Local Areas	IL-Rest of state	2021	Age	13-17 Years	79.0	73.6 to 83.5	434
1992	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2011	Age	13-17 Years	36.2	27.3 to 46.1	223
1993	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2008	Age	13-17 Years	13.3	8.2 to 20.9	200
1994	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2009	Age	13-17 Years	25.4	18.7 to 33.6	166
1995	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2015	Age	13-17 Years	38.6	31.9 to 45.8	254
1996	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2013	Age	13-17 Years	32.6	24.7 to 41.6	174
1997	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2014	Age	13-17 Years	46.5	38.5 to 54.7	208
1998	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2012	Age	13-17 Years	16.9	10.8 to 25.4	165
1999	HPV	≥3 Doses, Females	States/Local Areas	IL-Rest of state	2010	Age	13-17 Years	25.3	19.0 to 32.9	187
2000	Varicella	History of disease	HHS Regions/National	Region 8	2008	Age	13-17 Years	65.7	61.9 to 69.3	1854
2001	Varicella	History of disease	HHS Regions/National	Region 8	2014	Age	13-17 Years	25.4	22.6 to 28.5	2290
2002	Varicella	History of disease	HHS Regions/National	Region 8	2009	Age	13-17 Years	59.7	56.3 to 63.0	1974
2003	Varicella	History of disease	HHS Regions/National	Region 8	2006	Age	13-17 Years	75.3	63.3 to 84.4	118
2004	Varicella	History of disease	HHS Regions/National	Region 8	2011	Age	13-17 Years	43.6	39.6 to 47.6	2242
2005	Varicella	History of disease	HHS Regions/National	Region 8	2010	Age	13-17 Years	48.6	45.1 to 52.1	1890
2006	Varicella	History of disease	HHS Regions/National	Region 8	2013	Age	13-17 Years	28.6	25.7 to 31.7	1913
2007	Varicella	History of disease	HHS Regions/National	Region 8	2012	Age	13-17 Years	33.9	30.0 to 38.1	1936
2008	Varicella	History of disease	HHS Regions/National	Region 8	2018	Age	13-17 Years	11.9	9.4 to 14.8	1746
2009	Varicella	History of disease	HHS Regions/National	Region 8	2007	Age	13-17 Years	67.7	54.8 to 78.3	112
2010	Varicella	History of disease	HHS Regions/National	Region 8	2016	Age	13-17 Years	15.7	13.4 to 18.4	2022
2011	Varicella	History of disease	HHS Regions/National	Region 8	2015	Age	13-17 Years	20.3	17.8 to 23.2	2120
2012	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2018	Age	13-15 Years	50.1	42.5 to 57.7	520
2013	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2020	Age	13-15 Years	60.0	53.0 to 66.6	576
2014	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2019	Age	13-15 Years	58.4	50.7 to 65.7	507
2015	Varicella	History of disease	HHS Regions/National	Region 8	2017	Age	13-17 Years	14.1	11.7 to 16.7	2108
2016	Varicella	History of disease	HHS Regions/National	Region 8	2022	Age	13-17 Years	7.5	5.7 to 9.7	1736
2017	Varicella	History of disease	HHS Regions/National	Region 8	2021	Age	13-17 Years	9.2	7.0 to 12.1	1789
2018	Varicella	History of disease	HHS Regions/National	Region 8	2019	Age	13-17 Years	10.6	8.2 to 13.7	1845
2019	Varicella	History of disease	HHS Regions/National	Region 8	2020	Age	13-17 Years	9.4	7.4 to 11.9	2007
2020	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2021	Age	13-17 Years	65.0	59.7 to 70.0	949
2021	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2016	Age	13-17 Years	33.5	28.6 to 38.7	1069
2022	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 8	2020	Age	13-15 Years	55.8	50.9 to 60.5	1211
2023	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 8	2021	Age	13-15 Years	60.4	55.3 to 65.4	1112
2024	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2022	Age	13-17 Years	58.3	53.3 to 63.2	902
2025	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 8	2019	Age	13-15 Years	54.6	49.1 to 59.9	1129
2026	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2020	Age	13-15 Years	51.9	45.2 to 58.5	635
2027	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2019	Age	13-15 Years	51.1	43.5 to 58.6	622
2028	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 8	2022	Age	13-15 Years	60.3	55.6 to 64.8	1085
2029	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2020	Age	13-17 Years	54.2	49.0 to 59.3	1050
2030	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2019	Age	13-17 Years	51.7	45.8 to 57.5	1005
2031	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2017	Age	13-17 Years	45.0	40.2 to 49.9	1126
2032	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2018	Age	13-17 Years	52.3	46.8 to 57.7	901
2033	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2020	Age	13-17 Years	62.6	57.3 to 67.6	957
2034	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2022	Age	13-15 Years	55.5	49.1 to 61.8	584
2035	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2021	Age	13-15 Years	58.7	51.6 to 65.5	585
2036	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2022	Age	13-17 Years	65.5	60.3 to 70.4	834
2037	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2021	Age	13-17 Years	65.0	59.2 to 70.3	840
2038	HPV	Up-to-Date, Males	HHS Regions/National	Region 8	2018	Age	13-15 Years	51.8	44.6 to 59.0	538
2039	HPV	Up-to-Date, Females	HHS Regions/National	Region 8	2016	Age	13-17 Years	48.1	42.6 to 53.7	953
2040	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2018	Age	13-15 Years	48.6	42.0 to 55.3	345
2041	Varicella	History of disease	HHS Regions/National	Region 7	2020	Age	13-17 Years	10.3	8.3 to 12.6	1446
2042	Varicella	History of disease	HHS Regions/National	Region 7	2019	Age	13-17 Years	9.8	7.8 to 12.2	1256
2043	Varicella	History of disease	HHS Regions/National	Region 7	2021	Age	13-17 Years	7.1	5.4 to 9.4	1154
2044	Varicella	History of disease	HHS Regions/National	Region 7	2022	Age	13-17 Years	6.4	4.8 to 8.5	1048
2045	Varicella	History of disease	HHS Regions/National	Region 7	2017	Age	13-17 Years	14.2	12.0 to 16.6	1340
2046	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2019	Age	13-15 Years	58.2	51.4 to 64.7	386
2047	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2020	Age	13-15 Years	54.1	47.4 to 60.8	407
2048	Varicella	History of disease	HHS Regions/National	Region 7	2015	Age	13-17 Years	19.9	17.1 to 23.1	1451
2049	Varicella	History of disease	HHS Regions/National	Region 7	2016	Age	13-17 Years	18.3	15.9 to 21.0	1394
2050	Varicella	History of disease	HHS Regions/National	Region 7	2007	Age	13-17 Years	77.5	68.4 to 84.6	165
2051	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	43.7	38.8 to 48.7	664
2052	Varicella	History of disease	HHS Regions/National	Region 7	2012	Age	13-17 Years	38.3	34.4 to 42.4	1285
2053	Varicella	History of disease	HHS Regions/National	Region 7	2013	Age	13-17 Years	31.2	27.8 to 34.8	1251
2054	Varicella	History of disease	HHS Regions/National	Region 7	2010	Age	13-17 Years	50.1	46.8 to 53.3	1291
2055	Varicella	History of disease	HHS Regions/National	Region 7	2011	Age	13-17 Years	46.4	42.8 to 50.0	1528
2056	Varicella	History of disease	HHS Regions/National	Region 7	2009	Age	13-17 Years	62.9	59.6 to 66.0	1250
2057	Varicella	History of disease	HHS Regions/National	Region 7	2006	Age	13-17 Years	74.6	65.6 to 82.0	165
2058	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2007	Age	13-17 Years	34.5	26.3 to 43.6	165
2059	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	47.6	44.0 to 51.2	1191
2060	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	44.2	40.9 to 47.6	1340
2061	Varicella	History of disease	HHS Regions/National	Region 7	2018	Age	13-17 Years	13.3	10.9 to 16.1	1191
2062	Varicella	History of disease	HHS Regions/National	Region 7	2014	Age	13-17 Years	27.1	23.9 to 30.5	1362
2063	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2012	Age	13-17 Years	85.8	82.9 to 88.3	1285
2064	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2013	Age	13-17 Years	82.4	79.3 to 85.1	1251
2065	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2014	Age	13-17 Years	82.1	79.1 to 84.8	1362
2066	Varicella	History of disease	HHS Regions/National	Region 7	2008	Age	13-17 Years	67.5	64.1 to 70.7	1295
2067	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2006	Age	13-17 Years	13.7	8.8 to 20.7	165
2068	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2016	Age	13-17 Years	39.3	36.0 to 42.8	1394
2069	≥2 Doses MMR		HHS Regions/National	Region 7	2007	Age	13-17 Years	85.1	76.5 to 91.0	165
2070	≥2 Doses MMR		HHS Regions/National	Region 7	2006	Age	13-17 Years	87.1	80.2 to 91.8	165
2071	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2010	Age	13-17 Years	68.5	65.2 to 71.6	1291
2072	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2009	Age	13-17 Years	59.9	56.6 to 63.2	1250
2073	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2011	Age	13-17 Years	78.7	75.6 to 81.5	1528
2074	≥2 Doses MMR		HHS Regions/National	Region 7	2008	Age	13-17 Years	85.3	82.5 to 87.6	1295
2075	≥2 Doses MMR		HHS Regions/National	Region 7	2009	Age	13-17 Years	86.6	83.9 to 88.9	1250
2076	≥2 Doses MMR		HHS Regions/National	Region 7	2010	Age	13-17 Years	88.3	85.9 to 90.3	1291
2077	≥2 Doses MMR		HHS Regions/National	Region 7	2011	Age	13-17 Years	87.5	84.4 to 90.0	1528
2078	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2008	Age	13-17 Years	44.3	40.9 to 47.7	1295
2079	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2022	Age	13-15 Years	90.3	86.9 to 93.0	654
2080	HPV	≥2 Doses, Males	HHS Regions/National	Region 7	2019	Age	13-17 Years	57.6	52.2 to 62.9	648
2081	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2021	Age	13-17 Years	62.2	58.3 to 66.0	1154
2082	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	64.2	60.3 to 67.9	1048
2083	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	55.6	51.7 to 59.5	1256
2084	Tetanus	≥1 Dose Tdap	HHS Regions/National	Region 7	2015	Age	13-17 Years	86.3	83.5 to 88.6	1451
2085	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2020	Age	13-17 Years	56.6	53.0 to 60.1	1446
2086	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2017	Age	13-17 Years	50.5	45.6 to 55.4	624
2087	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2018	Age	13-15 Years	41.8	35.7 to 48.3	381
2088	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2021	Age	13-17 Years	66.2	60.5 to 71.4	535
2089	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2022	Age	13-17 Years	64.7	59.2 to 69.9	503
2090	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2021	Age	13-15 Years	66.1	59.0 to 72.5	333
2091	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2022	Age	13-15 Years	60.4	53.4 to 66.9	326
2092	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2022	Age	13-15 Years	61.4	56.4 to 66.1	654
2093	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2021	Age	13-15 Years	53.8	46.8 to 60.5	382
2094	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2022	Age	13-15 Years	62.5	55.4 to 69.1	328
2095	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2019	Age	13-15 Years	51.1	44.3 to 58.0	413
2096	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2020	Age	13-15 Years	50.2	44.1 to 56.3	487
2097	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2021	Age	13-17 Years	58.5	53.0 to 63.7	619
2098	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2019	Age	13-15 Years	54.7	49.8 to 59.5	799
2099	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2022	Age	13-17 Years	63.6	58.0 to 68.9	545
2100	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2021	Age	13-15 Years	59.9	54.9 to 64.7	715
2101	HPV	Up-to-Date, Males and Females	HHS Regions/National	Region 7	2020	Age	13-15 Years	52.1	47.5 to 56.6	894
2102	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2018	Age	13-17 Years	42.5	37.7 to 47.5	643
2103	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2017	Age	13-17 Years	38.2	33.7 to 42.9	716
2104	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2019	Age	13-17 Years	55.8	50.4 to 61.1	648
2105	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2020	Age	13-17 Years	53.7	48.9 to 58.5	795
2106	HPV	Up-to-Date, Males	HHS Regions/National	Region 7	2016	Age	13-17 Years	35.2	30.6 to 40.0	730
2107	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2020	Age	13-17 Years	59.7	54.4 to 64.8	651
2108	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2018	Age	13-17 Years	52.9	47.7 to 58.1	548
2109	HPV	Up-to-Date, Females	HHS Regions/National	Region 7	2019	Age	13-17 Years	55.5	49.9 to 61.0	608
2110	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Philadelphia	2022	Age	13-17 Years	76.6	69.2 to 82.7	267
2111	HPV	≥2 Doses, Males	States/Local Areas	PA-Philadelphia	2022	Age	13-17 Years	76.1	66.2 to 83.8	151
2112	HPV	≥2 Doses, Females	States/Local Areas	PA-Philadelphia	2022	Age	13-17 Years	77.2	65.5 to 85.8	116
2113	HPV	≥1 Dose, Males	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	92.3	87.6 to 95.3	240
2114	HPV	Up-to-Date, Females	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	76.1	68.0 to 82.8	227
2115	HPV	Up-to-Date, Males	States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	76.3	67.3 to 83.4	142
2116	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	95.1	91.0 to 97.4	266
2117	HPV	Up-to-Date, Females	States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	68.2	56.8 to 77.8	135
2118	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	72.4	65.2 to 78.6	277
2119	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	94.2	90.3 to 96.5	277
2120	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2023	Age	13-15 Years	94.4	90.4 to 96.8	277
2121	≥2 Doses Hep A		States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	93.3	89.5 to 95.8	467
2122	Varicella	History of disease	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	2.9	1.6 to 5.3	467
2123	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	95.7	93.1 to 97.3	452
2124	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	95.8	93.3 to 97.4	467
2125	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	97.7	96.1 to 98.6	452
2126	HPV	Up-to-Date, Males	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	80.1	73.5 to 85.3	240
2127	≥2 Doses MMR		States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	97.4	95.8 to 98.3	467
2128	≥3 Doses HepB		States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	93.1	89.3 to 95.6	467
2129	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	78.1	73.0 to 82.5	467
2130	HPV	≥1 Dose, Females	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	88.6	81.3 to 93.3	227
2131	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	90.5	86.4 to 93.4	467
2132	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	95.5	92.9 to 97.2	467
2133	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	94.2	91.2 to 96.2	467
2134	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2023	Age	13-17 Years	93.8	90.8 to 95.8	467
2135	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Urbanicity	Living In a MSA Principal City	91.1	88.9 to 92.8	1339
2136	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	White, Non-Hispanic	76.1	70.5 to 80.9	394
2137	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	96.4	91.9 to 98.4	165
2138	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Hispanic	88.0	81.9 to 92.2	290
2139	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	90.0	83.5 to 94.1	165
2140	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Black, Non-Hispanic	76.6	72.0 to 80.7	490
2141	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	72.7	63.2 to 80.5	165
2142	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Hispanic	70.4	63.0 to 76.8	290
2143	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Black, Non-Hispanic	92.2	88.7 to 94.6	490
2144	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	White, Non-Hispanic	93.2	89.4 to 95.7	394
2145	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	White, Non-Hispanic	91.1	86.7 to 94.1	394
2146	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Black, Non-Hispanic	90.4	86.8 to 93.1	490
2147	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Hispanic	93.8	89.1 to 96.5	290
2148	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	93.4	87.8 to 96.5	165
2149	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Hispanic	91.4	86.2 to 94.8	290
2150	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	White, Non-Hispanic	87.3	82.8 to 90.7	394
2151	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Race and Ethnicity	Black, Non-Hispanic	89.1	85.3 to 92.0	490
2152	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Living At or Above Poverty Level	88.5	85.6 to 90.9	916
2153	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Below Poverty Level	89.3	84.7 to 92.7	361
2154	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Below Poverty Level	93.8	90.1 to 96.1	361
2155	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Living At or Above Poverty Level	92.9	90.2 to 94.9	916
2156	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Below Poverty Level	74.6	68.7 to 79.7	361
2157	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Living At or Above Poverty Level	75.6	71.8 to 79.0	916
2158	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Below Poverty Level	91.7	87.7 to 94.5	361
2159	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Any Medicaid	92.1	88.9 to 94.5	606
2160	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Poverty	Living At or Above Poverty Level	91.4	88.7 to 93.5	916
2161	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Private Insurance Only	93.7	90.2 to 95.9	532
2162	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Private Insurance Only	88.6	84.4 to 91.7	532
2163	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Any Medicaid	87.8	84.1 to 90.8	606
2164	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Other	96.5	92.6 to 98.3	143
2165	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Uninsured	93.8	86.9 to 97.2	58
2166	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Other	89.8	83.4 to 93.9	143
2167	≥1 Dose MenACWY		States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Uninsured	92.7	77.9 to 97.9	58
2168	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Private Insurance Only	78.8	74.1 to 83.0	532
2169	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Any Medicaid	73.1	68.4 to 77.3	606
2170	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Other	81.2	72.9 to 87.4	143
2171	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Uninsured	46.7	31.1 to 63.0	58
2172	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Private Insurance Only	89.9	86.0 to 92.8	532
2173	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Any Medicaid	90.4	87.1 to 92.9	606
2174	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Uninsured	97.3	90.9 to 99.3	58
2175	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Philadelphia	2018-2022	Insurance Coverage	Other	95.2	87.5 to 98.2	143
2176	Varicella	History of disease	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	7.6	5.0 to 11.4	485
2177	Varicella	History of disease	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	5.5	3.4 to 8.6	599
2178	Varicella	History of disease	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	9.1	5.9 to 13.9	502
2179	Varicella	History of disease	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	7.1	4.2 to 11.7	492
2180	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2018	Age	13-15 Years	64.6	52.0 to 75.4	119
2181	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	52.9	40.9 to 64.6	156
2182	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	53.3	42.0 to 64.3	150
2183	Varicella	History of disease	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	23.7	18.8 to 29.5	393
2184	Varicella	History of disease	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	22.9	17.8 to 28.8	444
2185	Varicella	History of disease	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	35.7	30.2 to 41.5	371
2186	Varicella	History of disease	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	27.3	22.3 to 32.9	493
2187	Varicella	History of disease	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	16.1	12.2 to 21.0	442
2188	Varicella	History of disease	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	42.2	35.3 to 49.4	255
2189	Varicella	History of disease	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	8.5	5.0 to 14.0	412
2190	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	91.7	86.5 to 94.9	346
2191	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	92.8	86.2 to 96.4	280
2192	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	98.1	95.6 to 99.2	382
2193	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	97.7	95.0 to 98.9	466
2194	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	98.6	96.4 to 99.5	439
2195	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	97.0	93.7 to 98.6	466
2196	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	96.0	92.7 to 97.9	382
2197	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	92.0	88.2 to 94.7	571
2198	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	94.5	90.4 to 97.0	466
2199	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	96.7	94.1 to 98.1	466
2200	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	93.5	90.1 to 95.8	526
2201	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	93.8	90.2 to 96.2	492
2202	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	95.5	92.3 to 97.4	489
2203	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	97.8	94.3 to 99.2	303
2204	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	93.8	89.3 to 96.5	371
2205	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	96.1	92.2 to 98.1	255
2206	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2022	Age	13-15 Years	94.1	89.4 to 96.8	284
2207	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	95.9	91.1 to 98.1	238
2208	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	97.9	94.4 to 99.2	141
2209	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	48.2	39.9 to 56.5	179
2210	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	67.6	57.6 to 76.3	141
2211	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	98.1	95.8 to 99.2	357
2212	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	95.6	91.4 to 97.8	337
2213	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	81.0	74.6 to 86.1	238
2214	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	85.7	79.5 to 90.2	357
2215	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	90.4	84.4 to 94.3	303
2216	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	45.2	36.8 to 53.9	168
2217	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	52.4	41.6 to 62.9	114
2218	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	95.3	91.6 to 97.4	393
2219	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	93.9	89.7 to 96.5	493
2220	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	93.1	88.4 to 96.0	444
2221	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	94.8	91.1 to 97.0	442
2222	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	61.7	55.5 to 67.6	492
2223	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	63.0	55.1 to 70.2	270
2224	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	73.4	65.3 to 80.2	249
2225	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	54.9	46.8 to 62.8	286
2226	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	52.8	44.8 to 60.6	270
2227	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	42.7	34.3 to 51.5	224
2228	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	45.4	36.8 to 54.3	219
2229	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	18.8	13.1 to 26.2	222
2230	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	65.1	54.4 to 74.5	213
2231	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	77.3	70.6 to 82.8	322
2232	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	79.4	70.4 to 86.1	233
2233	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	55.4	49.6 to 61.0	526
2234	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	55.5	49.6 to 61.2	489
2235	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	74.2	66.1 to 80.9	223
2236	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	7.2	4.1 to 12.3	246
2237	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	75.6	68.3 to 81.6	277
2238	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	75.7	66.8 to 82.9	269
2239	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	91.6	87.4 to 94.5	452
2240	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	77.3	69.2 to 83.8	243
2241	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	56.6	49.0 to 63.8	412
2242	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	94.0	90.4 to 96.3	571
2243	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	97.1	94.8 to 98.4	452
2244	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	95.0	92.3 to 96.8	485
2245	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	92.2	88.6 to 94.8	599
2246	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	95.1	90.7 to 97.4	502
2247	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	74.5	65.0 to 82.1	199
2248	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	74.7	67.1 to 81.0	262
2249	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2014	Age	13-15 Years	97.3	93.9 to 98.8	265
2250	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2015	Age	13-15 Years	95.1	91.8 to 97.1	292
2251	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	69.9	62.1 to 76.7	240
2252	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	67.1	58.3 to 74.9	219
2253	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2016	Age	13-15 Years	93.6	89.0 to 96.3	312
2254	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	37.1	29.2 to 45.8	168
2255	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	94.4	91.3 to 96.4	492
2256	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	94.6	91.1 to 96.8	442
2257	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	95.3	92.4 to 97.2	526
2258	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	90.7	86.2 to 93.9	489
2259	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	62.3	56.6 to 67.6	526
2260	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	65.0	59.2 to 70.4	489
2261	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2012	Age	13-15 Years	88.5	82.1 to 92.8	242
2262	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2013	Age	13-15 Years	88.7	81.9 to 93.2	276
2263	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2017	Age	13-15 Years	94.2	89.7 to 96.8	297
2264	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018	Age	13-15 Years	94.6	90.1 to 97.2	240
2265	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	94.4	89.6 to 97.1	293
2266	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	43.5	33.3 to 54.3	114
2267	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	93.6	87.8 to 96.8	304
2268	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	47.9	39.4 to 56.5	175
2269	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	43.9	35.4 to 52.7	247
2270	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2009	Age	13-15 Years	66.8	57.3 to 75.1	157
2271	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2008	Age	13-15 Years	57.8	49.7 to 65.5	201
2272	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2011	Age	13-15 Years	83.2	75.7 to 88.7	294
2273	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2010	Age	13-15 Years	82.3	76.6 to 86.9	240
2274	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	50.0	40.9 to 59.0	171
2275	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	51.1	42.1 to 60.2	220
2276	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	82.3	76.7 to 86.8	337
2277	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	85.1	79.1 to 89.6	255
2278	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	92.3	86.8 to 95.6	412
2279	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	92.6	89.4 to 94.9	599
2280	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	69.7	62.6 to 76.0	412
2281	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	75.3	69.7 to 80.2	492
2282	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	91.4	87.2 to 94.3	393
2283	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	93.7	89.7 to 96.2	444
2284	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	84.5	79.0 to 88.8	371
2285	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	89.2	84.5 to 92.6	493
2286	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	97.2	94.6 to 98.5	502
2287	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	94.9	91.3 to 97.1	492
2288	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	76.4	71.6 to 80.7	599
2289	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	77.6	71.4 to 82.7	502
2290	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018	Age	13-15 Years	86.6	78.2 to 92.1	240
2291	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	55.7	46.6 to 64.4	223
2292	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	54.9	46.2 to 63.4	222
2293	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	62.6	54.4 to 70.1	240
2294	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	61.4	52.6 to 69.5	219
2295	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	74.5	69.0 to 79.2	485
2296	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	67.3	57.3 to 75.9	199
2297	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	64.4	55.5 to 72.4	243
2298	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	92.8	88.5 to 95.6	363
2299	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2013	Age	13-15 Years	86.9	80.1 to 91.7	276
2300	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2014	Age	13-15 Years	95.7	91.6 to 97.8	265
2301	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2015	Age	13-15 Years	93.0	88.8 to 95.7	292
2302	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2016	Age	13-15 Years	91.1	85.9 to 94.5	312
2303	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2017	Age	13-15 Years	90.9	84.9 to 94.7	297
2304	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2012	Age	13-15 Years	88.9	82.7 to 93.1	242
2305	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2011	Age	13-15 Years	82.8	75.7 to 88.2	294
2306	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2009	Age	13-15 Years	69.8	60.2 to 77.9	157
2307	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2010	Age	13-15 Years	80.0	73.3 to 85.3	240
2308	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	94.0	90.4 to 96.4	485
2309	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2008	Age	13-15 Years	55.6	47.6 to 63.3	201
2310	Varicella	History of disease	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	13.2	9.5 to 18.0	526
2311	Varicella	History of disease	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	11.0	8.0 to 14.9	492
2312	Varicella	History of disease	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	46.8	40.6 to 53.1	337
2313	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2022	Age	13-15 Years	66.8	59.8 to 73.2	302
2314	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	42.5	32.4 to 53.3	213
2315	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	46.4	38.9 to 54.0	270
2316	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	66.3	56.7 to 74.8	233
2317	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	56.9	48.1 to 65.3	249
2318	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	55.6	47.4 to 63.6	240
2319	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2022	Age	13-15 Years	66.7	56.6 to 75.5	146
2320	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	68.2	58.5 to 76.5	166
2321	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	54.4	45.6 to 62.9	219
2322	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	68.5	61.5 to 74.8	322
2323	Varicella	History of disease	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	9.6	6.6 to 13.8	489
2324	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	42.1	34.5 to 50.2	286
2325	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	55.1	46.4 to 63.5	304
2326	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	65.3	58.6 to 71.4	363
2327	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	65.4	57.7 to 72.4	262
2328	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	53.7	45.5 to 61.6	293
2329	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	61.6	51.4 to 70.9	199
2330	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	58.9	50.0 to 67.3	243
2331	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	65.6	56.4 to 73.8	269
2332	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	65.9	57.6 to 73.3	223
2333	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	67.5	59.9 to 74.3	277
2334	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2018	Age	13-15 Years	36.4	24.5 to 50.3	121
2335	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	46.5	38.7 to 54.5	270
2336	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	48.5	40.5 to 56.5	286
2337	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	49.8	42.2 to 57.5	270
2338	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	46.4	36.0 to 57.2	213
2339	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	11.4	7.1 to 17.8	222
2340	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	34.1	26.4 to 42.8	219
2341	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	25.7	18.8 to 34.1	224
2342	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	57.3	44.8 to 69.0	148
2343	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	54.0	42.4 to 65.2	143
2344	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	91.3	87.0 to 94.3	363
2345	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2020	Age	13-15 Years	94.3	89.1 to 97.1	304
2346	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	92.6	87.3 to 95.8	293
2347	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2022	Age	13-15 Years	67.0	56.9 to 75.7	156
2348	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2021	Age	13-15 Years	62.1	52.9 to 70.6	197
2349	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Other	84.3	73.5 to 91.3	162
2350	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Uninsured	87.7	65.7 to 96.4	35
2351	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Any Medicaid	92.5	89.2 to 94.9	607
2352	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Private Insurance Only	94.6	92.8 to 96.0	1686
2353	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Other	52.6	41.8 to 63.3	162
2354	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Any Medicaid	64.8	59.5 to 69.7	607
2355	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Private Insurance Only	62.6	59.2 to 65.9	1686
2356	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Uninsured	87.7	65.7 to 96.4	35
2357	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Other	65.8	54.8 to 75.4	162
2358	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Uninsured	58.6	35.4 to 78.5	35
2359	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Other	89.2	80.7 to 94.2	162
2360	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Any Medicaid	77.9	73.3 to 82.0	607
2361	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Private Insurance Only	74.7	71.5 to 77.6	1686
2362	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Private Insurance Only	95.2	93.6 to 96.4	1686
2363	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Living At or Above Poverty Level	94.0	92.4 to 95.3	2180
2364	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Insurance Coverage	Any Medicaid	94.4	91.6 to 96.3	607
2365	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Below Poverty Level	88.0	81.5 to 92.4	219
2366	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Living At or Above Poverty Level	60.3	57.3 to 63.2	2180
2367	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Below Poverty Level	68.4	59.8 to 75.9	219
2368	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Poverty	Living At or Above Poverty Level	94.4	92.8 to 95.6	2180
2369	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Poverty	Below Poverty Level	92.4	87.0 to 95.7	219
2370	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Below Poverty Level	85.6	79.0 to 90.4	219
2371	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Poverty	Living At or Above Poverty Level	72.5	69.7 to 75.2	2180
2372	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Black, Non-Hispanic	75.6	65.4 to 83.5	177
2373	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	White, Non-Hispanic	73.7	70.6 to 76.5	1814
2374	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Hispanic	93.3	87.5 to 96.5	244
2375	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	88.9	81.1 to 93.8	255
2376	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Hispanic	94.2	87.8 to 97.3	244
2377	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Black, Non-Hispanic	85.2	75.4 to 91.5	177
2378	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	White, Non-Hispanic	94.4	92.7 to 95.8	1814
2379	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	White, Non-Hispanic	95.6	94.2 to 96.7	1814
2380	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Black, Non-Hispanic	92.1	86.3 to 95.5	177
2381	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Hispanic	66.3	57.5 to 74.1	244
2382	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	60.1	51.0 to 68.5	255
2383	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Black, Non-Hispanic	64.6	54.0 to 73.9	177
2384	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	74.4	65.7 to 81.5	255
2385	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Hispanic	81.3	74.2 to 86.8	244
2386	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	Other or Multiple Races, Non-Hispanic	87.1	79.4 to 92.2	255
2387	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018-2022	Race and Ethnicity	White, Non-Hispanic	61.2	57.9 to 64.4	1814
2388	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Urbanicity	Living In a MSA Principal City	94.6	89.2 to 97.4	267
2389	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2018-2022	Urbanicity	Living In a MSA Non-Principal City	93.3	91.5 to 94.7	2130
2390	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	89.1	83.0 to 93.2	319
2391	Tetanus	≥1 Dose Td or Tdap	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	89.4	83.2 to 93.5	319
2392	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	91.7	86.1 to 95.2	319
2393	HPV	≥1 Dose, Males and Females	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	75.9	68.8 to 81.8	319
2394	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	76.1	66.0 to 83.9	149
2395	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	63.9	56.1 to 71.0	319
2396	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	89.6	83.5 to 93.7	319
2397	≥2 Doses MMR		States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	92.7	87.3 to 95.9	319
2398	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	62.2	51.1 to 72.2	170
2399	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	93.9	88.4 to 96.9	304
2400	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	91.2	85.7 to 94.8	319
2401	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	90.9	85.2 to 94.5	304
2402	≥2 Doses Hep A		States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	83.5	76.7 to 88.6	319
2403	≥1 Dose MenACWY		States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	92.1	84.5 to 96.2	188
2404	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	89.2	80.6 to 94.3	188
2405	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	63.1	52.7 to 72.3	188
2406	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	63.7	49.2 to 76.0	88
2407	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	92.1	84.8 to 96.0	180
2408	HPV	Up-to-Date, Males	States/Local Areas	PA-Rest of state	2023	Age	13-15 Years	62.5	47.6 to 75.3	100
2409	HPV	Up-to-Date, Females	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	65.7	54.7 to 75.2	149
2410	HPV	≥1 Dose, Males	States/Local Areas	PA-Rest of state	2023	Age	13-17 Years	75.7	65.2 to 83.9	170
2411	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	67.7	60.0 to 74.5	262
2412	HPV	≥2 Doses, Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	67.1	58.8 to 74.4	223
2413	HPV	≥2 Doses, Males and Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	67.4	61.8 to 72.5	485
2414	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2013	Age	13-15 Years	15.5	9.1 to 25.3	149
2415	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	24.9	18.2 to 33.0	219
2416	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	37.7	30.2 to 45.7	270
2417	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	15.4	10.1 to 22.6	224
2418	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	94.5	89.2 to 97.3	179
2419	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	95.0	91.8 to 97.0	489
2420	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	93.0	89.5 to 95.4	526
2421	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	96.3	93.3 to 98.0	412
2422	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	96.9	94.5 to 98.3	492
2423	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	92.3	87.8 to 95.3	492
2424	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	72.4	66.5 to 77.6	337
2425	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	92.2	88.3 to 94.9	485
2426	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	92.5	88.9 to 95.0	599
2427	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	95.0	91.3 to 97.2	502
2428	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	87.8	83.4 to 91.1	371
2429	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	81.3	74.6 to 86.5	255
2430	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2019	Age	13-15 Years	96.7	92.7 to 98.5	280
2431	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2018	Age	13-15 Years	96.2	92.2 to 98.2	228
2432	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2014	Age	13-15 Years	93.9	87.0 to 97.3	232
2433	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2015	Age	13-15 Years	93.2	87.2 to 96.4	263
2434	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	55.0	45.9 to 63.8	171
2435	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	57.0	47.9 to 65.8	220
2436	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	60.0	51.2 to 68.2	222
2437	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	65.1	56.3 to 72.9	223
2438	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2016	Age	13-15 Years	94.0	89.7 to 96.6	288
2439	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2017	Age	13-15 Years	96.1	92.0 to 98.1	273
2440	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	92.7	87.9 to 95.7	393
2441	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	89.6	84.9 to 92.9	493
2442	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	94.0	90.2 to 96.4	444
2443	Varicella	≥2 Doses or history of disease	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	95.6	92.0 to 97.6	442
2444	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	91.9	87.9 to 94.6	469
2445	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	91.4	86.3 to 94.7	431
2446	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	92.2	87.4 to 95.3	354
2447	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	94.8	90.6 to 97.2	371
2448	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	48.8	40.0 to 57.6	247
2449	HPV	≥1 Dose, Females	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	51.1	42.5 to 59.6	175
2450	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	94.5	91.0 to 96.7	439
2451	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2012	Age	13-15 Years	93.1	87.9 to 96.2	193
2452	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2013	Age	13-15 Years	92.5	86.0 to 96.1	233
2453	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2011	Age	13-15 Years	86.9	78.5 to 92.4	232
2454	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2010	Age	13-15 Years	83.7	76.7 to 89.0	175
2455	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2008	Age	13-15 Years	51.1	41.2 to 61.0	128
2456	Varicella	≥2 Doses with no disease history	States/Local Areas	PA-Rest of state	2009	Age	13-15 Years	65.3	53.0 to 75.9	102
2457	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	96.8	94.3 to 98.3	469
2458	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	97.7	93.7 to 99.2	431
2459	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	97.1	91.9 to 99.0	354
2460	Varicella	≥1 Dose with no disease history	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	99.5	98.6 to 99.8	371
2461	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	97.9	95.5 to 99.1	412
2462	≥3 Doses HepB		States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	94.7	90.7 to 97.0	492
2463	≥2 Doses Hep A		States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	85.3	79.7 to 89.5	502
2464	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	43.6	34.7 to 52.9	171
2465	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	39.9	31.7 to 48.8	247
2466	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	44.7	35.9 to 53.9	220
2467	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	46.7	37.9 to 55.8	223
2468	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2014	Age	13-15 Years	19.1	11.7 to 29.6	133
2469	HPV	≥3 Doses, Males	States/Local Areas	PA-Rest of state	2015	Age	13-15 Years	35.9	26.4 to 46.5	164
2470	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	26.5	19.5 to 34.9	168
2471	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	39.1	29.2 to 49.9	114
2472	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	42.2	33.9 to 50.9	175
2473	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	46.4	37.9 to 55.1	222
2474	≥2 Doses Hep A		States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	86.2	81.9 to 89.6	599
2475	≥2 Doses Hep A		States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	86.7	82.2 to 90.2	485
2476	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2017	Age	13-17 Years	50.3	44.5 to 56.0	489
2477	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2018	Age	13-17 Years	51.8	44.3 to 59.2	412
2478	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2012	Age	13-17 Years	88.6	84.2 to 91.9	393
2479	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2013	Age	13-17 Years	89.9	85.3 to 93.2	444
2480	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2014	Age	13-17 Years	93.4	89.7 to 95.8	442
2481	≥2 Doses MMR		States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	95.4	91.7 to 97.5	337
2482	≥2 Doses MMR		States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	94.3	89.5 to 97.0	255
2483	HPV	≥2 Doses, Males	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	59.2	50.4 to 67.5	249
2484	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2016	Age	13-17 Years	48.7	43.0 to 54.5	526
2485	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	81.0	75.7 to 85.4	493
2486	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	74.5	68.5 to 79.6	371
2487	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2009	Age	13-17 Years	68.3	61.1 to 74.7	255
2488	≥2 Doses MMR		States/Local Areas	PA-Rest of state	2010	Age	13-17 Years	97.0	94.6 to 98.4	371
2489	≥2 Doses MMR		States/Local Areas	PA-Rest of state	2011	Age	13-17 Years	93.5	88.9 to 96.3	493
2490	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2020	Age	13-17 Years	66.0	59.4 to 72.0	502
2491	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2019	Age	13-17 Years	57.9	51.6 to 63.9	492
2492	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2008	Age	13-17 Years	51.7	45.4 to 57.9	337
2493	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2022	Age	13-15 Years	93.2	87.8 to 96.3	302
2494	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2022	Age	13-17 Years	65.6	60.1 to 70.8	485
2495	HPV	Up-to-Date, Males and Females	States/Local Areas	PA-Rest of state	2021	Age	13-17 Years	68.0	62.9 to 72.7	599
2496	Tetanus	≥1 Dose Tdap	States/Local Areas	PA-Rest of state	2015	Age	13-17 Years	92.5	88.9 to 95.0	492
2497	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2008	Age	13-15 Years	30.6	21.1 to 42.2	101
2498	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2011	Age	13-15 Years	29.3	20.4 to 40.1	156
2499	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2010	Age	13-15 Years	39.6	29.5 to 50.6	115
2500	HPV	≥3 Doses, Females	States/Local Areas	PA-Rest of state	2009	Age	13-15 Years	26.7	17.1 to 39.3	68

The file is too large to be shown. View raw